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Abstract 
Background. An optimal diet is essential for adequate neurodevelopment. Behavior 
problems during adolescence are highly prevalent and result in adverse health outcomes in the 
short- and long-term. The role of middle childhood diet on adolescent behavior problems is 
uncertain.  
Objectives. We examined the associations of the following dietary exposures in middle 
childhood with externalizing and internalizing behavior problems in adolescence: 1) iron 
deficiency (ID) and anemia, 2) vitamin D deficiency (VDD) and vitamin D binding protein 
(DBP) concentrations, and 3) serum n-3 and n-6 polyunsaturated fatty acid (PUFA) 
concentrations. 
Methods. These studies take place in the context of the Bogota School Children Cohort 
(BoSCCo), a longitudinal investigation of nutrition and health in Bogota, Colombia. Three 
thousand two hundred and two schoolchildren, aged 5-12 y, were recruited into BoSCCo from 
primary public schools in February, 2006. Upon recruitment, parents completed a background 
survey on family sociodemographic information and the health habits of their child. Research 
assistants obtained a baseline fasting blood sample from 88% of the children. After a median 6 y, 
total externalizing and internalizing behavior problems and their subscales (aggressive behavior, 
rule breaking behavior, anxious/depressed, withdrawn/depressed, and somatic complaints) were 
assessed with use of the Youth Self Report in a random sample of approximately one-third of the 
cohort.  
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We assessed whether ID (ferritin <15 µg/L when C-reactive protein ≤10 mg/L), anemia 
(hemoglobin <12.7 g/dL) or blood concentrations of zinc, vitamins A and B-12, and erythrocyte 
folate in middle childhood were associated with behavior problems in adolescence in 1,042 
schoolchildren. The associations between middle childhood VDD (25-hydroxy vitamin D <50 
nmol/L) or low DBP concentration (<2497 nmol/L) and adolescent behavior problems were 
examined in 278 schoolchildren. Finally, we investigated the relations between PUFA 
concentrations in middle childhood and behavior problems in adolescence among 444 
schoolchildren. 
In bivariate analysis, behavior problems score distributions were compared across levels 
of potential confounding variables measured at baseline. Then, the continuous distributions of 
behavior problems scores were compared across categories of each of the nutritional exposures 
of interest. Mean differences in behavior problems scores were estimated by categories of 
nutritional exposures with the use of multivariable linear regression.  
Results. After controlling for potential confounding variables, ID, anemia, and low 
vitamin B-12 in middle childhood were each positively related to total externalizing problems 
scores among boys. In addition, ID was positively related to total internalizing problems scores 
among boys. Middle childhood VDD was positively associated with total externalizing problems 
scores while low DBP was positively related to aggressive behavior and anxious/depressed 
scores. Docosapentaenoic acid was inversely associated with total externalizing problems scores 
whereas docosahexaenoic acid was positively associated with this outcome. In addition, the Δ5-
desaturase enzyme activity index was inversely related to total externalizing problems scores. 
Alpha-linolenic acid was positively associated with total internalizing problems scores whereas 
adrenic acid was inversely related to this outcome.  
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Conclusions and significance. Nutrition in middle childhood was associated with 
behavior problems in adolescence. Adolescents with externalizing and internalizing problems are 
at high risk for psychiatric disorders in adulthood. In a country that has experienced over 50 
years of civil war, the long-term consequences of behavior problems may be of critical public 
health concern. These studies could provide a basis for the planning of nutritional intervention 
studies. 
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Chapter 1. Introduction 
Overview 
 Psychiatric disorders are the leading cause of years lived with disability worldwide (1). 
As life expectancy increases, the disease burden attributable to psychiatric disorders is expected 
to increase. Externalizing (e.g., conduct and attention deficit hyperactivity disorders) and 
internalizing disorders (e.g., depressive and anxiety disorders) alone account for 107 million 
years lived with disability / disability adjusted life years globally (1). In adolescence, the 
prevalence of externalizing or internalizing disorders is greater than 10% (2). An externalizing or 
internalizing disorder in adolescence can indicate onset of lifelong psychiatric disorders (3). 
These disorders lie at the extreme end of a spectrum of externalizing and internalizing behavior 
problems, which are also highly predictive of mental health disorders later in life (4). 
Prenatal and infant nutrition play a key role in the development of behavior problems 
throughout childhood (5). Specific nutrients in the prenatal or infancy period, including iron (6, 
7), vitamin D (8, 9), and polyunsaturated fatty acids (PUFA) (10-12), alter monoamine 
neurotransmitter metabolism or the formation of neuronal networks in the developing brain. 
Much less is known about the potential effects of diet in middle childhood (from approximately 
6 to 11 years of age). Middle childhood is a period of changes in functional activity in the central 
nervous system (13) that may be responsive to environmental exposures. Identifying modifiable 
factors that predict externalizing and internalizing problems in middle childhood could provide 
the basis for cost-effective school-based interventions.   
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Specific Aims 
This work aims to investigate the relation between nutrition in middle childhood and 
externalizing and internalizing problems in adolescence within the context of the Bogotá School 
Children Cohort, a prospective study of nutrition and health in Bogotá, Colombia.  
Aim 1. To examine the relations between iron deficiency (ID) and anemia in middle 
childhood and externalizing and internalizing problems in adolescence independent of other 
micronutrients that are relevant for neurodevelopment, such as zinc, vitamin A, folate, and 
vitamin B-12. A secondary aim is to assess the associations of middle childhood 
sociodemographic characteristics and health habits of children and their families with behavior 
problems in adolescence. 
Aim 2. To evaluate whether vitamin D serostatus in middle childhood is associated with 
externalizing and internalizing problems in adolescence. As an exploratory, hypothesis 
generating aim, I will examine the associations of vitamin D binding protein (DBP) 
concentrations in middle childhood with externalizing and internalizing problems in adolescence. 
Aim 3. To investigate the relations of serum concentrations of n-3 and n-6 
polyunsaturated fatty acids (PUFA) in middle childhood with externalizing and internalizing 
problems in adolescence. Since endogenous conversion of alpha-linolenic acid and linoleic acid 
into long-chain PUFA depends on desaturase enzyme activity, as an exploratory aim I will assess 
the associations of the Δ6-desaturase (D6D) and Δ5-desaturase (D5D) enzyme activity indices 
with adolescent behavior problems.  
This research will contribute new knowledge on the role of middle childhood diet on 
adolescent behavior problems.   
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Overview of Externalizing and Internalizing Problems 
Definition and Burden of Disease 
The central feature of externalizing problems is defiant, aggressive, or irregular behavior. 
Externalizing disorders typically include conduct and attention deficit hyperactivity disorder. On 
the other hand, internalizing problems are characterized by disordered mood or emotions and 
encompass depressive and anxiety disorders. The distributions of externalizing and internalizing 
disorders vary by age and sex. Externalizing disorders are often diagnosed in middle childhood 
whereas the prevalence of internalizing disorders increases in adolescence, especially among 
girls (2). Externalizing disorders are more prevalent in boys while the prevalence of internalizing 
disorders is higher in girls (14).  
Externalizing and internalizing problems in childhood or adolescence are predictive of 
adult psychiatric disorders (4) and substance use disorders (15). Internalizing problems in 
childhood are associated with having a major depressive episode, bipolar disorder, or dysthymia 
in adulthood whereas childhood externalizing problems are related to anxiety disorders in 
adulthood (4). In one study, the odds of having cannabis use disorder in young adulthood were 
2.6 times higher among adolescents with externalizing problems compared with adolescents 
without externalizing problems (15). Individuals with psychiatric disorders may find day-to-day 
tasks difficult to manage and some, including those with bipolar (16) and obsessive-compulsive 
disorder (17), can be constantly plagued by self-doubt. These disorders can negatively impact 
their relationships with friends and family as well. In addition to being caustic to an individual’s 
mental wellbeing and their close relations, these disorders are at higher risk of adverse physical 
and economic outcomes. For example, depressive disorders are positively related to 
cardiovascular disease (18), suicide (19), and increased health care costs (20).   
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The prevalence and burden of psychiatric disorders vary by country (1, 21). Culture, 
urbanicity, and economic and conflict status are each associated with the prevalence of 
psychiatric disorders in a country (21). Globally, exposure to war, revolution, or persecution in a 
country has been associated with a 60% higher prevalence of anxiety disorders on the country 
level compared with countries which were not exposed to such conflicts (21). Although high 
income countries have higher reported prevalence of psychiatric disorders, psychiatric disorders’ 
contribution to years lived with disability and disability adjusted life-years is increasing in low- 
and middle-income countries (1) which may not have the infrastructure or resources to treat these 
disorders adequately (22).  
Potential Biologic Mechanisms of Externalizing and Internalizing Problems 
Complex biologic mechanisms govern mood and behavior in individuals. Altered 
connectivity between the prefrontal cortex and the basal ganglia, areas of the brain responsible 
for decision making, memory formation, and emotion regulation, is associated with behavior 
problems (23). Prenatal environmental factors, including nutrition and environmental toxicants, 
influence dendritic arborization and synaptic connectivity (7, 10, 11, 24). The metabolism of the 
monoamine neurotransmitters dopamine and serotonin are also regulated by environmental 
factors such as iron, vitamin D, and pesticide exposure (8, 9, 25, 26). Among other functions, 
dopamine regulates higher order cognitive and emotional processes (27), while serotonin plays a 
key role in governing mood, sleep, and the stress response (28). Thus, alterations of these 
monoamine metabolisms may play a role in the development of behavior problems. 
Another relevant system is the hypothalamic-pituitary-adrenal (HPA) axis, a 
neuroendocrine system involved in the production, release, and regulation of cortisol, a 
glucocorticoid involved in the stress response. Altered cortisol levels can impair learning and 
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memory, reduce neurogenesis, and lead to cell apoptosis. In addition, high levels of cortisol 
reduce the mRNA expression and alter the binding function of the post-synaptic serotonergic 
receptors 5-HT1A in animal studies (29). These alteration in the serotonergic metabolism may 
further dysregulate the HPA axis function (29). Increased production of cortisol occurs in adults 
with major depressive disorders, however, it is unknown if this is a consequence or a cause of the 
disorder (30). In children, dysregulation of the HPA axis and higher cortisol levels have been 
associated with externalizing and internalizing problems (31). 
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Predictors of Externalizing and Internalizing Problems 
Genetic factors account for approximately 50-60% of the variation in externalizing and 
internalizing problems (32, 33). Environmental modifications also influence the development of 
behavior problems. During the prenatal and perinatal periods, maternal exposure to alcohol 
intake (34), nutritional deficiencies (35), heavy metals (36), and endocrine disruptors (37) affect 
fetal brain development and are associated with more behavior problems in children and 
adolescents. Studies of the relations between childhood exposures and behavior problems have 
focused on childhood habits, parenting strategies, and markers of socioeconomic status. For 
example, physical activity is associated with fewer behavior problems in youth in experimental 
studies (38). Time spent watching television or playing video games is related to more 
internalizing, hyperactivity, and inattention problems (39). Child maltreatment and parental 
substance use disorders are positively associated with childhood behavior problems (40, 41). By 
contrast, parenting styles that provide children with learning opportunities and cognitively 
stimulating experiences are associated with more self-confidence and positive affect in children 
(42). Indicators of low socioeconomic status, such as household food insecurity (43), lower 
family income and parental education (44), and neighborhood disadvantage (45), are associated 
with more externalizing and internalizing problems in children.  
The brain continues to develop into the third decade of life. Exposures that are 
hypothesized to affect brain development in the prenatal or infancy period may influence middle 
childhood brain maturation, depending on the particular aspects of central nervous system 
development that mature late. Most central nervous system development occurs before the age of 
2 y, however, many gains in higher-order cognitive abilities occur in middle childhood (46, 47). 
Metabolic rates for glucose are higher in children ages 3-16 years than in adults, indicating 
7 
 
greater energy metabolism in the brain during this period, possibly due to increased energy 
requirements for development of brain tissue (47). Both progressive (involving tissue growth) 
and regressive (involving tissue loss) alterations occur in the brain after birth (47). After age 4 y, 
higher order cortical regions like the prefrontal cortex and the temporal association areas 
experience the most alterations compared to other regions of the brain (13). Between the ages of 
4 and 18 y, hippocampal volume increases in girls while amygdala volume increases in boys (47, 
48). These areas of the brain are involved in complex decision making, personality 
determination, memory formation, and sensory processing (13). Nutrients hypothesized to affect 
brain development in the intrauterine period, including iron, vitamin D, and PUFA, may also 
influence middle childhood brain development. However, few studies have examined the 
associations of childhood nutrition with behavior problems.  
Iron is an essential nutrient with multiple functions in the circulatory, immune, and 
neurological systems. Although the most commonly recognized function of iron is enabling 
oxygen transport in erythrocytes, iron also plays a role in myelination, dendritic growth, 
synaptogenesis, and neurotransmitter metabolism in the central nervous system (49). Iron is a 
cofactor in tyrosine hydroxylase, an enzyme involved in the formation of the monoamine 
neurotransmitters dopamine, serotonin, and norepinephrine (49). In addition, prenatal iron may 
alter the metabolic pathways of the monoamine neurotransmitters, glutamate, and GABA (25, 
50, 51). For example, dopamine receptors are downregulated in the presence of ID in the 
striatum and nucleus accumbens (51). In animal experiments, animals who were iron deficient 
(ID) in utero exhibit less exploratory and more anxiety-related behaviors (52, 53). Prospective 
studies have found an association between chronic iron deficiency in infancy and behavior 
problems later in childhood (54-57). The prospective association between ID or anemia in 
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middle childhood and later behavior problems has not been investigated. Mechanisms governing 
a potential association between middle childhood ID and behavior are speculative. As with 
prenatal ID, middle childhood ID may alter the expression of brain-derived neurotrophic factor 
(BDNF) (58), which influences synaptic plasticity (59) and thus may be associated with 
psychiatric disorders (60). 
Vitamin D deficiency (VDD) in infancy or childhood may be related to emotional, 
cognitive, or developmental problems later in life. Although vitamin D is best known for its role 
in bone metabolism, in recent years the vitamin has been investigated as a neurosteroid (61). 
Vitamin D enhances the expression of tyrosine hydroxylase (62, 63), an enzyme involved in the 
formation of dopaminergic neurons and the function of dopamine, norepinephrine, and 
epinephrine, suggesting a role on behavior. In animal models, developmental VDD is associated 
with morphological alterations in the offspring’s brain stereology, including smaller lateral 
ventricles, smaller hippocampi, and larger striatum compared with controls (64). Animals with 
developmental VDD also exhibit behavioral alterations such as hyperlocomotion (65). In 
humans, the effects of prenatal VDD may be dependent on the timing of the deficiency. VDD in 
the first trimester of pregnancy is related to behavior problems in childhood (66, 67), whereas 
VDD in the latter half of pregnancy is not associated with these outcomes (68-71). Only one 
study has investigated the association of VDD in middle childhood with later behavior problems, 
higher vitamin D concentrations at 10 y were associated with more prosocial behavior 2 years 
later (72). The mechanisms by which VDD in middle childhood impact later behavior may differ 
from those in the prenatal period. In middle childhood, vitamin D enhances the expression of 
glial cell line-derived neurotrophic factor, which promotes the survival of dopaminergic neurons 
(73, 74).  
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Polyunsaturated fatty acids (PUFA), fatty acids that contain more than one double bond, 
have also been hypothesized to relate to behavior problems. There are two main groups of 
PUFA: omega-3 (n-3) and omega-6 (n-6). Their nomenclature depends on the location of double 
bonds; n-3 fatty acids (FA) have their first double bond on the third carbon, whereas n-6 FA have 
their first double bond on the sixth carbon. The n-3 and n-6 PUFA docosahexaenoic acid (22:6 n-
3, DHA), arachidonic acid (20:4 n-6, AA), and adrenic acid (22:4 n-6, AdA) concentrate in the 
brain during the third trimester of pregnancy. DHA continues to accumulate in the brain 
throughout childhood (75). Precursors to these PUFA, alpha-linolenic acid (18:3 n-3, ALA) and 
linoleic acid (18:2 n-6, LA), cannot be synthesized in humans and are therefore considered 
essential as they must be obtained in diet. These precursors are metabolized into longer chain n-3 
and n-6 PUFA through a series of elongation and desaturation reactions. However, this process is 
inefficient. Longer chain PUFA are also obtained in the diet. N-3 PUFA may influence 
behavioral outcomes through three primary pathways (76). First, PUFA that have accumulated in 
the brain are incorporated into the plasma membranes of neuronal and glial cells (77). The FA 
composition of the cell membrane influences membrane protein function and fluidity. Second, n-
3 PUFA are precursors of anti-inflammatory eicosanoids which may exhibit neuroprotective 
effects (76). Finally, n-3 PUFA may influence transcription factors regulating neuroinflammation 
(76). N-6 PUFA also promote and regulate neuroinflammation. However, n-6 PUFA metabolize 
into pro-inflammatory eicosanoids (78), which may dysregulate the HPA axis (79) and damage 
neurons (78). Longitudinal observational studies that examine the associations between maternal 
or infant PUFA and behavior problems in childhood have mixed results (80-86). No study of 
prenatal exposure extends into adolescence when many behavior problems develop. In short-
term supplementation trials of n-3 PUFA during adolescence, the supplemented group had 
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decreased aggression or disruptive behavior compared with the control group after 3-12 months 
(87, 88). No study has examined the association between middle childhood PUFA exposure and 
adolescent behavior problems after an extended follow-up. A potential mechanism of PUFA in 
middle childhood is that PUFA concentrations may influence synaptic plasticity through the 
regulation of long-term potentiation (89, 90).  
The previous lack of focus on middle childhood exposures points towards the need to 
improve understanding of how dietary factors influence behavior throughout the lifespan. As the 
majority of children are in schools during middle childhood, interventions at this time are 
relatively cost-effective and easy to implement. This question is especially salient within the 
context of Colombia, where the prevalence of childhood behavior problems may have increased 
(91) because of the more than 50-year civil war and resulting “culture of violence” that has 
developed in reaction to the unrest (92). Thus, studying modifiable determinants of behavior 
problems may be particularly important to public health in Colombia.   
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Summary of Chapters 
This dissertation contributes new knowledge on modifiable nutritional factors that predict 
adolescent behavior problems in middle childhood. Middle childhood is a period highly 
amenable to intervention and brain development continues in this period. However, predictors of 
later behavior problems are understudied.  
The following chapters of this dissertation describe the relations between middle 
childhood nutrition and self-reported adolescent externalizing and internalizing problems in a 
sample of schoolchildren from Bogotá, Colombia. Chapter 2 focuses on middle childhood iron 
deficiency and anemia as exposures. Chapter 2 also examines micronutrients related to 
neurodevelopment that may be associated with iron intake or anemia, including zinc, vitamin A, 
folate, and vitamin B-12. Chapter 3 evaluates the associations of middle childhood vitamin D 
serostatus and vitamin D binding protein with behavior problems. Chapter 4 examines n-3 and n-
6 PUFA as exposures. Finally, a summary of the dissertation’s main findings and public health 
importance are discussed in Chapter 5.  
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Chapter 2. Iron Deficiency, Anemia, and Low Vitamin B-12 Serostatus                                 
in Middle Childhood are Associated with Behavior Problems in Adolescent Boys 
Abstract 
Iron deficiency (ID) in infancy is related to subsequent behavior problems. The effects of 
micronutrient status in middle childhood are uncertain. The aim of the study was to examine the 
associations of micronutrient status biomarkers in middle childhood with externalizing and 
internalizing behavior problems in adolescence. We assessed whether ID (ferritin <15 µg/L when 
C-reactive protein ≤10 mg/L), anemia (hemoglobin <12.7 g/dL), or blood concentrations of zinc, 
vitamins A and B-12, and folate at ages 5-12 y were associated with externalizing or 
internalizing behavior problems in adolescence in 1,042 schoolchildren from Bogotá, Colombia. 
Behavior problems were assessed with the Youth Self Report questionnaire after a median 6.2 y 
of follow-up. Mean problem score differences with 95% confidence intervals (CI) were 
estimated between categories of micronutrient status biomarkers with use of multivariable linear 
regression. Mean ± standard deviation externalizing and internalizing problems scores were 52.6 
± 9.6 and 53.8 ± 9.9, respectively. Among boys, middle childhood ID, anemia, and low plasma 
vitamin B-12 were associated with 5.9 (95% CI: 1.0, 10.7), 6.6 (95% CI: 1.9, 11.3), and 2.7 
(95% CI: 0.4, 4.9) units higher mean externalizing problems scores in adolescence, respectively; 
after adjustment for baseline age, time spent watching television/playing video games, mother’s 
height, and socioeconomic status. Also in boys, ID was related to an adjusted 6.4 (95% CI: 1.2, 
11.6) units higher mean internalizing problems scores. There were no associations among girls. 
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Other micronutrient status biomarkers were not associated with behavior problems. ID, anemia, 
and low vitamin B-12 in middle childhood are related to behavior problems in adolescent boys. 
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Introduction 
Mental health problems affect 10-20% of children and adolescents worldwide (1) and are 
associated with adverse health outcomes in the short- and long-term (2). Among these problems, 
externalizing and internalizing behavior disorders, including conduct, attention-deficit 
hyperactivity, depressive, and anxiety disorders, pose a particularly hefty burden accounting for 
>100 million disability-adjusted life years globally (3). These disorders are at the extreme end of 
a spectrum of more subtle, yet also highly relevant, behavior problems that are predictive of 
impaired mental (4) and physical (5) health in adulthood.  
Nutrition plays an important role in the development of behavior from infancy through 
adolescence (6), but the effects of individual nutrients throughout the life cycle are not well 
characterized. Most research has focused on micronutrient status in infancy. For example, iron 
deficiency (ID) in infancy is associated with lower positive affect in infancy (7) and middle 
childhood (8), externalizing (9-11) and internalizing (9, 10, 12) behavior problems in 
adolescence, and lower self-rated emotional health in young adulthood (13). Nevertheless, the 
effects of exposure to iron or other micronutrient deficiencies later in childhood have not been 
studied in prospective investigations. Structural changes in areas of the brain that may be 
important in the development of behavior problems, including the basal ganglia, hippocampus, 
amygdala, and prefrontal cortex, occur throughout childhood (14). Rodent experiments indicate 
that exposure to gestational, perinatal, and post-weaning iron deficiency (15-17), post-weaning 
zinc (18) or vitamin A (19) deficiencies, low gestational vitamin B-12 (20), or gestational folate 
deficiency (21) can disrupt the normal development of these regions, but data in humans are 
scant. 
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The objective of this study was to investigate the associations between micronutrient 
status in middle childhood and externalizing and internalizing behavior problems in adolescence 
in a cohort of schoolchildren from Bogotá, Colombia. We hypothesized that low concentrations 
of micronutrient status biomarkers (ferritin, hemoglobin, zinc, vitamins A and B-12, and folate) 
in middle childhood would be related to increased externalizing and internalizing problems in 
adolescence. 
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Methods 
Study design and population  
We conducted a prospective study in the context of the Bogotá School Children Cohort, a 
longitudinal investigation of nutrition and health in Bogotá, Colombia. Details on the cohort 
design have been previously reported (22). Briefly, beginning in February 2006, we recruited 
3,202 randomly selected children aged 5-12 years (y) from primary public schools. A majority of 
children in the public school system in Bogotá are from low- and middle-income socioeconomic 
backgrounds. Therefore, our sample pertains to these groups.  
Baseline information 
At the time of enrollment we collected information on child, parental, and household 
characteristics with the use of a survey that was sent to the children’s homes. The questionnaire 
inquired about children’s background and habits, including the time usually spent watching 
television/playing video games or playing outdoors. The survey also included questions on 
parental age, marital status, and education level and on maternal parity, height, and weight. 
Household characteristics involved the local government’s socioeconomic status (SES) 
classification and the level of food insecurity according to a validated version of the United 
States Department of Agriculture Household Food Security Survey module (23).  
 During the weeks following enrollment, trained research assistants scheduled data and sample 
collection school visits, after contacting the primary caregivers requesting that the child fast 
overnight before the visit day. At these visits, height was measured without shoes to the nearest 1 
mm using a wall-mounted portable Seca 202 stadiometer (Seca, Hanover, MD) and weight was 
measured in light clothing to the nearest 0.1 kg using Tanita H5301 electronic scales (Tanita, 
Arlington Heights, IL). Height and weight were also measured among the children’s mothers 
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who were present at schools (37%). At the same visits, the research assistants obtained fasting 
blood samples through antecubital venipuncture in 88% of the children. Twelve percent of 
children were unwilling to provide a blood sample. One aliquot was collected in an EDTA-
coated tube and a second one in a metal-free polypropylene tube without anticoagulant for 
separation of serum. The samples were protected from sunlight and transported in refrigerated 
coolers on the day of collection to the Colombian National Institute of Health, where they were 
processed and cryostored for future analyses.  
Follow-up 
Between 2011-2015 we conducted an in-person follow-up assessment in a random 
sample of approximately one-third of cohort members (n = 1,139). Adolescents were assessed at 
school or home if absent from school. At this assessment, we ascertained child behavior with the 
use of the Spanish language version of the Youth Self Report (YSR) questionnaire (24), a widely 
used method to assess behavioral and emotional problems in adolescents. The YSR is a self-
administered questionnaire consisting of 112 statements addressing behaviors or feelings that 
children rate as false, sometimes true, or very/often true. From responses to these questions, an 
Assessment Data Manager (ADM) software (25) calculates continuous scores for 8 behavior 
problem subscales: aggressive behavior, rule breaking behavior, anxious/depressed, 
withdrawn/depressed, somatic complaints, attention problems, social problems, and thought 
problems. The sum of the aggressive and rule breaking behavior subscale scores constitute the 
total externalizing problems score, whereas the sum of anxious/depressed, withdrawn/depressed, 
and somatic complaints scores comprise the total internalizing problems score (26). The ADM 
software standardizes the scores by age and sex to a reference population derived from data 
collected periodically in United States national surveys (25). The YSR has been validated for use 
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in adolescents ages 11-18 y from English-speaking populations (27), has high reliability (24), 
and is generalizable to Spanish-speaking populations (28). It has been utilized in studies of 
Chilean (12), Costa Rican (9), and Puerto Rican (24) adolescents. A general questionnaire was 
also administered to primary care givers at the follow-up visit to update information on mother’s 
marital status, education, parity, and BMI, and household food security and socioeconomic 
status. 
The parents or primary caregivers of all children gave written informed consent prior to 
enrollment into the study and before the follow-up assessment. Children gave written assent to 
participate. The study protocol was approved by the Ethics Committee of the National University 
of Colombia Medical School. The Institutional Review Board at the University of Michigan 
approved the use of data from the study. 
Laboratory methods 
All analyses took place at the Colombian National Institute of Health. Plasma ferritin 
concentration was measured using a competitive chemiluminescent immunoassay in an ADVIA 
Centaur analyzer (BayerDiagnostics, Tarrytown, NY, USA). Serum C-reactive protein (CRP) 
level was measured using a turbidimetric immunoassay on an ACS180 analyzer (Bayer 
Diagnostics, Tarrytown, NY). Hemoglobin concentrations were determined by the 
hemiglobincyanide method. Serum zinc concentrations were determined using an atomic 
absorption technique (29) on a Shimadzu AA6300 spectrophotometer. Plasma retinol was 
measured with high performance liquid chromatography on a Waters 600 System. Plasma 
vitamin B-12 and erythrocyte folate were also quantified using a competitive chemiluminescent 
immunoassay in an ADVIA Centaur analyzer.  
Data analysis 
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The YSR was completed by 1,097 of the 1,139 cohort members who participated in the 
follow-up assessment; 13 forms could not be processed by the ADM software due to an excess of 
missing values. Forty-two children who were younger than 11 y or older than 18 y were 
excluded from the analysis, because the YSR was developed and validated for use in 11- to 18 
year-olds (30); thus, the final sample consisted of 1,042 children. The sample size had been 
calculated to provide >85% statistical power to detect differences in mean behavior scores >10% 
between extreme quartiles of exposure, assuming a type I error of 5% and mean ± SD scores of 
50.0 ± 10.0 in the unexposed. Power would be >95% to detect linear trends in multivariable 
analyses with as many as 10 covariates. Compared with cohort participants who were not 
included in the analysis (i.e., did not participate in the follow-up assessment, did not complete 
the YSR, or were not between the ages of 11-18 y), children in the analytic sample spent more 
time watching television/playing video games, had better educated mothers, were of higher SES, 
and the boys had lower prevalence of anemia at baseline (Table 1). They did not differ with 
regard to the distributions of other micronutrient status biomarkers. 
The primary outcomes of interest were the continuous distributions of total externalizing 
and internalizing problems scores. Secondary endpoints were the subscales of these composite 
scores: aggressive and rule breaking behavior for externalizing problems and anxious/depressed, 
withdrawn/depressed, and somatic complaints for internalizing problems. In supplemental 
analyses we considered attention, social, and thought problems subscales.  
We considered as exposures biomarkers for micronutrients that are relevant to 
neurobehavioral development. These included iron, zinc, vitamin A, vitamin B-12, and folate. ID 
was defined as plasma ferritin <15 µg/L (31). Thirteen children with serum CRP >10 mg/L were 
excluded from the analysis of ID. Anemia was defined as hemoglobin <12.7 g/dL after 
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adjustment for the altitude of Bogotá (32). Vitamin A status was categorized as deficient (plasma 
retinol <20 µg/dL), low (20 to <30 µg/dL), or adequate (≥30 µg/dL) (33). Serum zinc, plasma 
vitamin B-12, and erythrocyte folate were categorized into sex-specific quartiles since the 
prevalence of these micronutrient deficiencies according to conventional cut-points was low 
(<2%).  
Covariates included sociodemographic, anthropometric, and health-related characteristics 
measured at baseline. Children’s height- and body mass index (BMI)-for-age Z scores were 
calculated according to the World Health Organization (WHO) growth reference for children and 
adolescents (34). Maternal BMI was calculated as kg/m2 from objectively measured height and 
weight in 37% of mothers and from self-reported data in the rest. Correlations between 
objectively measured and reported values were 0.79 (P<0.0001) for height and 0.81 (P<0.0001) 
for BMI. Covariates were categorized as presented in Table 2. 
All analyses were conducted separately by sex. First, to identify independent predictors 
of the outcomes, we compared the distributions of total externalizing and internalizing problems 
scores across categories of baseline characteristics using means ± standard deviation (SD). Next, 
we examined the distributions of these outcomes by levels of micronutrient status indicators. For 
ordinal exposures in which levels have a hierarchical relation with each other, we conducted tests 
for linear trend by fitting linear regression models with the behavior problems scale as the 
outcome and a variable representing ordinal categories of each predictor as a continuous 
covariate. This is a conventional method to examine linearity of associations for nutritional 
exposures that are categorized into quantiles (35). For ID and anemia, we used the χ2 score 
statistic. In all models, an independent correlation matrix was used to account for clustering by 
sibship, since there were 107 siblings in the sample. Empirical estimates of the variance were 
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specified to overcome potential deviations from the multivariate normality assumption. We 
estimated mean adjusted differences and 95% confidence intervals (CI) for total externalizing or 
internalizing problems scores between categories of sociodemographic and nutritional predictors 
with the use of multivariable linear regression. In each model, adjustment variables included 
independent predictors of the outcome. Child’s age at baseline was included in all final models 
as it was considered important from a mechanistic viewpoint. Other covariates were retained in 
the final model when they remained statistically significant (P<0.05). We examined the 
associations of micronutrient status biomarkers with scores on each subscale following an 
analogous approach.  
To further understand if changes in sociodemographic factors from middle childhood 
through adolescence that could represent underlying changes in micronutrient status were related 
to the outcomes, we examined differences in total externalizing and internalizing problems by 
changes in maternal marital status, education, parity, and BMI, and household food security and 
socioeconomic status. 
All analyses were performed using the Statistical Analyses System version 9.4 (SAS 
Institute Inc.). 
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Results 
Mean ± SD age at enrollment was 8.5 ± 1.6 y; 56.1% of children were girls. Prevalence 
of ID, anemia, and vitamin A deficiency was 3.2%, 3.0%, and 14.8%, respectively. None of the 
anemic children had ID, 32.1% of the anemic children had vitamin A deficiency, and 14.3% of 
the non-anemic children had vitamin A deficiency. Among children with and without ID, the 
prevalence of vitamin A deficiency was 13.8% and 14.9%, respectively. Mean ± SD age at the 
time of follow-up assessment was 14.7 ± 1.7 y. Children were followed for a median of 6.2 y.  
Total externalizing problems. Mean ± SD total externalizing problems scores were 51.9 
± 9.6 in boys and 53.1 ± 9.6 in girls. In bivariate analysis, age at follow-up assessment and time 
spent watching television/playing video games at baseline were positively associated with total 
externalizing problems scores in boys and girls (Table 2). In girls, baseline age was positively 
related to total externalizing problems scores, whereas maternal height and low socioeconomic 
status were inversely associated with this outcome (Table 2). ID, anemia, and low vitamin B-12 
concentrations were each related to higher total externalizing problems scores among boys 
(Table 3). In girls, anemia was related to lower total externalizing problems scores.  
In multivariable analysis, ID, anemia, and low vitamin B-12 serostatus were positively 
associated with total externalizing problems scores in boys after adjustment for age at baseline, 
time spent watching television/playing video games, maternal height, and socioeconomic status. 
Boys with ID had an adjusted 5.9 units (95% CI: 1.0, 10.7) higher mean total externalizing 
problems scores compared with iron-sufficient boys (Table 4). Compared with non-anemic boys, 
boys with anemia had an adjusted 6.6 units (95% CI: 1.9, 11.3) higher total externalizing 
problems scores. Boys with plasma vitamin B-12 in the lowest quartile had adjusted mean total 
externalizing problems scores 2.7 units (95% CI: 0.4, 4.9) higher than did boys with higher 
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concentrations. Anemia was not associated with total externalizing problems in girls after 
adjustment for these covariates. 
Externalizing problems subscales. The distributions of aggressive and rule breaking 
behavior subscale scores varied significantly by sociodemographic characteristics and 
micronutrient status biomarkers (Supplemental Table 1). In multivariable analysis among boys, 
vitamin B-12 concentrations in the lowest quartile were related to a 2.3 units higher mean 
aggressive behavior score (95% CI: 0.4, 2.3) compared with higher concentrations 
(Supplemental Figure 1). Among girls, anemia was associated with a 2.5 units lower mean rule 
breaking behavior score (95% CI: -3.7, -1.3) (Supplemental Figure 1). 
Total internalizing problems. In boys and girls, mean total internalizing problems 
scores were 53.4 ± 9.7 and 54.1 ± 10.1, respectively. In bivariate analysis among girls, baseline 
age, BMI-for-age Z score, and maternal BMI were positively related to total internalizing 
problems scores, whereas maternal education, severe food insecurity, and low socioeconomic 
status were inversely related to this outcome (Table 5). ID among boys and vitamin A status 
among girls were positively associated with total internalizing problems scores (Table 6).  
 In multivariable analysis, ID was related to total internalizing problems scores in boys. 
After adjustment for child’s age and BMI-for-age Z score, maternal education, and household 
food insecurity and socioeconomic status, boys with ID had 6.4 units (95% CI: 1.2, 11.6) higher 
mean total internalizing problems scores than did iron-sufficient boys (Table 7). Vitamin A 
status was not significantly associated with total internalizing problems scores in girls after 
adjustment for these covariates. 
Internalizing problems subscales. The distributions of anxious/depressed, 
withdrawn/depressed, and somatic complaints subscale scores varied by sociodemographic 
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characteristics and micronutrient status biomarkers (Supplemental Table 2). In multivariable 
analyses among boys, anxious/depressed scores were positively related to ID and anemia 
(Supplemental Figure 2). Among girls, ID was inversely related to withdrawn/depressed scores 
(Supplemental Figure 2). Somatic complaints scores were positively associated with ID, 
anemia, and vitamin B-12 concentrations in the lowest quartile among boys (Supplemental 
Figure 2).  
Attention, social, and thought problems subscales. None of the nutritional status 
biomarkers examined were associated with attention or social problems scores. Thought 
problems scores among boys were positively related to ID and anemia (Supplemental Figure 3).  
Changes in sociodemographic factors. Single motherhood, maternal education level, 
parity, and BMI, and the percent of households with food security were higher at the follow-up 
assessment during adolescence than at recruitment in middle childhood, whereas the percent of 
households in the lowest socioeconomic strata did not change (Supplemental Table 3). None of 
the changes in sociodemographic characteristics from middle childhood to adolescence was 
related to total externalizing or internalizing problems scores among boys or girls 
(Supplemental Table 4).    
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Discussion 
In this longitudinal study of low- and middle-income Colombian schoolchildren, ID, 
anemia, and low plasma vitamin B-12 in middle childhood were associated with increased total 
externalizing behavior problems scores in adolescence among boys. In addition, boys with ID in 
middle childhood had higher total internalizing problems scores in adolescence than did iron-
sufficient boys. These associations were independent of other micronutrient status indicators and 
child, parental, and household characteristics. After adjustment for potential confounding 
variables, there were no statistically significant associations between the micronutrients 
examined and total externalizing or internalizing problems scores in girls.  
The nutritional causes of behavior problems in adolescence are poorly understood. 
Previous longitudinal studies primarily focused on the effects of early-life iron status on 
cognitive and behavioral development. ID in infancy was related to total externalizing (9) and 
internalizing problems (9, 10) during early adolescence in Costa Rica. In Chile, iron deficiency 
anemia in infancy was associated with more rule breaking behavior, an externalizing problem, at 
15 y of age (11); whereas ID was related to total internalizing problems at age 10 y (12). 
However, the potential effect of exposure to ID during middle childhood on subsequent behavior 
problems was not investigated.  
The results of our study may not be comparable with those from previous investigations, 
because the mechanisms operating in infancy could differ from those in middle childhood. The 
mechanisms through which ID in infancy may result in behavior problems during adolescence 
could involve developmental alterations in myelination throughout the brain (16) as well as 
diminished hippocampal oligodendrocyte function and dendritic arborization (15), according to 
rodent studies. Further, ID is associated with lower D1 and D2 receptor densities (17), elevated 
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levels of extracellular dopamine (36), and lower dopamine transporter density (37) in the basal 
ganglia. Dopamine is essential in the regulation of emotion, reward, motivation, and motor 
control; thus, dopaminergic dysfunction may be associated with behavior problems. In addition, 
ID may alter the metabolism of serotonin, norepinephrine, and gamma-aminobutyric acid, which 
could relate to emotional or behavioral development (38). Whether the same mechanisms could 
explain the effects of exposure to ID in middle childhood is speculative. Iron gradually 
concentrates in the basal ganglia (38); activity in this region during a cognitive task in children 
and adolescents aged 6-20 y is associated with future working memory capacity, a marker of 
cognitive and behavioral development (39). It is also possible that ID measured in middle 
childhood was already present in infancy. In this case, our findings could represent the 
cumulative effect of ID on behavioral development. Of note, in our study ID in middle childhood 
was associated with externalizing and internalizing problems in boys only. Some rodent studies 
suggest that males may be more sensitive to the effects of ID than females (17, 40); however, 
previous epidemiologic studies did not examine sex-specific associations. 
Anemia in middle childhood was also associated with higher total externalizing problems 
scores in adolescence among boys. In this population, anemia was not due to ID and was 
generally uncorrelated with biomarkers of micronutrients that are relevant for hemoglobin 
metabolism, including zinc, folate, and vitamins B-12 and A (22). Other causes of anemia, such 
as parasitic infections, sickle cell disease, and thalassemia, are relatively infrequent in children 
from Bogotá. Thus, the nature of the association between anemia and externalizing behavior 
problems is uncertain. It could reflect low intake of nutrients we did not measure, such as 
riboflavin or vitamin C.  
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Among boys, low plasma vitamin B-12 was associated with higher externalizing 
problems scores, possibly due to increased aggressive behavior. Growing evidence suggests that 
vitamin B-12 status is associated with cognition in childhood (41). However, evidence related to 
potential effects on behavior is limited. Three cross-sectional studies examined the association 
between vitamin B-12 intake and externalizing and internalizing problems (42) or depressive 
symptoms (43, 44) in adolescence. None found an association, which could be due to lack of 
variability in the exposure, reverse causation bias, measurement error, or confounding. The 
mechanisms to explain a potential effect of vitamin B-12 on behavior could be related to its role 
in the metabolism of S-adenosylmethionine (SAM), a methyl donor involved in the synthesis of 
dopamine, serotonin, and norepinephrine. SAM may improve mood among adults with 
depressive disorders (45), especially in males.  
Although the micronutrient status biomarkers studied were not related to the primary 
outcomes in girls, anemia and ID were related to decreased scores in the rule breaking behavior 
and withdrawn/depressed subscales, respectively. In rodent models, ID among females was 
associated with higher serotonin transporter density in several brain regions whereas among 
males ID was related to lower serotonin transporter density (40). This may help explain why 
anemia would be associated with higher behavior problems in boys but lower behavior problems 
in girls.  
Family level socioeconomic status indicators, including mother’s height, mother’s 
education, and household food security, were inversely related to internalizing problems among 
girls. Low maternal education level and household food insecurity may impact parental mental 
and physical health (46, 47), while mother’s height is a marker of intergenerational 
socioeconomic status (48). Parental wellbeing and socioeconomic status have previously been 
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associated with the development of behavior problems (49). On the other hand, household 
socioeconomic status, as measured through a neighborhood level indicator, was positively 
associated with externalizing and internalizing problems in girls. The positive association with 
neighborhood socioeconomic status is contrary to results from studies in the United States (50) 
and the Netherlands (51). In Colombia, neighborhoods with low socioeconomic status may have 
higher social cohesion which can modify the association between neighborhood socioeconomic 
status and behavior problems (52). Changes in sociodemographic factors that could represent 
underlying changes in micronutrient status from middle childhood to adolescence were unrelated 
to the outcomes of interest. This suggests that a potential effect of micronutrients in middle 
childhood might be independent of these factors. 
This study has several strengths. First, its longitudinal nature minimizes the potential for 
reverse causation bias. Prospective collection of outcome information reduces misclassification. 
We used objectively measured biomarkers of micronutrient status as the exposures, which 
precludes recall bias. The YSR questionnaire is valid in populations similar to ours (28). Finally, 
we controlled for many potential confounders of the association between micronutrient status 
and behavior problems.  
There are limitations as well. First, we did not have a baseline measurement of behavior 
problems in middle childhood. If behavior problems in adolescence were already present at the 
time of exposure assessment, reverse causation cannot be disregarded as an explanation of some 
of these results. Second, we lacked an assessment of micronutrient status during adolescence. If 
micronutrient status in middle childhood was correlated with that during adolescence, then the 
results may reflect exposure in adolescence rather than exposure in middle childhood. Third, 
some of the biomarkers we used may result in misclassification of micronutrient status. For 
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example, plasma vitamin B-12 represents both intake and stores of the vitamin, not necessarily 
the vitamin available in tissues. Since plasma vitamin B-12 concentrations are maintained while 
depletion occurs in the tissues, low plasma vitamin B-12 may not capture developing 
deficiencies. Further, low concentrations may reflect long-term marginal intake or absorption 
abnormalities rather than deficiency (53). Concentrations of vitamin B-12 metabolites, 
methylmalonic acid or homocysteine, may be more sensitive to capturing deficiency than plasma 
vitamin B-12 concentrations alone (53), but we did not have the means to quantify these 
analytes. Fourth, boys included in the analysis were less likely to be anemic than those who were 
not included. If the anemic children who were not included had less total externalizing problems 
than those included, we may have overestimated the association of anemia with externalizing 
behavior problems. Fifth, not all children had an available measurement for all micronutrients 
examined. Sixth, unmeasured independent predictors of behavior problems that may be 
associated with micronutrient status indicators, such as blood lead levels, history of child 
behavior problems, history of parental psychiatric disorders, or exposure to violence, could have 
resulted in residual confounding. Another limitation is that we did not have objectively measured 
anthropometric data in all mothers. Measurement error could have obscured the associations of 
these covariates with the outcomes. The prevalence of ID and anemia are low, which limits the 
public health significance of our findings since improvement of these conditions would only 
benefit a few children. Finally, our results might not be generalizable to other populations, 
especially high-income children. Nevertheless, in a recent national nutrition survey in Colombia, 
prevalence of ID, anemia, and vitamin B-12 deficiency among children of the highest 
socioeconomic strata were comparable to those of children in our study (54).   
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In conclusion, ID in middle childhood was strongly related to both externalizing and 
internalizing behavior problems in male adolescents. Anemia and low vitamin B-12 serostatus in 
boys were each related to increased externalizing behavior problems. Intervention studies are 
warranted to test whether improving status of these micronutrients in middle childhood enhances 
behavioral development through adolescence. 
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Table 2.1. Sociodemographic characteristics in middle childhood among children included vs. 
not included in the analysis 
Characteristic 
Boys   Girls 
Included 
(n=458) 
 Not Included 
(n=1109) 
 Included 
(n=584) 
 Not included 
(n=1051) 
Mean ± SD1  Mean ± SD  Mean ± SD  Mean ± SD 
        
Child’s age at baseline, y  8.4 ± 1.6   8.8 ± 1.9   8.5 ± 1.7   8.9 ± 1.8 
        
Height-for-age Z score2 at 
baseline  -0.77 ± 0.94 
 
 -0.82 ± 0.95   -0.76 ± 0.97 
 
 -0.75 ± 1.05 
         
BMI-for-age Z score2 at 
baseline  0.22 ± 1.09 
 
 0.20 ± 1.05   0.07 ± 0.96 
 
 0.09 ± 0.92 
        
Time spent watching television 
/ playing video games, h/wk  21.8 ± 17.9 
 
 18.0 ± 14.9   20.8 ± 17.6 
 
 18.4 ± 14.1 
        
Time playing outdoors, h/wk  8.4 ± 9.1   8.5 ± 10.1   6.7 ± 8.9   7.4 ± 9.8 
        
Mother’s education, y  9.2 ± 3.2   8.5 ± 3.3   8.8 ± 3.3   8.5 ± 3.5 
        
Mother’s parity  2.7 ± 1.1   2.7 ± 1.1   2.7 ± 1.1   2.8 ± 1.1 
        
Mother’s height, cm  157.6 ± 6.5   157.8 ± 6.3   157.7 ± 6.3   157.9 ± 6.5 
        
Mother’s BMI, kg/m2  24.1 ± 3.8    24.2 ± 3.9   24.1 ± 3.6   24.0 ± 3.7 
        
Food insecure, % 74.0  75.1  76.8  76.4 
        
Socioeconomic status, %        
1 5.9  6.9  5.7  6.8 
2 29.9  34.6  30.8  33.0 
3 56.3  51.4  56.9  53.0 
4 7.9  7.0  6.7  7.3 
        
Plasma ferritin, µg/L  41.9 ± 22.9   41.1 ± 23.5   43.4 ± 24.1   42.8 ± 22.7 
        
Iron deficiency3, % 3.4  3.2  3.0  3.3 
        
Hemoglobin, g/dL  14.5 ± 1.3   14.5 ± 1.2   14.6 ± 1.1   14.5 ± 1.1 
        
Anemia4, % 2.4  4.8  3.5  3.1 
        
Serum zinc, µmol/L  21.7 ± 6.7   21.4 ± 6.3   21.3 ± 6.4   21.4 ± 6.1 
        
Vitamin A, µg/dL  29.3 ± 10.2   29.9 ± 9.8   29.4 ± 9.8   29.9 ± 10.0 
        
Plasma vitamin B-12, pmol/L  322 ± 104   317 ± 103   339 ± 105   333 ± 110 
        
Erythrocyte folate, nmol/L  861 ± 223   875 ± 294   822 ± 227   857 ± 239 
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Footnotes to Table 2.1 
 
1 Values are mean ± SD unless noted otherwise. 
 
2 According to the World Health Organization growth reference for children and adolescents 
(34). 
 
3 Plasma ferritin concentration <15 µg/L. 47 children with CRP >10 mg/L were excluded from 
the analysis. 
 
4 Hemoglobin <12.7 g/dL 
  
47 
 
Table 2.2.  Sociodemographic characteristics in middle childhood and total externalizing 
problems score at 11-18 years of age in the Bogotá School Children Cohort 
Characteristic 
 Boys   Girls 
n1 Mean  ±  SD  n Mean  ±  SD 
      
Overall 458  51.9 ± 9.6  584  53.1 ± 9.6 
      
Child’s age at baseline, y      
5-6 100  50.3 ± 11.7  122  49.5 ± 10.7 
7-8 168  51.9 ± 8.7  216  52.8 ± 9.8 
9-10 176  53.0 ± 9.0  221  54.9 ± 8.2 
11-12 14  50.4 ± 9.2  25  56.8 ± 8.1 
P-trend2  0.10   <0.0001 
      
Child’s age at assessment, y      
<12 41  50.1 ± 12.0  47  47.3 ± 10.7 
12-13 103  48.7 ± 10.2  137  50.1 ± 10.6 
14-15 195  53.0 ± 8.8  248  54.4 ± 8.8 
>15 119  53.4 ± 8.8  152  55.3 ± 8.1 
P-trend  0.001   <0.0001 
      
Height-for-age Z score3 at baseline      
<-2.0  40  51.3 ± 11.0  58  52.1 ± 9.2 
-2.0 to <-1.0 145  51.9 ± 9.0  186  53.1 ± 9.4 
-1.0 to <0.0 166  52.4 ± 10.1  210  52.6 ± 9.7 
≥0.0  92  51.7 ± 9.2  122  54.3 ± 10.1 
P-trend  0.83   0.22 
      
BMI-for-age Z score3 at baseline      
<-1.0  58  50.9 ± 8.8  76  51.5 ± 9.4 
-1.0 to <0.0 137  52.3 ± 9.3  200  52.9 ± 9.7 
0.0 to <1.0 152  52.6 ± 10.6  202  53.7 ± 9.5 
≥1.0 95  51.1 ± 9.2  97  53.2 ± 9.9 
P-trend  0.99   0.19 
      
Time spent watching television /        
playing video games, h/wk 
     
<10 124  50.5 ± 9.6  155  52.2 ± 9.1 
10 to <20 108  52.4 ± 9.9  171  52.6 ± 10.1 
20 to <30 110  50.9 ± 9.0  125  53.2 ± 9.5 
≥30 104  54.2 ± 9.6  116  54.9 ± 9.4 
P-trend  0.02   0.02 
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Table 2.2 (continued). 
 
Characteristic 
 Boys   Girls 
n1 Mean  ±  SD  n Mean  ±  SD 
      
Time playing outdoors, h/wk      
<1.5 53  53.7 ± 10.8  109  53.4 ± 9.8 
1.5 to <4.5 82  50.1 ± 9.4  113  53.4 ± 9.7 
4.5 to <10 97  50.6 ± 8.4  94  52.1 ± 9.9 
≥10 96  52.5 ± 10.1  86  52.7 ± 9.4 
P-trend  0.94   0.44 
      
Mother’s education, y      
Incomplete primary, 1-4  24  53.7 ± 9.2  34  52.7 ± 8.2 
Complete primary, 5  76  51.1 ± 10.3  109  54.4 ± 9.0 
Incomplete secondary, 6-10  114  52.0 ± 9.0  135  52.5 ± 9.5 
Complete secondary, 11  190  51.8 ± 10.1  242  53.1 ± 10.1 
University, >11  42  51.9 ± 8.2  41  51.8 ± 9.4 
P-trend  0.89   0.31 
      
Mother’s parity      
1 47  50.7 ± 11.2  69  52.8 ± 9.7 
2 182  51.4 ± 9.7  198  52.5 ± 9.7 
3 132  52.2 ± 9.6  184  53.4 ± 9.8 
4 45  51.4 ± 5.6  66  53.2 ± 9.4 
≥5 40  54.8 ± 10.4  50  54.1 ± 8.2 
P-trend  0.08   0.26 
      
Mother’s height quartile (median), cm      
Q1, (150) 113  50.7 ± 9.6  140  54.4 ± 10.4 
Q2, (155) 121  52.5 ± 9.3  160  53.1 ± 9.7 
Q3, (160) 101  52.0 ± 9.8  126  53.4 ± 9.3 
Q4, (165) 113  52.3 ± 9.8  144  51.5 ± 8.8 
P-trend  0.31   0.02 
      
Mother’s BMI, kg/m2      
<18.5 19  54.4 ± 11.0  16  50.6 ± 7.4 
18.5 to <25.0 261  52.2 ± 9.5  364  52.9 ± 9.9 
25.0 to <30.0 135  50.8 ± 9.4  146  53.3 ± 8.9 
≥30.0 30  52.9 ± 10.8  39  55.1 ± 9.5 
P-trend  0.36   0.12 
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Table 2.2 (continued). 
 
Characteristic 
 Boys   Girls 
n1 Mean  ±  SD  n Mean  ±  SD 
      
Food insecurity in the household      
None 119  50.6 ± 9.4  135  53.8 ± 9.5 
Insecure – no hunger 222  52.5 ± 9.5  283  52.6 ± 9.9 
Insecure – moderate hunger 78  51.8 ± 10.4  98  54.1 ± 8.9 
Insecure – severe hunger 38  52.9 ± 9.1  66  52.0 ± 9.4 
P-trend  0.21   0.53 
      
Socioeconomic status      
1 (lowest) 27  52.1 ± 11.8  33  47.6 ± 10.0 
2 137  53.0 ± 9.0  180  54.5 ± 9.1 
3 258  51.4 ± 9.7  332  53.0 ± 9.7 
4 36  51.1 ± 9.7  39  51.4 ± 8.9 
P-trend  0.24   0.83 
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Footnotes to Table 2.2 
 
1 Sums may be less than the total due to missing values in covariates. 
 
2  Test for linear trend when a variable representing ordinal categories of the characteristic was 
introduced into a linear regression model as a continuous covariate.  Empirical estimates of the 
variance were used in all models.  
 
3 According to the World Health Organization growth reference for children and adolescents 
(34). 
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Table 2.3. Micronutrient status in middle childhood and total externalizing problems score at 11-
18 years of age in the Bogotá School Children Cohort 
Micronutrient status indicator 
   Boys     Girls 
n1 Mean ± SD  n Mean ± SD 
      
Iron deficiency2      
Yes 14  57.3 ± 8.2  15  52.1 ± 9.9 
No 400  51.9 ± 9.7  489  53.1 ± 9.6 
P3  0.01   0.71 
      
Anemia4      
Yes 10  57.5 ± 6.8  18  48.1 ± 9.2 
No 413  51.9 ± 9.7  498  53.4 ± 9.6 
P  0.008   0.01 
      
Serum zinc quartile (median boys/girls),  
 µmol/L 
    
 
Q1, (15.3/15.1) 106  51.7 ± 10.2  127  53.6 ± 10.0 
Q2, (18.6/18.2) 104  51.9 ± 9.4  128  53.8 ± 9.1 
Q3, (22.1/22.3) 104  51.8 ± 10.1  127  52.1 ± 10.2 
Q4, (30.7/29.6) 107  53.0 ± 9.0  128  53.1 ± 9.2 
P-trend5  0.37   0.40 
      
Vitamin A, µg/dL      
<20 63  53.5 ± 10.6  76  52.7 ± 10.4 
20-29.9 188  51.9 ± 9.3  211  52.1 ± 10.0 
≥30 173  51.7 ± 9.6  228  54.2 ± 8.8 
P-trend  0.31   0.07 
      
Plasma vitamin B-12 quartile (median 
boys/girls), pmol/L 
 
 
  
 
Q1, (204/218) 105  54.2 ± 9.4  123  53.5 ± 10.0 
Q2, (278/303) 100  51.2 ± 10.0  122  53.6 ± 9.9 
Q3, (345/363) 104  52.0 ± 9.8  123  52.4 ± 9.1 
Q4, (450/452) 103  51.4 ± 9.2  124  53.4 ± 9.2 
P-trend  0.06   0.68 
      
Erythrocyte folate quartile (median boys/girls), 
nmol/L      
Q1, (633/573) 100  51.4 ± 8.3  123  53.5 ± 9.5 
Q2, (759/735) 102  51.5 ± 10.6  124  52.1 ± 10.0 
Q3, (898/874) 101  53.0 ± 10.0  124  53.4 ± 9.8 
Q4, (1122/1062) 101  51.9 ± 9.5  124  53.8 ± 9.4 
P-trend  0.46   0.60 
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Footnotes to Table 2.3 
 
1 Sums may be less than the total due to missing values in covariates. 
 
2 Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis. 
 
3 From linear regression with externalizing problems score as the continuous outcome and the 
nutrient biomarker as the categorical predictor.  Empirical estimates of the variance were used in 
all models.   
 
4 Hemoglobin <12.7 g/dL. 
 
5 Test for linear trend when a variable representing ordinal categories of the predictor was 
introduced into the model as a continuous covariate.   
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Table 2.4. Adjusted mean differences and 95% confidence intervals (CI)1 in total externalizing 
problems score at 11-18 years of age according to iron deficiency, anemia, and 
sociodemographic characteristics in middle childhood in the Bogotá School Children Cohort 
 Boys  Girls  
 Difference (95% CI)  Difference (95% CI)  
       
Iron deficiency2, yes vs. no  5.9  (1.0, 10.7)  0.0 (-4.4, 4.4)  
     
Anemia3, yes vs. no  6.6  (1.9, 11.3)   -3.3   (-7.7, 1.1)  
     
Plasma vitamin B-12, quartile 1 vs. >1  2.7  (0.4, 4.9)   1.0  (-0.8, 2.9)  
     
Child’s age at baseline, per 1 year  0.7  (0.0, 1.4)   1.4  (0.9, 1.9)  
     
Time spent watching television / playing  
video games, ≥30 h/wk vs. <30 h/wk  3.7  (1.0, 6.4) 
 
 1.8  (-0.3, 3.9) 
 
     
Mother’s height quartile (median), cm     
Q1, (150)  -1.2  (-4.0, 1.6)   2.8  (0.4, 5.2)  
Q2, (155)  1.0  (-1.8, 3.7)   1.1  (-1.1, 3.3)  
Q3, (160)  -0.4  (-3.5, 2.6)   1.0  (-1.3, 3.3)  
Q4, (165)   Reference    Reference  
P-trend4   0.64    0.03  
     
Socioeconomic status, 1 (lowest) vs. >1  -1.3 (-6.8, 4.2)   -5.5  (-9.8, -1.1)  
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Footnotes to Table 2.4 
 
1 Adjusted mean difference and 95% CI from a linear regression model with total externalizing 
problems score as the continuous outcome.  Predictors included all variables presented.  
Empirical variances were specified.   
 
2 Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis. 
 
3 Hemoglobin <12.7 g/dL. 
 
4 Test for linear trend when a variable representing ordinal categories of the predictor was 
introduced into the model as a continuous covariate. 
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Table 2.5.  Sociodemographic characteristics in middle childhood and total internalizing 
problems score at 11-18 years of age in the Bogotá School Children Cohort 
Characteristic 
 Boys   Girls 
n1 Mean  ±  SD  n Mean  ±  SD 
      
Overall 458  53.4 ± 9.7  584  54.1 ± 10.1 
      
Child’s age at baseline, y      
5-6 100  53.2 ± 11.0  122  51.6 ± 10.9 
7-8 168  53.4 ± 9.7  216  54.2 ± 10.3 
9-10 176  53.8 ± 8.8  221  54.9 ± 9.1 
11-12 14  49.0 ± 8.4  25  58.9 ± 10.1 
P-trend2  0.88   0.0005 
      
Child’s age at assessment, y      
<12 41  54.0 ± 11.7  47  51.4 ± 10.7 
12-13 103  51.2 ± 9.8  137  50.9 ± 10.5 
14-15 195  53.8 ± 9.5  248  55.3 ± 9.4 
>15 119  54.5 ± 9.0  152  56.0 ± 9.8 
P-trend  0.12   <0.0001 
      
Height-for-age Z score3 at baseline      
<-2.0  40  52.4 ± 10.5  58  52.8 ± 9.6 
-2.0 to <-1.0 145  53.4 ± 9.8  186  53.5 ± 10.1 
-1.0 to <0.0 166  53.1 ± 9.9  210  54.7 ± 10.3 
≥0.0  92  54.6 ± 8.7  122  54.8 ± 10.1 
P-trend  0.28   0.10 
      
BMI-for-age Z score3 at baseline      
<-1.0  58  53.0 ± 9.9  76  51.5 ± 9.1 
-1.0 to <0.0 137  53.9 ± 9.4  200  53.8 ± 10.6 
0.0 to <1.0 152  53.0 ± 10.2  202  55.4 ± 9.5 
≥1.0 95  53.5 ± 9.2  97  54.4 ± 10.9 
P-trend  0.95   0.02 
      
Time spent watching television /    
playing video games, h/wk 
     
<10 124  54.3 ± 8.9  155  53.5 ± 8.9 
10 to <20 108  52.2 ± 9.7  171  53.7 ± 10.7 
20 to <30 110  53.3 ± 10.6  125  53.7 ± 10.7 
≥30 104  53.9 ± 9.4  116  55.5 ± 9.5 
P-trend  0.94   0.12 
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Table 2.5 (continued). 
 
Characteristic 
 Boys   Girls 
n1 Mean  ±  SD  n Mean  ±  SD 
      
Time playing outdoors, h/wk      
 <1.5 53  53.1 ± 9.4  109  55.7 ± 9.7 
 1.5 to <4.5 82  53.3 ± 10.6  113  53.0 ± 10.4 
 4.5 to <10 97  54.0 ± 8.4  94  53.5 ± 10.0 
 ≥10 96  52.3 ± 9.9  86  53.3 ± 10.3 
 P-trend  0.64   0.14 
      
Mother’s education, y      
 Incomplete primary, 1-4  24  55.4 ± 9.2  34  55.8 ± 10.3 
 Complete primary, 5  76  52.6 ± 9.3  109  55.1 ± 9.9 
 Incomplete secondary, 6-10  114  53.7 ± 9.1  135  54.5 ± 9.9 
 Complete secondary, 11  190  53.5 ± 10.5  242  53.7 ± 10.4 
 University, >11  42  53.1 ± 8.5  41  51.9 ± 8.4 
 P-trend  0.78   0.04 
      
Mother’s parity      
 1 47  54.5 ± 10.7  69  55.2 ± 10.3 
 2 182  53.3 ± 9.6  198  53.5 ± 10.4 
 3 132  53.7 ± 9.9  184  54.4 ± 9.9 
 4 45  51.9 ± 8.0  66  55.3 ± 9.9 
 ≥5 40  53.8 ± 10.1  50  53.4 ± 9.3 
 P-trend  0.59   0.99 
      
Mother’s height quartile (median), cm      
 Q1, (150) 113  53.4 ± 9.7  140  55.1 ± 11.3 
 Q2, (155) 121  54.4 ± 10.1  160  53.4 ± 10.4 
 Q3, (160) 101  53.2 ± 9.1  126  54.9 ± 9.1 
 Q4, (165) 113  53.0 ± 9.8  144  53.0 ± 9.3 
 P-trend  0.54   0.20 
      
Mother’s BMI, kg/m2      
 <18.5 19  52.9 ± 12.9  16  51.3 ± 6.5 
 18.5 to <25.0 261  53.5 ± 10.0  364  53.8 ± 10.5 
 25.0 to <30.0 135  53.4 ± 8.9  146  54.1 ± 9.4 
 ≥30.0 30  54.4 ± 8.4  39  57.4 ± 9.7 
 P-trend  0.68   0.03 
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Table 2.5 (continued). 
 
Characteristic 
 Boys   Girls 
n1 Mean  ±  SD  n Mean  ±  SD 
      
Food insecurity in the household      
 None 119  52.4 ± 9.8  135  55.3 ± 10.5 
 Insecure – no hunger 222  53.7 ± 9.5  283  54.0 ± 10.3 
 Insecure – moderate hunger 78  54.1 ± 10.4  98  54.9 ± 8.8 
 Insecure – severe hunger 38  52.9 ± 8.9  66  51.5 ± 9.9 
 P-trend  0.45   0.04 
      
Socioeconomic status      
 1 (lowest) 27  55.1 ± 11.1  33  50.7 ± 9.1 
 2 137  54.2 ± 10.7  180  54.4 ± 10.0 
 3 258  52.9 ± 9.1  332  54.2 ± 10.3 
 4 36  52.7 ± 8.7  39  55.4 ± 8.7 
 P-trend  0.16   0.15 
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Footnotes to Table 2.5 
 
1 Sums may be less than the total due to missing values in covariates. 
 
2  Test for linear trend when a variable representing ordinal categories of the characteristic was 
introduced into a linear regression model as a continuous covariate.  Empirical estimates of the 
variance were used in all models.  
 
3 According to the World Health Organization growth reference for children and adolescents 
(34). 
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Table 2.6. Micronutrient status in middle childhood and total internalizing problems score at 11-
18 years of age in the Bogotá School Children Cohort 
  
Micronutrient status indicator 
   Boys     Girls 
n1 Mean ± SD  n Mean ± SD 
      
Iron deficiency2      
Yes 14  60.1 ± 9.3  15  53.6 ± 7.9 
No 400  53.3 ± 9.6  489  54.3 ± 10.1 
P3  0.005   0.74 
      
Anemia4      
Yes 10  58.0 ± 11.6  18  52.1 ± 10.2 
No 413  53.3 ± 9.7  498  54.4 ± 10.0 
P  0.18   0.32 
      
Serum zinc quartile (median boys/girls), µmol/L      
Q1, (15.3/15.1) 106  54.1 ± 8.7  127  54.8 ± 10.1 
Q2, (18.6/18.2) 104  52.0 ± 10.1  128  54.4 ± 9.5 
Q3, (22.1/22.3) 104  53.9 ± 10.3  127  54.3 ± 10.9 
Q4, (30.7/29.6) 107  53.9 ± 9.6  128  53.7 ± 9.7 
P-trend5  0.72   0.41 
      
Vitamin A, µg/dL      
<20 63  55.3 ± 10.0  76  53.3 ± 9.7 
20-29.9 188  53.3 ± 9.9  211  53.6 ± 11.0 
≥30 173  52.9 ± 9.4  228  55.3 ± 9.2 
P-trend  0.14   0.05 
      
Plasma vitamin B-12 quartile (median 
boys/girls), pmol/L 
 
 
  
 
Q1, (204/218) 105  54.3 ± 10.4  123  54.4 ± 9.5 
Q2, (278/303) 100  52.3 ± 9.3  122  55.0 ± 10.1 
Q3, (345/363) 104  53.5 ± 9.8  123  52.9 ± 11.2 
Q4, (450/452) 103  53.8 ± 9.5  124  55.1 ± 8.8 
P-trend  0.95   0.98 
      
Erythrocyte folate quartile (median boys/girls), 
nmol/L      
Q1, (633/573) 100  52.2 ± 9.2  123  54.3 ± 10.7 
Q2, (759/735) 102  53.8 ± 9.9  124  53.4 ± 9.6 
Q3, (898/874) 101  53.9 ± 9.5  124  55.2 ± 10.1 
Q4, (1122/1062) 101  54.0 ± 10.0  124  54.6 ± 9.6 
P-trend  0.20   0.54 
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Footnotes to Table 2.6 
 
1 Sums may be less than the total due to missing values in covariates. 
 
2  Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis.  
 
3 From linear regression with internalizing problems score as the continuous outcome and the 
nutrient biomarker as the categorical predictor.  Empirical estimates of the variance were used in 
all models.   
 
4 Hemoglobin <12.7 g/dL. 
 
5 Test for linear trend when a variable representing ordinal categories of the predictor was 
introduced into the model as a continuous covariate.  
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Table 2.7. Adjusted mean differences and 95% confidence intervals (CI)1 in total internalizing 
problems score at 11-18 years of age according to iron deficiency and sociodemographic 
characteristics in middle childhood in the Bogotá School Children Cohort 
 Boys  Girls  
 Difference (95% CI)  Difference (95% CI)  
       
Iron deficiency2, yes vs. no  6.4 (1.2, 11.6)   0.9 (-2.6, 4.4)  
     
Child’s age at baseline, per 1 year  0.1 (-0.6, 0.7)   1.1 (0.5, 1.7)  
     
BMI-for-age Z score3 at baseline,  
<-1.0 vs. ≥-1.0  -0.7 (-3.8, 2.4) 
 
 -3.7  (-6.0, -1.4) 
 
     
Mother’s education, y     
Incomplete primary, 1-4   Reference   Reference  
Complete primary, 5   -2.3 (-6.7, 2.2)   -1.9 (-5.8, 2.0)  
Incomplete secondary, 6-10   -1.5 (-5.9, 2.8)   -1.9 (-5.7, 1.9)  
Complete secondary, 11   -1.8 (-6.1, 2.5)   -3.7 (-7.4, 0.0)  
University, >11   -2.3 (-7.2, 2.7)   -6.3 (-10.9, -1.6)  
P-trend4   0.70    0.005  
     
Food insecurity, severe hunger vs.  
no severe hunger 
 -1.2 (-4.2, 1.8)   -3.3 (-6.0, -0.6)  
      
Socioeconomic status, 1 (lowest) vs. >1  1.9 (-3.2, 7.0)   -3.6 (-7.2, -0.1)  
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Footnotes to Table 2.7 
 
1 Adjusted mean difference and 95% CI from a linear regression model with total internalizing 
problems score as the continuous outcome.  Predictors included all variables presented.  
Empirical variances were specified.   
 
2 Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis. 
 
3 According to the World Health Organization growth reference for children and adolescents 
(34). 
 
4 Test for linear trend when a variable representing ordinal categories of the predictor was 
introduced into the model as a continuous covariate. 
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Supplemental Table 2.1. Sociodemographic characteristics and micronutrient status in middle 
childhood and externalizing problems subscales score at 11-18 years of age in the Bogotá School 
Children Cohort 
 Boys  Girls 
 
n1  
Aggressive 
Behavior2  
Rule 
Breaking 
Behavior2  n  
Aggressive 
Behavior  
Rule 
Breaking 
Behavior 
                    
Overall 458  55.6 ± 7.1  54.2 ± 5.1  584  56.7 ± 7.4  54.4 ± 4.7 
            
Sociodemographic characteristic            
Child’s age at baseline, y            
5-6 100  55.6 ± 8.2  54.2 ± 5.7  122  55.5 ± 7.4  52.8 ± 3.5 
7-8 168  55.2 ± 6.8  53.9 ± 4.9  216  56.5 ± 7.5  54.4 ± 5.0 
9-10 176  56.0 ± 6.9  54.6 ± 5.1  221  57.3 ± 7.1  55.1 ± 4.7 
11-12 14  54.6 ± 6.3  53.0 ± 4.0  25  58.8 ± 8.6  56.4 ± 5.1 
P-trend3   0.70  0.66    0.01  <0.0001 
            
Child’s age at assessment, y            
<12 41  55.6 ± 8.0  54.2 ± 5.8  47  54.6 ± 6.7  51.9 ± 2.9 
12-13 103  54.3 ± 7.0  52.9 ± 4.2  137  55.2 ± 7.5  53.8 ± 4.8 
14-15 195  55.8 ± 7.2  54.7 ± 5.3  248  57.2 ± 7.6  54.9 ± 4.7 
>15 119  56.5 ± 6.8  54.6 ± 5.2  152  57.9 ± 7.0  55.0 ± 4.6 
P-trend   0.08  0.07    0.0001  <0.0001 
            
Height-for-age Z score4 at baseline            
<-2.0  40  55.6 ± 7.5  54.6 ± 4.7  58  56.3 ± 8.0  53.2 ± 3.7 
-2.0 to <-1.0 145  55.4 ± 7.0  54.0 ± 5.1  186  56.7 ± 7.0  54.3 ± 4.4 
-1.0 to <0.0 166  56.0 ± 7.3  54.7 ± 5.7  210  56.1 ± 7.4  54.5 ± 4.8 
≥0.0 92  55.4 ± 7.3  54.1 ± 4.7  122  57.9 ± 7.9  55.0 ± 5.2 
P-trend   0.93  0.95    0.28  0.02 
                  
BMI-for-age Z score4 at baseline                  
<-1.0  58  54.7 ± 6.3  53.6 ± 4.0  76  55.5 ± 6.8  53.9 ± 4.7 
-1.0 to <0.0 137  55.7 ± 7.4  54.3 ± 5.2  200  56.5 ± 7.3  54.4 ± 4.5 
0.0 to <1.0 152  56.4 ± 7.9  54.8 ± 5.7  202  57.3 ± 7.8  54.5 ± 4.7 
≥1.0 95  55.0 ± 6.2  53.9 ± 5.1  97  56.8 ± 7.4  54.6 ± 4.9 
P-trend   0.73  0.67    0.17  0.34 
            
Time spent watching television / 
playing video games, h/wk 
    
 
   
 
 
 
<10 124  54.7 ± 6.4  53.7 ± 4.8  155  55.7 ± 6.6  53.9 ± 4.3 
10 to <20 108  55.9 ± 7.3  54.8 ± 5.4  171  56.3 ± 7.4  54.6 ± 4.7 
20 to <30 110  54.8 ± 6.2  53.5 ± 5.0  125  57.0 ± 8.0  54.3 ± 4.6 
≥30 104  57.2 ± 8.5  55.2 ± 5.3  116  58.0 ± 7.8  55.2 ± 5.1 
P-trend   0.04  0.12    0.008  0.04 
            
Time playing outdoors, h/wk            
<1.5 53  56.9 ± 8.6  55.6 ± 6.2  109  56.9 ± 7.6  54.9 ± 5.2 
1.5 to <4.5 82  54.1 ± 5.9  53.8 ± 5.1  113  56.9 ± 7.6  54.4 ± 4.6 
4.5 to <10 97  54.8 ± 6.0  53.1 ± 3.8  94  56.4 ± 6.8  53.8 ± 4.3 
≥10 96  56.3 ± 8.1  54.3 ± 4.9  86  56.1 ± 7.4  54.4 ± 4.9 
P-trend   0.79  0.26    0.40  0.30 
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 Boys  Girls 
 
n1  
Aggressive 
Behavior2  
Rule 
Breaking 
Behavior2  n  
Aggressive 
Behavior  
Rule 
Breaking 
Behavior 
            
Mother’s education, y            
Incomplete primary, 1-4  24  57.5 ± 8.5  53.6 ± 4.9  34  55.3 ± 6.0  54.9 ± 4.6 
Complete primary, 5  76  55.0 ± 7.0  54.7 ± 5.4  109  57.1 ± 7.1  55.1 ± 5.1 
Incomplete secondary, 6-10  114  55.6 ± 7.1  54.1 ± 4.6  135  56.3 ± 7.3  53.9 ± 4.5 
Complete secondary, 11  190  55.8 ± 7.3  54.3 ± 5.4  242  57.1 ± 7.9  54.4 ± 4.7 
University, >11  42  54.9 ± 6.3  53.6 ± 4.9  41  55.5 ± 6.6  53.9 ± 3.8 
P-trend   0.69  0.75    0.80  0.16 
            
Mother’s parity            
1 47  56.0 ± 8.2  53.6 ± 4.9  69  57.0 ± 7.1  53.7 ± 4.5 
2 182  55.3 ± 6.9  54.1 ± 5.3  198  56.0 ± 7.3  54.5 ± 5.0 
3 132  55.9 ± 7.5  54.4 ± 5.1  184  57.1 ± 7.5  54.5 ± 4.6 
4 45  54.0 ± 4.2  52.9 ± 3.7  66  56.6 ± 8.2  54.6 ± 4.4 
≥5 40  57.4 ± 8.5  56.1 ± 5.6  50  57.1 ± 6.9  54.4 ± 4.2 
P-trend   0.60  0.17    0.51  0.45 
            
Mother’s height quartile (median), 
cm    
 
 
 
   
 
 
Q1, (150) 113  54.9 ± 6.7  53.9 ± 4.7  140  58.3 ± 8.4  55.0 ± 5.2 
Q2, (155) 121  56.1 ± 7.1  54.3 ± 4.8  160  56.7 ± 7.1  54.4 ± 4.9 
Q3, (160) 101  55.9 ± 7.7  54.0 ± 5.4  126  56.8 ± 7.4  54.4 ± 4.4 
Q4, (165) 113  55.6 ± 7.3  54.7 ± 5.7  144  55.1 ± 6.2  53.7 ± 4.0 
P-trend   0.56  0.39    0.0005  0.02 
              
Mother’s BMI, kg/m2              
<18.5 19  57.1 ± 8.5  56.1 ± 6.7  16  53.7 ± 3.0  52.8 ± 2.4 
18.5 to <25.0 261  55.7 ± 7.4  54.3 ± 5.2  364  56.8 ± 7.7  54.5 ± 4.8 
25.0 to <30.0 135  54.9 ± 6.4  53.8 ± 4.6  146  56.7 ± 6.9  54.1 ± 4.0 
≥30.0 30  57.0 ± 8.3  54.8 ± 5.8  39  58.1 ± 7.7  55.6 ± 5.9 
P-trend   0.71  0.39    0.20  0.31 
            
Food insecurity            
None 119  54.8 ± 6.4  53.3 ± 4.6  135  57.4 ± 8.2  54.4 ± 4.6 
Insecure – no hunger 222  55.8 ± 7.5  54.6 ± 5.4  283  56.3 ± 7.4  54.5 ± 4.9 
Insecure – moderate hunger 78  56.0 ± 7.2  54.4 ± 5.2  98  57.3 ± 7.1  54.4 ± 4.4 
Insecure – severe hunger 38  55.9 ± 6.8  54.8 ± 5.1  66  55.8 ± 6.4  54.1 ± 4.4 
P-trend   0.24  0.07    0.33  0.61 
            
Socioeconomic status            
1 (lowest) 27  56.5 ± 8.4  55.3 ± 5.4  33  54.2 ± 5.6  52.2 ± 2.9 
2 137  56.5 ± 7.7  54.1 ± 5.1  180  57.5 ± 7.4  55.1 ± 4.8 
3 258  55.1 ± 6.7  54.3 ± 5.1  332  56.7 ± 7.7  54.3 ± 4.6 
4 36  55.0 ± 6.4  53.8 ± 5.1  39  54.9 ± 5.7  54.2 ± 4.8 
P-trend   0.09  0.52    0.71  0.81 
            
Micronutrient status             
Iron deficiency5            
Yes 14  59.4 ± 9.9  56.0 ± 4.0  15  56.5 ± 8.3  53.5 ± 5.7 
No 400  55.6 ± 7.2  54.3 ± 5.3  489  56.7 ± 7.4  54.5 ± 4.6 
P6   0.14  0.11    0.93  0.48 
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 Boys  Girls 
 
n1  
Aggressive 
Behavior2  
Rule 
Breaking 
Behavior2  n  
Aggressive 
Behavior  
Rule 
Breaking 
Behavior 
            
Anemia7            
Yes 10  59.9 ± 7.0  55.6 ± 4.1  18  53.8 ± 6.9  51.7 ± 2.2 
No 413  55.6 ± 7.3  54.3 ± 5.2  498  56.8 ± 7.5  54.6 ± 4.8 
P   0.04  0.30    0.06  <0.0001 
            
Serum zinc quartile (median 
boys/girls), µmol/L 
  
 
 
 
   
 
 
 
Q1, (15.3/15.1) 106  55.7 ± 6.9  54.3 ± 5.7  127  57.3 ± 8.2  54.8 ± 5.1 
Q2, (18.6/18.2) 104  55.6 ± 6.8  54.3 ± 5.0  128  56.8 ± 7.1  54.7 ± 4.6 
Q3, (22.1/22.3) 104  55.5 ± 8.0  54.4 ± 5.2  127  56.4 ± 7.3  54.1 ± 4.4 
Q4, (30.7/29.6) 107  56.1 ± 7.5  54.4 ± 5.1  128  56.4 ± 7.6  54.5 ± 4.7 
P-trend   0.67  0.84    0.29  0.47 
            
Vitamin A, µg/dL            
<20 63  57.0 ± 8.6  55.3 ± 5.9  76  56.6 ± 7.6  54.7 ± 4.6 
20-29.9 188  55.6 ± 6.8  53.9 ± 4.8  211  56.2 ± 7.5  54.3 ± 4.7 
≥30 173  55.4 ± 7.2  54.4 ± 5.3  228  57.2 ± 7.5  54.7 ± 4.7 
P-trend   0.20  0.56    0.30  0.75 
            
Plasma vitamin B-12 quartile 
(median boys/girls), pmol/L 
  
 
 
 
   
 
 
 
Q1, (204/218) 105  57.6 ± 8.3  54.7 ± 5.4  123  57.1 ± 8.3  54.7 ± 5.0 
Q2, (278/303) 100  55.1 ± 7.3  54.2 ± 5.3  122  57.3 ± 8.0  54.7 ± 4.8 
Q3, (345/363) 104  55.2 ± 6.6  55.1 ± 5.6  123  55.6 ± 6.1  54.4 ± 4.8 
Q4, (450/452) 103  55.3 ± 6.7  53.6 ± 4.6  124  56.9 ± 7.4  54.3 ± 4.1 
P-trend   0.03  0.26    0.46  0.38 
            
Erythrocyte folate quartile (median 
boys/girls), nmol/L    
 
 
 
   
 
 
Q1, (633/573) 100  54.8 ± 6.0  53.7 ± 4.5  123  57.3 ± 7.5  54.3 ± 4.5 
Q2, (759/735) 102  55.9 ± 8.3  54.4 ± 5.1  124  56.3 ± 7.7  54.2 ± 4.8 
Q3, (898/874) 101  56.3 ± 7.7  54.9 ± 6.0  124  56.8 ± 8.0  54.8 ± 4.7 
Q4, (1122/1062) 101  55.6 ± 6.7  54.1 ± 4.9  124  56.9 ± 7.2  54.8 ± 4.9 
P-trend   0.33  0.43    0.85  0.26 
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Footnotes to Supplemental Table 2.1 
 
1  Sums may be less than the total due to missing values in covariates. 
2  Mean ± SD 
3  Test for linear trend when a variable representing ordinal categories of the characteristic was 
introduced into a linear regression model as a continuous predictor.  Empirical estimates of the 
variance were used in all models.  
4  According to the World Health Organization growth reference for children and adolescents 
(34). 
5  Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis.  
6  From linear regression with externalizing problems subscales score as the continuous outcome 
and the nutrient biomarker as the categorical predictor.   
7  Hemoglobin <12.7 g/dL. 
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Supplemental Table 2.2. Sociodemographic characteristics and micronutrient status in middle childhood and internalizing problems 
subscales score at 11-18 years of age in the Bogotá School Children Cohort 
 Boys  Girls 
 
n1  
Anxious/ 
Depressed2  
Withdrawn 
/Depressed2  
Somatic 
Complaints2  n  
Anxious/ 
Depressed  
Withdrawn 
/Depressed  
Somatic 
Complaints 
                
Overall 458  55.7 ± 6.5  55.4 ± 6.1  56.1 ± 6.6  584  55.7 ± 7.0  55.8 ± 6.7  57.6 ± 7.8 
                
Sociodemographic characteristic                
Child’s age at baseline, y                
5-6 100  56.4 ± 7.4  55.4 ± 6.9  56.3 ± 6.5  122  54.6 ± 6.3  54.6 ± 6.0  56.9 ± 7.6 
7-8 168  55.8 ± 6.8  55.2 ± 5.9  56.2 ± 7.0  216  56.1 ± 7.6  55.8 ± 6.4  57.3 ± 7.6 
9-10 176  55.5 ± 5.7  55.7 ± 5.9  56.0 ± 6.3  221  55.6 ± 6.4  56.1 ± 7.0  58.1 ± 8.0 
11-12 14  52.4 ± 3.7  52.9 ± 3.7  54.9 ± 6.1  25  59.1 ± 8.2  59.5 ± 7.8  59.1 ± 8.7 
P-trend3   0.07  0.90  0.53    0.04  0.003  0.10 
                
Child’s age at assessment, y                
<12 41  57.7 ± 8.4  55.3 ± 6.4  56.7 ± 7.1  47  54.6 ± 5.7  54.3 ± 5.2  56.6 ± 6.9 
12-13 103  54.5 ± 6.3  54.2 ± 6.4  55.4 ± 6.2  137  54.2 ± 6.5  54.1 ± 5.1  56.3 ± 7.8 
14-15 195  55.5 ± 6.3  55.7 ± 5.7  56.4 ± 6.7  248  56.0 ± 7.1  56.4 ± 7.2  58.1 ± 7.6 
>15 119  56.4 ± 6.0  55.8 ± 6.3  56.0 ± 6.6  152  56.9 ± 7.2  57.0 ± 7.0  58.1 ± 8.4 
P-trend   0.77  0.17  0.96    0.0004  <0.0001  0.04 
                
Height-for-age Z score4 at baseline                
<-2.0  40  55.6 ± 6.1  54.9 ± 6.1  56.0 ± 7.7  58  55.4 ± 6.6  55.7 ± 7.3  55.8 ± 6.3 
-2.0 to <-1.0 145  56.0 ± 6.8  55.4 ± 6.3  55.7 ± 6.2  186  55.1 ± 6.5  55.3 ± 6.2  57.6 ± 7.9 
-1.0 to <0.0 166  55.5 ± 6.6  55.2 ± 5.6  56.3 ± 6.6  210  55.9 ± 7.0  56.2 ± 7.0  58.3 ± 8.4 
≥0.0 92  55.6 ± 6.3  56.0 ± 6.6  56.7 ± 6.9  122  56.5 ± 7.6  56.2 ± 6.6  57.4 ± 7.3 
P-trend   0.74  0.42  0.32    0.11  0.28  0.23 
                
BMI-for-age Z score4 at baseline                
<-1.0  58  55.5 ± 6.6  55.0 ± 5.1  55.9 ± 6.6  76  54.1 ± 4.6  54.7 ± 6.1  55.5 ± 6.0 
-1.0 to <0.0 137  56.1 ± 7.2  55.4 ± 6.1  56.3 ± 6.6  200  55.8 ± 7.5  55.7 ± 6.9  57.4 ± 7.9 
0.0 to <1.0 152  55.4 ± 6.2  55.7 ± 6.6  56.1 ± 7.0  202  56.3 ± 7.1  56.3 ± 6.5  58.2 ± 8.1 
≥1.0 95  55.5 ± 5.9  55.2 ± 6.0  56.1 ± 6.2  97  55.7 ± 7.0  56.2 ± 7.1  58.5 ± 8.3 
P-trend   0.64  0.82  0.98    0.08  0.09  0.008 
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 Boys  Girls 
 
n1  
Anxious/ 
Depressed2  
Withdrawn 
/Depressed2  
Somatic 
Complaints2  n  
Anxious/ 
Depressed  
Withdrawn 
/Depressed  
Somatic 
Complaints 
                
Time spent watching television / 
playing video games, h/wk 
  
 
 
 
 
 
   
 
 
 
 
 
<10 124  56.0 ± 6.9  55.1 ± 5.8  56.8 ± 7.2  155  55.0 ± 5.5  55.4 ± 6.1  56.8 ± 7.0 
10 to <20 108  55.0 ± 6.0  55.1 ± 5.2  55.2 ± 6.4  171  55.6 ± 7.4  55.7 ± 6.8  57.5 ± 8.3 
20 to <30 110  55.7 ± 6.8  55.7 ± 6.7  56.7 ± 6.8  125  56.0 ± 7.5  55.4 ± 6.4  57.5 ± 7.7 
≥30 104  56.0 ± 6.2  55.6 ± 6.5  55.9 ± 5.8  116  56.0 ± 6.8  56.3 ± 6.7  58.7 ± 8.3 
P-trend   0.84  0.36  0.66    0.14  0.36  0.07 
                
Time playing outdoors, h/wk                
<1.5 53  55.5 ± 6.1  55.0 ± 5.8  55.8 ± 6.1  109  56.4 ± 7.0  56.5 ± 6.9  58.5 ± 8.1 
1.5 to <4.5 82  56.2 ± 7.6  55.2 ± 5.6  56.1 ± 6.4  113  55.7 ± 7.0  55.6 ± 6.0  56.4 ± 7.2 
4.5 to <10 97  55.3 ± 6.5  55.3 ± 5.8  56.6 ± 6.7  94  55.7 ± 7.7  55.1 ± 6.3  57.2 ± 7.3 
≥10 96  55.1 ± 5.7  54.5 ± 5.9  55.9 ± 7.1  86  55.2 ± 6.7  55.2 ± 5.8  57.1 ± 8.0 
P-trend   0.40  0.58  0.90    0.24  0.11  0.34 
                
Mother’s education, y                
Incomplete primary, 1-4  24  56.4 ± 6.4  56.4 ± 5.8  56.7 ± 6.0  34  56.2 ± 7.4  57.2 ± 8.2  59.7 ± 8.5 
Complete primary, 5  76  55.0 ± 6.4  54.5 ± 5.1  56.0 ± 6.7  109  55.8 ± 6.6  56.4 ± 6.7  58.1 ± 8.4 
Incomplete secondary, 6-10  114  55.5 ± 6.2  55.5 ± 6.1  56.2 ± 6.8  135  56.2 ± 7.2  55.8 ± 6.5  57.5 ± 7.6 
Complete secondary, 11  190  56.2 ± 6.9  55.6 ± 6.6  56.2 ± 6.7  242  55.6 ± 7.2  55.6 ± 6.8  57.5 ± 7.9 
University, >11  42  54.9 ± 5.3  54.8 ± 5.3  56.1 ± 6.2  41  53.7 ± 5.0  54.9 ± 5.7  55.3 ± 4.9 
P-trend   0.80  0.88  0.91    0.17  0.09  0.03 
                
Mother’s parity                
1 47  56.4 ± 7.3  56.5 ± 7.1  56.5 ± 7.0  69  56.5 ± 8.3  56.9 ± 8.3  57.6 ± 6.9 
2 182  55.6 ± 6.1  55.4 ± 6.1  56.3 ± 6.5  198  55.3 ± 6.9  55.5 ± 6.7  57.4 ± 7.2 
3 132  56.0 ± 7.0  55.4 ± 5.8  56.2 ± 7.0  184  55.9 ± 6.6  56.0 ± 6.1  57.6 ± 8.3 
4 45  54.2 ± 5.3  54.4 ± 5.3  55.1 ± 5.1  66  55.9 ± 7.3  56.3 ± 6.7  59.1 ± 9.0 
≥5 40  56.1 ± 6.9  55.0 ± 6.1  56.7 ± 7.1  50  55.5 ± 6.1  54.9 ± 6.3  56.4 ± 7.9 
P-trend   0.59  0.20  0.73    0.84  0.46  0.96 
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 Boys  Girls 
 
n1  
Anxious/ 
Depressed2  
Withdrawn 
/Depressed2  
Somatic 
Complaints2  n  
Anxious/ 
Depressed  
Withdrawn 
/Depressed  
Somatic 
Complaints 
Mother’s height quartile (median), 
cm    
 
 
 
 
 
   
 
 
 
 
Q1, (150) 113  56.0 ± 6.5  54.9 ± 5.6  56.0 ± 6.2  140  56.6 ± 7.7  56.7 ± 7.8  58.6 ± 9.2 
Q2, (155) 121  56.2 ± 7.4  56.2 ± 6.9  56.7 ± 6.7  160  55.4 ± 6.5  55.9 ± 6.4  56.9 ± 7.5 
Q3, (160) 101  55.2 ± 5.5  55.3 ± 6.0  56.2 ± 6.8  126  55.7 ± 6.4  56.1 ± 6.7  57.8 ± 7.8 
Q4, (165) 113  55.6 ± 6.3  55.1 ± 5.7  55.7 ± 6.8  144  54.9 ± 6.8  54.6 ± 5.3  56.8 ± 6.6 
P-trend   0.48  0.87  0.61    0.08  0.02  0.13 
                
Mother’s BMI, kg/m2                
<18.5 19  57.0 ± 6.0  55.4 ± 5.2  56.5 ± 8.2  16  52.8 ± 2.4  53.6 ± 3.9  54.8 ± 5.3 
18.5 to <25.0 261  55.9 ± 6.8  55.5 ± 6.2  56.2 ± 6.9  364  55.7 ± 7.1  55.8 ± 6.7  57.4 ± 7.8 
25.0 to <30.0 135  55.4 ± 6.3  55.4 ± 6.2  56.0 ± 5.9  146  55.4 ± 6.6  55.8 ± 6.7  57.3 ± 7.0 
≥30.0 30  55.8 ± 5.5  55.2 ± 5.3  56.3 ± 6.8  39  57.2 ± 6.7  56.8 ± 6.8  60.6 ± 10.2 
P-trend   0.42  0.83  0.88    0.20  0.27  0.06 
                
Food insecurity                
None 119  55.1 ± 6.0  54.9 ± 5.5  55.5 ± 6.0  135  56.6 ± 8.0  56.3 ± 6.8  58.3 ± 8.1 
Insecure – no hunger 222  55.7 ± 6.7  55.4 ± 6.0  56.6 ± 6.8  283  55.5 ± 7.0  55.8 ± 6.9  57.8 ± 8.2 
Insecure – moderate hunger 78  56.4 ± 6.7  56.4 ± 7.5  56.2 ± 6.9  98  55.9 ± 6.5  55.9 ± 6.9  57.3 ± 6.4 
Insecure – severe hunger 38  55.8 ± 5.9  54.2 ± 4.7  55.1 ± 6.1  66  54.5 ± 5.0  54.7 ± 5.1  55.8 ± 7.3 
P-trend   0.26  0.69  0.95    0.08  0.11  0.03 
                
Socioeconomic status                
1 (lowest) 27  58.5 ± 9.7  55.5 ± 7.2  56.4 ± 6.5  33  53.6 ± 5.7  53.3 ± 4.5  56.4 ± 6.9 
2 137  56.3 ± 7.0  55.8 ± 6.0  57.2 ± 7.6  180  55.9 ± 6.9  56.4 ± 7.1  57.5 ± 7.8 
3 258  55.2 ± 5.8  55.2 ± 5.9  55.6 ± 6.1  332  55.7 ± 7.0  55.8 ± 6.6  57.8 ± 8.0 
4 36  55.1 ± 6.1  54.7 ± 6.5  55.3 ± 5.0  39  56.6 ± 8.0  55.5 ± 6.2  57.4 ± 6.8 
P-trend   0.03  0.35  0.04    0.21  0.58  0.50 
                
Micronutrient status                 
Iron deficiency5                
Yes 14  60.4 ± 8.6  56.6 ± 6.8  61.4 ± 8.5  15  54.3 ± 6.9  52.9 ± 2.9  58.3 ± 6.9 
No 400  55.6 ± 6.5  55.4 ± 6.1  56.1 ± 6.6  489  55.9 ± 7.0  55.9 ± 6.6  57.6 ± 8.0 
P6   0.03  0.49  0.02    0.37  0.0002  0.67 
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 Boys  Girls 
 
n1  
Anxious/ 
Depressed2  
Withdrawn 
/Depressed2  
Somatic 
Complaints2  n  
Anxious/ 
Depressed  
Withdrawn 
/Depressed  
Somatic 
Complaints 
Anemia7                
Yes 10  59.8 ± 6.2  55.1 ± 5.2  61.0 ± 8.0  18  55.1 ± 8.6  54.1 ± 6.2  57.4 ± 6.4 
No 413  55.6 ± 6.6  55.4 ± 6.1  56.1 ± 6.6  498  55.9 ± 7.0  55.9 ± 6.5  57.7 ± 8.0 
P   0.03  0.87  0.04    0.68  0.21  0.83 
                
Serum zinc quartile (median 
boys/girls), µmol/L 
  
 
 
 
 
 
   
 
 
 
 
 
Q1, (15.3/15.1) 106  56.1 ± 5.8  55.3 ± 6.4  56.3 ± 7.1  127  56.2 ± 7.1  55.8 ± 6.4  58.3 ± 8.4 
Q2, (18.6/18.2) 104  55.2 ± 6.1  55.0 ± 5.2  55.1 ± 5.6  128  55.5 ± 6.5  55.4 ± 5.7  57.9 ± 8.6 
Q3, (22.1/22.3) 104  56.1 ± 7.7  55.9 ± 7.4  56.4 ± 6.9  127  56.3 ± 7.3  56.4 ± 7.4  57.3 ± 7.6 
Q4, (30.7/29.6) 107  55.7 ± 6.8  55.3 ± 5.3  56.9 ± 7.1  128  55.3 ± 6.9  55.6 ± 6.6  57.3 ± 7.3 
P-trend   0.98  0.71  0.31    0.53  0.88  0.26 
                
Vitamin A, µg/dL                
<20 63  56.9 ± 7.7  56.7 ± 7.0  57.3 ± 7.1  76  55.5 ± 7.2  55.0 ± 6.4  56.8 ± 7.0 
20-29.9 188  55.8 ± 6.7  55.4 ± 6.3  56.1 ± 6.1  211  55.5 ± 7.1  55.9 ± 6.8  57.7 ± 8.4 
≥30 173  55.3 ± 6.0  54.9 ± 5.5  56.0 ± 7.1  228  56.3 ± 6.9  56.0 ± 6.3  58.0 ± 8.0 
P-trend   0.13  0.06  0.28    0.26  0.26  0.28 
                
Plasma vitamin B-12 quartile 
(median boys/girls), pmol/L 
  
 
 
 
 
 
   
 
 
 
 
 
Q1, (204/218) 105  56.6 ± 7.9  55.2 ± 7.1  57.3 ± 7.8  123  55.5 ± 6.5  55.9 ± 6.7  57.8 ± 7.7 
Q2, (278/303) 100  55.1 ± 5.8  55.4 ± 5.7  54.9 ± 5.8  122  56.5 ± 7.1  56.5 ± 6.8  57.6 ± 8.2 
Q3, (345/363) 104  55.8 ± 6.3  55.4 ± 5.8  56.4 ± 6.6  123  55.4 ± 7.7  55.4 ± 6.5  57.2 ± 8.2 
Q4, (450/452) 103  55.7 ± 6.3  55.7 ± 6.0  56.3 ± 6.4  124  55.9 ± 6.4  55.7 ± 6.2  58.0 ± 7.8 
P-trend   0.49  0.61  0.60    0.99  0.47  0.97 
                
Erythrocyte folate quartile (median 
boys/girls), nmol/L    
 
 
 
 
 
   
 
 
 
 
Q1, (633/573) 100  54.6 ± 6.0  55.1 ± 6.2  55.4 ± 6.1  123  56.4 ± 7.9  55.9 ± 7.1  57.5 ± 8.5 
Q2, (759/735) 102  56.2 ± 7.3  54.8 ± 6.4  57.0 ± 7.4  124  54.7 ± 6.0  55.4 ± 6.0  57.2 ± 7.4 
Q3, (898/874) 101  56.0 ± 6.5  55.4 ± 5.8  56.4 ± 7.2  124  56.7 ± 7.5  56.0 ± 6.3  58.1 ± 8.0 
Q4, (1122/1062) 101  55.9 ± 6.1  56.3 ± 6.2  56.0 ± 5.9  124  55.5 ± 6.4  55.9 ± 6.7  58.1 ± 8.1 
P-trend   0.19  0.14  0.62    0.80  0.86  0.42 
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Footnotes to Supplemental Table 2.2 
 
1  Sums may be less than the total due to missing values in covariates. 
 
2  Mean ± SD 
 
3  Test for linear trend when a variable representing ordinal categories of the characteristic was 
introduced into a linear regression model as a continuous predictor.  Empirical estimates of the 
variance were used in all models.  
 
4  According to the World Health Organization growth reference for children and adolescents 
(34). 
 
5  Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis.  
 
6  From linear regression with internalizing problems subscales score as the continuous outcome 
and the nutrient biomarker as the categorical predictor.   
 
7  Hemoglobin <12.7 g/dL.
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Supplemental Table 2.3. Sociodemographic characteristics in middle childhood and in 
adolescence in the Bogotá School Children Cohort 
Characteristic n 
Middle 
childhood 
 Adolescence 
 
P1 
       
Single mother, % 902 25.5  28.1  0.05 
       
Mother’s education, y, mean ± SD 882  9.0 ± 3.2   9.5 ± 3.5  <0.0001 
       
Mother’s parity, mean ± SD 917  2.7 ± 1.1   2.8 ± 1.1  <0.0001 
       
Mother’s BMI, kg/m2, mean ± SD 836  24.1 ± 3.7   25.6 ± 4.1  <0.0001 
       
Food secure, % 983 24.8  51.0  <0.0001 
       
Low socioeconomic status (strata 1), % 966 5.6  5.7  0.84 
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Footnotes to Supplemental Table 2.3 
 
1   From an intercept-only linear regression model with change in the covariate as the outcome. 
Empirical estimates of the variance and an independent correlation matrix were specified in all 
models. 
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Supplemental Table 2.4. Change in sociodemographic characteristics from middle childhood to 
adolescence and behavior problems in adolescence in the Bogotá School Children Cohort 
Characteristic 
 Total 
externalizing 
problems 
Mean difference 
(95% CI)1 
 Total 
internalizing 
problems 
Mean difference 
(95% CI) 1 
 
   
      
Mother became single, yes vs. no                         
Boys  -1.3 (-4.6, 2.0)  -0.7 (-3.7, 2.3)  
Girls  0.0 (-3.3, 3.2)  -0.9 (-3.7, 2.0)  
      
Change in mother’s education, per 1 year      
Boys  0.0 (-0.4, 0.4)  0.0 (-0.5, 0.4)  
Girls  -0.3 (-0.7, 0.1)  -0.4 (-0.8, 0.0)  
      
Change in mother’s parity, per 1 child      
Boys  1.5 (-0.4, 3.4)  0.8 (-0.8, 2.4)  
Girls  -0.2 (-2.3, 2.0)  0.2 (-2.3, 2.6)  
      
Change in mother’s BMI, per kg/m2      
Boys  0.3 (-0.1, 0.6)  0.0 (-0.4, 0.3)  
Girls  -0.2 (-0.6, 0.1)  0.0 (-0.3, 0.3)  
      
Household became food secure, yes vs. no      
Boys  -1.0 (-2.9, 1.0)  -0.6 (-2.5, 1.4)  
Girls  -0.5 (-2.2, 1.3)  0.6 (-1.2, 2.4)  
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Footnotes to Supplemental Table 2.4 
 
1  From a linear regression model with behavior problems score as the continuous outcome and 
change in the covariate as the exposure. Empirical estimates of the variance and an independent 
correlation matrix were specified in all models. 
 
76 
 
Supplemental Figure 2.1. Adjusted mean differences and 95% confidence intervals (CI) in externalizing problems subscale score (A. 
aggressive behavior scores and B. rule breaking behavior scores) at 11-18 years of age according to micronutrient status and 
sociodemographic characteristics in middle childhood in the Bogotá School Children Cohort.  
A.  Aggressive behavior scores 
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B. Rule breaking behavior scores 
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Footnotes to Supplemental Figure 2.1 
 
1  Adjusted mean difference and 95% CI from a linear regression model with aggressive behavior 
score as the continuous outcome.  Predictors included all variables presented.  Empirical 
variances were specified.   
 
2  χ2 score statistic for plasma vitamin B-12, child’s age at baseline, BMI-for-age Z score at 
baseline, time spent watching television/playing video games, and mother’s BMI. Test for linear 
trend for mother’s height quartile. 
 
3  According to the World Health Organization growth reference for children and adolescents 
(34). 
 
4  Adjusted mean difference and 95% CI from a linear regression model with rule breaking 
behavior score as the continuous outcome.  Predictors included all variables presented.  
Empirical variances were specified.   
 
5  χ2 score statistic for anemia, child’s age at baseline, time spent watching television/playing 
video games, and socioeconomic status. Test for linear trend for height-for-age Z score at 
baseline and mother’s height quartile. 
 
6  Hemoglobin <12.7 g/dL.
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Supplemental Figure 2.2. Adjusted mean differences and 95% confidence intervals (CI) in internalizing problems subscale score (A. 
anxious/depressed scores, B. withdrawn/depressed scores, and C. somatic complaints scores) at 11-18 years of age according to 
micronutrient status and sociodemographic characteristics in middle childhood in the Bogotá School Children Cohort.   
 
A.  Anxious/depressed scores 
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B.  Withdrawn/depressed scores   
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C. Somatic complaints scores 
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Footnotes to Supplemental Table 2.2 
 
1  Adjusted mean difference and 95% CI from a linear regression model with anxious/depressed 
behavior score as the continuous outcome.  Predictors included all variables presented.  
Empirical variances were specified.   
 
2  χ2 score statistic for iron deficiency, anemia, child’s age at baseline, BMI-for-age Z score at 
baseline, and socioeconomic status. Test for linear trend for mother’s height quartile and food 
insecurity in the household. 
 
3  Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis. 
 
4  Hemoglobin <12.7 g/dL. 
 
5  According to the World Health Organization growth reference for children and adolescents 
(34). 
 
6  Adjusted mean difference and 95% CI from a linear regression model with 
withdrawn/depressed score as the continuous outcome.  Predictors included all variables 
presented.  Empirical variances were specified.   
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7  χ2 score statistic for iron deficiency, child’s age at baseline, BMI-for-age Z score at baseline, 
and socioeconomic status. Test for linear trend for mother’s height quartile. 
 
8  Adjusted mean difference and 95% CI from a linear regression model with somatic complaints 
score as the continuous outcome.  Predictors included all variables presented.  Empirical 
variances were specified.   
 
9  χ2 score statistic for iron deficiency, anemia, plasma vitamin B-12, child’s age at baseline, 
BMI-for-age Z score at baseline, and socioeconomic status. Test for linear trend for mother’s 
education, mother’s height quartile, and food insecurity in the household.
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Supplemental Figure 2.3. Adjusted mean differences and 95% confidence intervals (CI) in though problems subscale score at 11-18 
years of age according to micronutrient status and sociodemographic characteristics in middle childhood in the Bogotá School 
Children Cohort 
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Footnotes to Supplemental Table 2.3 
 
1  Adjusted mean difference and 95% CI from a linear regression model with thought problems 
score as the continuous outcome.  Predictors included all variables presented.  Empirical 
variances were specified.   
 
2  χ2 score statistic for iron deficiency, anemia, child’s age at baseline, BMI-for-age Z score at 
baseline, mother’s BMI, and socioeconomic status. Test for linear trend for mother’s height 
quartile and food insecurity in the household. 
 
3  Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis. 
 
4  Hemoglobin <12.7 g/dL. 
 
5  According to the World Health Organization growth reference for children and adolescents 
(34). 
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Chapter 3. Vitamin D Deficiency and Vitamin D Binding Protein in Middle Childhood         
and Behavior Problems in Adolescence 
Abstract 
Vitamin D deficiency (VDD) is associated with adverse psychiatric outcomes in adults. 
Vitamin D binding protein (DBP) transports vitamin D to target tissues and may influence 
vitamin D status. It is uncertain whether VDD or DBP in middle childhood are associated with 
later behavior problems. We examined whether VDD (25-hydroxy vitamin D <50 nmol/L) or 
low DBP concentration (<2497 nmol/L) at ages 5-12 y were associated with total externalizing 
and internalizing behavior problems and their subscales, after a median 6 y among 278 
schoolchildren from Bogotá, Colombia. Behavior problems were assessed with the Youth Self-
Report. We estimated mean problems score differences and 95% CIs between exposure 
categories with the use of multivariable linear regression. The percent of the associations 
between DBP and behavior problems mediated through VDD was assessed under the 
assumptions of a counterfactual frame. Mean ± SD externalizing and internalizing problems 
scores were 53.2 ± 9.5 and 53.7 ± 9.8, respectively. Prevalence of VDD was 10.3%. VDD was 
associated with an adjusted 3.8 (95% CI 0.7, 7.0; P=0.02) units higher total externalizing 
problems. Low DBP concentration was related to an adjusted 1.8 (95% CI 0.1, 3.6; P=0.04) and 
2.1 (95% CI 0.6, 3.6; P=0.006) units higher aggressive behavior and anxious/depressed scores, 
respectively. The associations between low DBP and behavior problems were not mediated 
87 
 
through VDD. VDD and low DBP in middle childhood are related to behavior problems in 
adolescence. 
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Introduction 
 Psychiatric disorders are the leading cause of years lived with disability worldwide. 
Vitamin D deficiency (VDD) is associated with depression in adults (1), but little is known about 
VDD during development. Externalizing and internalizing behavior problems in childhood and 
adolescence are related to psychiatric disorders later in life. Results of prospective studies on 
vitamin D in pregnancy and behavior problems of the offspring are inconsistent (2-4). Although 
the brain develops throughout childhood, only one study has investigated the relation of middle 
childhood vitamin D on behavior problems in adolescence. Among 2267 children in England, 
serum 25-hydroxy vitamin D [25(OH)D] was inversely associated with prosocial problems (5). 
Little else is known about vitamin D’s role in the development of adolescent behavior problems, 
which may predict adverse psychiatric outcomes in adults. 
Vitamin D binding protein (DBP) binds and transports vitamin D to target tissues. Extra-
hepatic synthesis of DBP has been demonstrated in hypothalamic regions that produce 
neurotransmitters involved in the stress response (6), which suggests a potential role of DBP on 
behavior. However, this association has not been investigated. 
The objective of this study was to examine the associations of VDD and circulating DBP 
in middle childhood with externalizing and internalizing behavior problems in adolescence. We 
hypothesized that VDD and low DBP concentration would be positively associated with 
behavior problems in adolescence.   
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Methods 
Study design and population 
We conducted this longitudinal investigation as part of the Bogota School Children 
Cohort, which has been detailed previously (7). In brief, in February 2006 we recruited 3202 
children aged 5-12 y through random selection from primary public schools in Bogotá, 
Colombia. At baseline, we obtained information on sociodemographic characteristics and health 
habits of children and their parents with the use of a parental self-administered survey. Trained 
research assistants measured the children’s height and weight and obtained fasting blood samples 
through antecubital venipuncture. Samples were protected from sunlight and transported on the 
day of collection to the Colombian National Institute of Health, where they were cyrostored.  
Between 2011-2015, we conducted an in-person follow-up assessment for a random 
sample of 1139 participants. During this assessment, we ascertained behavior problems with the 
Youth Self-Report (YSR) of the Child Behavior Checklist series. The YSR, a self-administered 
questionnaire validated for adolescents aged 11-18 y (8), consists of 112 questions on behaviors 
or feelings that adolescents may experience. It has been widely used in other Latin American 
settings (9). From the participants’ responses to the questionnaire, we computed sex- and age-
standardized continuous scores for 8 behavior problems subscales (aggressive and rule breaking 
behavior, anxious/depressed, withdrawn/depressed, somatic complaints, and attention, social, 
and thought problems) using the Assessment Data Manager software. The software then 
computed scores for total externalizing and internalizing problems composite scales, which are 
comprised of the aggressive and rule breaking behavior, and the anxious/depressed, 
withdrawn/depressed, and somatic complaints subscales, respectively.  
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 Primary caregivers gave written informed consent. Youth gave written assent to 
participate. The Ethics Committee of the National University of Colombia Medical School and 
the Institutional Review Board at the University of Michigan (UM) approved the study. 
Laboratory methods 
Plasma 25(OH)D was quantified in a random subset of the samples collected at 
recruitment at Children’s Hospital Boston by an enzyme immunoassay (Immunodiagnostic 
Systems Inc.) with a competitive binding technique (10). This validated method has a sensitivity 
of 2.5 ng/mL, and an inter- and intra-assay CV of 11.2% and 8.1%. Plasma DBP was measured 
with a Quantikine ELISA kit (R&D Systems, Inc.) that uses a monoclonal antibody specific to 
DBP at the Center for Chemical Genomics, UM. The mean CV for replicate measures was 
13.21%; individual sample CVs ranged from 0.02% to 33.05%. 
Data analysis 
278 children in the vitamin D subset completed the YSR. Five children who were not 11-
18 y old were excluded from the analyses; thus, the final sample consisted of 273 children. The 
primary outcomes were the continuous scores for total externalizing and internalizing problems. 
Secondary outcomes were the 8 behavior problems subscales scores. Primary exposures were 
VDD defined as plasma 25(OH)D <50 nmol/L, a cutpoint recommended by the United States 
Endocrine Society (11), and low plasma DBP defined as DBP below the population median 
(2497 nmol/L), since there are no conventionally accepted cutpoints.  
 In bivariate analysis, we compared the distributions of behavior problems scores across 
categories of VDD and low DBP with the use of the Wilcoxon rank-sum test. We then estimated 
mean adjusted differences and 95% CIs in behavior problems scores between exposure 
categories with the use of multivariable linear regression with empirical estimates of variance. 
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All models were adjusted for baseline age, sex, and time spent watching television/playing video 
games, which are independent predictors of behavior problems in this population (Robinson et 
al., accepted J Nutr). Estimates by VDD categories were additionally adjusted for low DBP, 
since DBP may influence 25(OH)D concentrations (12). In supplemental analyses, we calculated 
the proportion of the associations of low DBP with the outcomes that was mediated through 
VDD, assuming no unmeasured confounding and no effect of the exposure on confounders of the 
mediator-outcome relation, with use of the %mediation macro (13) for the Statistical Analysis 
System version 9.4 (SAS Institute Inc.).  
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Results 
Mean ± SD age at enrollment was 8.6 ± 1.6 y; 53.5% of children were girls. Mean ± SD 
age at the follow-up assessment was 14.7 ± 1.7 y. Mean ± SD externalizing and internalizing 
problems scores were 53.2 ± 9.5 and 53.7 ± 9.8, respectively. 
Vitamin D. Mean ± SD plasma 25(OH)D was 74.1 ± 25.8 nmol/L. VDD prevalence was 
10.3%. In bivariate analysis, VDD was positively associated with total externalizing problems, 
aggressive behavior, and rule breaking behavior scores (Table 1). After multivariable 
adjustment, children with VDD had 3.8 units (P=0.02) higher total externalizing problems scores 
compared with children without VDD. Total internalizing problems and subscale scores were 
higher in children with versus without VDD, but these differences were not statistically 
significant after adjustment. 
DBP. Mean ± SD DBP concentration was 2660 ± 1131 nmol/L. Low DBP concentration 
was associated with higher aggressive behavior scores in bivariate analysis (Table 2). In 
multivariable analysis, low DBP concentration was associated with higher aggressive behavior 
(P=0.04) and anxious/depressed (P=0.006) scores (Table 2).  
Mediation. Low DBP and VDD were weakly positively associated with each other; the 
prevalence of VDD in low and high DBP categories was 11.0% and 9.6%, respectively. VDD 
did not mediate the association between low DBP and total externalizing problems (% 
mediated=0.8) or aggressive behavior (% mediated=0.4) scores. 
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Discussion 
 In this longitudinal study, VDD in middle childhood was associated with higher total 
externalizing problems scores in adolescence. In addition, low DBP concentration was associated 
with higher aggressive behavior and anxious/depressed scores.  
 Previous studies focused on the potential effects of vitamin D status in pregnancy on 
behavior problems of the offspring. Early pregnancy 25(OH)D concentrations were inversely 
associated with externalizing problems in childhood (2), whereas late pregnancy 25(OH)D 
concentrations were not associated with behavior problems (3, 4). The potential effects of early 
pregnancy VDD on behavior could relate to altered brain morphology and neurotransmitter 
metabolism, which may impact inhibitory and social responses, according to studies in rodents 
(14). Only one previous investigation addressed the relation of vitamin D status in middle 
childhood and later behavior. Among 2267 English children, serum 25(OH)D at ages 7-9 y was 
inversely associated with prosocial problems at age 11 y (5). Follow-up was short; externalizing 
and internalizing problems often develop later in adolescence. Mechanisms by which VDD in 
middle childhood influences behavioral development may differ from those related to 
intrauterine exposure. During middle childhood, dopamine receptor density decreases, which 
may indicate synaptic pruning. VDD could influence this process by modifying the expression of 
glial cell line-derived neurotrophic factor, which promotes the survival of dopaminergic neurons. 
Dopamine regulates emotions and motivation, and thus alterations in the dopaminergic system 
may have long lasting impacts on behavior. 
In our study, low DBP concentration was associated with higher aggressive behavior and 
anxious/depressed scores. This is contrary to results from two case-control studies in adults in 
which major depressive disorder (MDD) was positively related to DBP concentration (15, 16). 
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Results may not be comparable due to reverse causation; MDD alters the inflammatory response, 
which may be associated with higher concentrations of DBP. Further, exposure in adulthood 
could have different effects than in middle childhood. Mechanisms that might explain this 
association are speculative as this association was not mediated by vitamin D. The functions of 
DBP in the innate immune response as a chemotaxic enhancer, a macrophage-activating factor, 
and through binding extracellular actin (17) could relate to behavior problems. 
 The strengths of our study include its prospective nature, which minimizes reverse 
causation bias. Further, the vitamin D biomarker we used integrates dietary and sunlight sources 
of the vitamin. We also tested a novel hypothesis on the potential role of DBP on behavioral 
development. Finally, we used a validated questionnaire to measure adolescent behavior 
problems (8).  
 There are limitations as well. We lacked a baseline measurement of behavior. Moreover, 
25(OH)D and DBP concentrations may reflect long-term exposure, rather than middle childhood 
exposure specifically. This limits our ability to identify target ages for intervention. Plasma DBP 
concentrations vary by isoform of the protein, determined by genetic variants in the GC gene. 
Among Hispanics, the predominant isoform is 1f/1f (34-35%), followed by 1s/2 (16-18%), 1s/1s 
(14-18%), 1f/2 (15-16%), 1f/1f (13-14%) and 2/2 (3-4%) (12, 18). If isoform distribution is 
related to behavior outcomes, our results may be confounded by genetics. Finally, the findings 
may not be generalizable to settings with higher or lower income populations or different 
nutritional profiles.  
 In conclusion, VDD and low DBP concentration in middle childhood were associated 
with behavior problems in adolescence. Additional studies in other populations with different 
distributions of vitamin D status and DBP are warranted.   
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Table 3.1. Youth Self-Report behavior scores at 11-18 y of age according to plasma 25-hydroxy 
vitamin D [25(OH)D] concentrations in middle childhood among children from Bogotá, 
Colombia 
Behavior problems1  Plasma 25(OH)D  P2  Adjusted 
difference  
(95% CI)3 
 ≥50 nmol/L 
n=245 
 <50 nmol/L 
n=28 
  
              
Externalizing problems              
Total   52.7 ± 9.6  57.4 ± 7.7  0.009  3.8 (0.7, 7.0) 
Aggressive behavior  56.1 ± 7.5  58.7 ± 7.9  0.03  2.2 (-0.9, 5.3) 
Rule breaking behavior  54.8 ± 5.4  56.6 ± 5.4  0.03  1.8 (-0.4, 3.9) 
              
Internalizing problems              
Total  53.4 ± 9.9  56.0 ± 8.3  0.22  2.7 (-0.5, 6.0) 
Anxious/depressed  55.5 ± 6.5  55.9 ± 7.1  0.80  0.6 (-2.2, 3.4) 
Withdrawn/depressed  55.3 ± 6.0  56.5 ± 7.1  0.32  1.4 (-1.4, 4.1) 
Somatic complaints  56.9 ± 7.6  58.5 ± 8.7  0.14  1.7 (-1.7, 5.2) 
              
Other problems              
Attention problems  52.4 ± 4.1  51.9 ± 2.6  0.83  -0.9 (-2.0, 0.2) 
Social problems  56.4 ± 6.9  56.2 ± 7.0  0.81  -0.4 (-3.0, 2.3) 
Thought problems  54.7 ± 5.8  55.5 ± 5.6  0.32  0.7 (-1.6, 3.0) 
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Footnotes to Table 3.1. 
 
1 Mean ± SD. 
 
2 From Wilcoxon rank-sum tests. 
 
3 From linear regression models with the behavior problems score as the continuous outcome. 
Predictors included indicator variables for VDD, sex, and low DBP, and baseline age and usual 
weekly hours spent watching television/playing video games as continuous. Empirical variances 
were specified in each model.   
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Table 3.2. Youth Self-Report behavior scores at 11-18 y of age according to plasma vitamin D 
binding protein (DBP) concentrations in middle childhood among children from Bogotá, 
Colombia 
 
Behavior problems1  Plasma DBP   P2  Adjusted 
difference 
(95% CI)3 
 ≥2497 nmol/L 
n=136 
 <2497 nmol/L 
n=137 
  
              
Externalizing problems              
Total   52.3 ± 9.1  54.0 ± 10.0  0.10  1.6 (-0.6, 3.8) 
Aggressive behavior  55.3 ± 6.9  57.3 ± 8.0  0.02  1.8 (0.1, 3.6) 
Rule breaking behavior  54.8 ± 5.3  55.2 ± 5.5  0.67  0.4 (-0.9, 1.7) 
              
Internalizing problems              
Total  53.1 ± 8.6  54.3 ± 10.9  0.16  1.5 (-0.8, 3.8) 
Anxious/depressed  54.6 ± 5.6  56.5 ± 7.2  0.07  2.1 (0.6, 3.6) 
Withdrawn/depressed  55.4 ± 5.8  55.5 ± 6.5  0.91  0.2 (-1.3, 1.6) 
Somatic complaints  56.4 ± 7.5  57.6 ± 7.9  0.21  1.3 (-0.5, 3.2) 
              
Other problems              
Attention problems  52.2 ± 3.9  52.6 ± 3.9  0.15  0.3 (-0.6, 1.3) 
Social problems  55.8 ± 6.0  57.0 ± 7.7  0.49  1.3 (-0.3, 2.9) 
Thought problems  54.2 ± 4.9  55.4 ± 6.5  0.23  1.3 (0.0, 2.7) 
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Footnotes to Table 3.2 
 
1 Mean ± SD. 
 
2 From Wilcoxon rank-sum tests. 
 
3 From linear regression models with the behavior problems score as the continuous outcome. 
Predictors included indicator variables for low DBP and sex, and baseline age and usual weekly 
hours spent watching television/playing video games as continuous. Empirical variances were 
specified in each model.   
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Chapter 4. Polyunsaturated Fatty Acids in Middle Childhood and                                
Externalizing and Internalizing Behavior Problems in Adolescence 
Abstract 
Long-chain omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acids (PUFA) are essential 
for brain structural and functional development. It is unclear whether PUFA status in childhood 
could be related to neurobehavioral outcomes later in life. We sought to determine the 
associations of n-3 and n-6 PUFA in middle childhood with externalizing and internalizing 
behavior problems in adolescence. We quantified n-3 and n-6 PUFA in serum samples of 444 
Colombian schoolchildren who were 5-12 y of age at the time of enrollment into a cohort study, 
using gas-liquid chromatography. After a median 6 y follow-up, adolescent externalizing and 
internalizing behavior problems were determined with the Youth Self Report questionnaire. We 
estimated adjusted mean behavior problems score differences with 95% confidence intervals (CI) 
between quartiles of each PUFA, with the use of multivariable linear regression. We also 
considered as exposures the Δ6-desaturase (D6D) and Δ5-desaturase (D5D) enzyme activity 
indices. Docosapentaenoic acid (DPA) was inversely associated with externalizing problems in a 
linear manner. Every standard deviation (SD) of DPA concentration was related to an adjusted 
0.9 unit lower externalizing problems score (95% CI: -1.7, 0.0). By contrast, every SD of the 
docosahexaenoic acid (DHA) distribution was associated with 1 adjusted unit higher 
externalizing problems score (95% CI: 0.1, 1.9). The D5D enzyme activity index was inversely 
related to externalizing problems. Alpha-linolenic acid (ALA) concentration was positively 
associated with internalizing problems, whereas adrenic acid (AdA) was inversely related to this 
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outcome. DPA in middle childhood is inversely related to externalizing problems in adolescence 
whereas DHA is positively associated with this endpoint. ALA and AdA are related to 
internalizing problems in opposite directions. Some of these associations might reflect the role of 
D5D enzyme activity.  
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Introduction 
One in five adolescents worldwide has an externalizing or internalizing disorders such as 
attention deficit hyperactivity, bipolar, depressive, or anxiety disorder (1). These disorders lie at 
the extreme end of a continuum of behavior problems in adolescence. Externalizing and 
internalizing problems in youth are relevant to adult health and social status because they are 
associated with low educational attainment (2), substance use (3), psychiatric disorders (4), and 
criminality (5) later in life. 
Omega-3 (n-3) and omega-6 (n-6) polyunsaturated fatty acids (PUFA) are essential for 
adequate neurodevelopment. The precursors of each family, alpha-linolenic acid (18:3 n-3, ALA) 
and linoleic acid (18:2 n-6, LA), respectively, cannot be synthesized in humans and are therefore 
considered essential as they must be obtained from the diet. ALA and LA are metabolized into 
longer chain PUFA through a series of elongation and desaturation reactions. Conversion of 
ALA and LA to longer chain PUFA is considered biologically inefficient and efficiency varies 
from person-to-person depending on the Δ6-desaturase (D6D) and Δ5-desaturase (D5D) enzyme 
activity. These long-chain PUFA can also be obtained directly from diet.  
Different mechanisms explain the roles of PUFA on brain function and development. The 
long-chain PUFA docosahexaenoic acid (22:6 n-3, DHA), arachidonic acid (20:4 n-6, AA), and 
adrenic acid (22:4 n-6, AdA) accumulate in the fetal brain (6) and DHA accretion continues 
throughout childhood (7). PUFA incorporate into neuronal and glial cell membranes where they 
impact membrane protein function and fluidity, neuronal arborization, and synaptogenesis (8). 
N-3 PUFA, such as DHA, influence monoamine neurotransmitter transportation and metabolism 
(9, 10) and long-chain n-3 PUFA are precursors to anti-inflammatory eicosanoids, which exert 
antidepressant effects in rodent models (11). On the other hand, long-chain n-6 PUFA, such as 
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AA and AdA, metabolize into oxidative, pro-inflammatory eicosanoids which promote 
neuroinflammation, (12) and thus may play an etiologic role in the development of psychiatric 
disorders (13).  
Epidemiologic research on the role of PUFA on behavior has focused primarily on 
maternal or infant DHA and AA PUFA status in relation to behavior problems in early or middle 
childhood. DHA concentration has been inversely associated with internalizing problems in 
some (14-16) but not all (17, 18) studies. Results for AA are similarly mixed (14-18). Although 
approximately half of externalizing or internalizing disorders develop in adolescence (19), very 
few studies have included this age group. In Australia, n-3 PUFA intake in adolescence was not 
associated with depressive symptoms three years later (20). In a short-term trial of adolescents 
from the United Kingdom (UK), supplementation with n-3 PUFA, vitamins, and minerals 
resulted in improved behavior after 12 weeks but the effect cannot be necessarily attributed to 
PUFA (21). Among Mauritian children 8-16 y of age, n-3 PUFA supplementation for 6 months 
decreased aggression after one year (22). No study has examined the relations of PUFA status in 
middle childhood and behavior problems in adolescence, after an extended follow-up.  
The aim of this study was to investigate the associations between serum PUFA 
concentrations at ages 5-12 y and externalizing and internalizing problems in adolescence among 
schoolchildren from Bogotá, Colombia. We hypothesized that high concentrations of n-3 PUFA 
would be inversely related to externalizing and internalizing problems in adolescence whereas 
high concentrations of n-6 PUFA would be positively related to these outcomes. Because 
endogenous conversion of essential fatty acids (FA) into long-chain PUFA depends on 
desaturase enzymes, as an exploratory aim we examined the associations of desaturase 
enzymatic activity indices with behavioral outcomes.  
106 
 
Methods 
Study design and population 
We conducted this study in the context of the Bogotá School Children Cohort, a 
prospective investigation of nutrition and health in Bogotá, Colombia. Details on the cohort 
design have been previously published (23). In brief, in February 2006, we randomly sampled 
3202 primary schoolchildren aged 5-12 y from public schools in Bogotá and enrolled them into 
the study. Since the majority of children in the public school system in Bogotá are from low- and 
middle-income socioeconomic backgrounds, our sample pertains to these groups. The parents or 
primary caregivers of all children gave written informed consent prior to enrollment into the 
study and before the follow-up assessment. Children gave written assent to participate. The study 
protocol was approved by the Ethics Committee of the National University of Colombia Medical 
School. The Institutional Review Board at the University of Michigan approved the use of data 
from the study.  
Baseline information 
At the time of enrollment, we obtained information on sociodemographic characteristics 
of children and their families through a parental self-administered questionnaire. The survey 
inquired about child characteristics and health habits, maternal age, education level, height, and 
weight, and the household’s socioeconomic status (SES) per the classification by the local 
government for tax and planning purposes. The level of household food insecurity was assessed 
with a Spanish-language version of the United States Department of Agriculture Household Food 
Security Survey module (24) that has been validated for use in this setting (25).  
During the weeks following enrollment, trained research assistants visited schools to 
collect anthropometric data and blood samples from the children. At these visits, height was 
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measured without shoes to the nearest 1 mm with a wall-mounted portable Seca 202 stadiometer 
(Seca, Hanover, MD) and weight was measured in light clothing to the nearest 0.1 kg with Tanita 
H5301 electronic scales (Tanita, Arlington Heights, IL). Research assistants also measured 
height and weight among mothers who were present at schools. At the end of the visit, 
investigators collected fasting blood samples through antecubital venipuncture in 88% of 
children. One aliquot was collected in a metal-free polypropylene tube without anticoagulant for 
separation of serum. The samples were protected from sunlight and transported on dry ice to the 
Colombian National Institute of Health on the day of collection, where they were processed and 
cryostored. Samples were then transported to the United States for analyses.   
Follow-up 
Between 2011-2015 we conducted an in-person follow-up assessment on a random 
sample of 1139 cohort participants. At this assessment, we ascertained adolescent behavior 
problems with the Spanish language version of the Youth Self Report (YSR) (26). The YSR is a 
self-administered questionnaire designed for use in adolescents aged 11-18 y (27). The 
questionnaire consists of 112 statements of behaviors or feelings that the adolescents rate as 
never/false, sometimes true, or very/often true. From responses to these questions, we calculated 
continuous scores for 8 behavior problems subscales using software provided by the test 
developer (28): aggressive behavior, rule breaking behavior, anxious/depressed, 
withdrawn/depressed, somatic complaints, attention problems, social problems, and thought 
problems. We then computed scores for total externalizing and internalizing problems scores. 
The total externalizing problems score is calculated as the sum of the aggressive and rule 
breaking behavior subscale scores while the sum of anxious/depressed, withdrawn/depressed, 
and somatic complaints subscale scores comprise the total internalizing problems score. The 
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scores are standardized by age and sex to a reference population derived from data collected 
periodically in the United States (28). The YSR has been widely used in other Latin American 
settings (26, 29, 30). 
Laboratory methods 
Quantification of serum FA took place at the University of Michigan Metabolomics and 
Obesity Research Center. Lipids were extracted from baseline serum samples in a random subset 
of approximately 20% of participants. We prepared FA methyl esters of total lipids with BF3-
methanol (31). Methyl esters were extracted from a thin-layer chromatography plate, and the 
solvents were dried and resuspended in hexane. Approximately 2 ml of sample was injected via 
an autosampler and analyzed on a gas–liquid chromatography machine using a 100 m SP-2560 
column with optimum conditions for separation (Model 6890 N, Agilent, Santa Clara, CA). 
Eluted peaks were analyzed with the use of the Chemstation software (Agilent). The 
concentration of each FA was determined using a calibration curve with C17:0 methyl ester as 
the standard. Serum concentrations of n-3 ALA, eicosapentaenoic acid (20:5 n-3, EPA), 
docosapentaenoic acid (22:5 n-3, DPA) and DHA; and n-6 LA, gamma-linolenic acid (18:3 n-6, 
GLA), eicosadienoic acid (20:2 n-6, EDA), dihomo-gamma-linolenic acid (20:3 n-6, DGLA), 
AA, and AdA were each expressed as percentage weight concentrations of total FA. Inter-assay 
coefficients of variation ranged from 1.1% to 2.3% for all PUFA. 
Data analysis 
Four-hundred forty-four children in the subset selected for quantification of FA 
completed the YSR at 11-18 years of age. The primary outcomes of interest were the continuous 
total externalizing and internalizing problems scores. Secondary outcomes were scores on the 5 
behavior problems subscales that comprise total externalizing and internalizing problems. The 
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primary exposures of interest were the percentage of total weight concentrations for serum n-3 
(ALA, EPA, DPA, and DHA) and n-6 (LA, GLA, EDA, DGLA, AA, and AdA) PUFA. We also 
examined as exposures the ratios of GLA to LA and AA to DGLA as indices of enzymatic 
activity for Δ6-desaturase (D6D) and Δ5-desaturase (D5D), respectively. 
Covariates included sociodemographic and anthropometric characteristics as well as 
health habits measured at baseline. Children’s height-for-age Z scores were calculated according 
to the World Health Organization (WHO) growth reference for children and adolescents (32). 
Maternal BMI was calculated as kg/m2 from objectively measured height and weight in 34.7% of 
mothers and from self-reported data in the rest. Covariates were categorized as presented in 
Table 1.  
We first compared the distributions of total externalizing and internalizing problems 
scores across categories of baseline characteristics using means and standard deviation (SD). For 
ordinal exposures, we conducted tests for linear trend by fitting linear regression models with the 
behavior problems score as the continuous outcome and a variable representing ordinal 
categories of each predictor as a continuous covariate. For sex, we used the χ2 score statistic.  
We then compared the distributions of total externalizing and internalizing problems 
scores across quartiles of serum FA concentrations. Tests for linear trend were conducted by 
introducing a variable representing the median of each quartile into a linear regression model as 
a continuous predictor. In adjusted analyses, we estimated mean differences with 95% 
confidence intervals (CI) for total externalizing and internalizing problems scores between 
quartiles of FA. In addition, we estimated unadjusted and adjusted mean differences with 95% CI 
in behavior problems scores per 1 SD of serum FA concentrations when the associations seemed 
linear. In adjusted models, we included as covariates baseline characteristics which were 
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associated with total externalizing or internalizing problems in bivariate analysis (P<0.05). 
Child’s sex and age at baseline were included in all models as they were considered important 
from a mechanistic viewpoint. We deliberately avoided adjusting for child’s BMI-for-age Z 
score because PUFA may influence the development of adiposity (33). N-3 (ALA, EPA, DPA, 
and DHA) and n-6 PUFA (LA, GLA, EDA, DGLA, AA, and AdA) were adjusted for LA and 
ALA, respectively. Long-chain FA were additionally adjusted for their immediate FA 
precursor(s). Enzyme activity indices were adjusted in the same manner as their n-6 products; the 
D6D activity index was adjusted for ALA and LA, whereas the D5D activity index was adjusted 
for ALA, GLA, and EDA. Empirical estimates of the variance were specified in all models to 
overcome potential deviations from the multivariate normality assumption.  
In supplemental analyses, we examined the associations of n-3 and n-6 PUFA with scores 
on the component subscales for total externalizing and internalizing problems following an 
analogous approach to that used for the primary outcomes.  
All analyses were performed with the Statistical Analyses System version 9.4 (SAS 
Institute Inc.). 
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Results 
Mean ± SD age at enrollment was 8.6 ± 1.6 y; 57.4% of children were girls. Mean ± SD 
age at the time of follow-up assessment was 14.4 ± 1.6 y. In adolescence, mean ± SD total 
externalizing and internalizing problems scores were 52.0 ± 9.5 and 53.2 ± 9.7, respectively. 
Child’s age at baseline and time spent watching television / playing video games were positively 
associated with total externalizing problems scores (Table 1). Child’s BMI-for-age Z score and 
mother’s BMI at baseline were positively related to total externalizing and internalizing 
problems scores, whereas mother’s education level was inversely associated with these outcomes 
(Table 1). 
Total externalizing problems. In bivariate analysis, EPA and DPA concentrations and 
the D5D activity index were inversely associated with total externalizing problems scores 
whereas DHA concentration was positively related to this outcome (Table 2). In multivariable 
analysis, every SD of DPA or DHA concentrations was related to a -0.9 (P=0.05) and a 1.0 
(P=0.03) unit difference in total externalizing problems scores, respectively. Total externalizing 
problems were 3.2 units (P=0.02) lower in children with a D5D activity index in the highest 
quartile compared with those in the lowest quartile (Table 2).  
Externalizing problems subscales. In multivariable analysis, DPA concentration and the 
D5D activity index were inversely related to aggressive behavior scores whereas DHA 
concentration was positively associated with this outcome (Supplemental Table 2). DPA and 
AA concentrations and the D5D activity index were inversely associated with rule breaking 
behavior scores (Supplemental Table 3). In addition, rule breaking behavior scores were higher 
in children with DGLA concentration in the highest quartile compared with those in the lowest 
quartile (Supplemental Table 3).  
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Total internalizing problems. In bivariate analysis, ALA concentration was positively 
associated with total internalizing problems scores, whereas AdA concentration was inversely 
associated with these scores (Table 3). After adjustment for potential confounders, every SD of 
ALA concentration was related to a 1.2 (P=0.01) unit difference in total internalizing problems 
scores (Table 3). The adjusted difference in total internalizing problems scores between the 
highest and lowest quartile of AdA concentration was -3.2 units (P= 0.01) (Table 3). 
Internalizing problems subscales. In multivariable analysis, ALA concentration was 
positively associated with anxious/depressed scores whereas DPA and AdA concentrations and 
the D5D activity index were inversely related to this outcome (Supplemental Table 4). DPA 
concentration was inversely related to withdrawn/depressed scores in a nonlinear manner 
(Supplemental Table 5). AA concentration was also inversely associated with this outcome 
(Supplemental Table 5). There were no associations between PUFA concentrations and the 
somatic complaints scores (Supplemental Table 6).  
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Discussion 
In this prospective study of schoolchildren from Bogotá, Colombia, serum concentrations 
of DPA in middle childhood were related to decreased total externalizing problems scores in 
adolescence, whereas DHA concentrations were associated with increased scores. The D5D 
enzyme activity index was inversely related to externalizing problems. Alpha-linolenic acid 
concentration was positively associated with internalizing problems, whereas AdA was inversely 
related to this outcome. These associations were independent of baseline child, parental, and 
household characteristics. 
The inverse associations of DPA with total externalizing problems and the internalizing 
problems subscales anxious/depressed and withdrawn/depressed had not been previously 
reported among children or adolescents. Nevertheless, DPA in blood has been inversely 
associated with depressive symptoms in pregnant (34) and postmenopausal women (35). 
Evidence from animal experiments offers insights into potential explanatory mechanisms. 
Rodents supplemented with DPA perform better on the forced swim test (36), an animal model 
of depressive behavior. DPA could enhance hippocampal long-term potentiation (37), thereby 
countering stress- or glucocorticoid-induced damage which may be associated with psychiatric 
disorders (38).  
The positive association between serum DHA and total externalizing problems scores in 
adolescence was against our initial hypothesis. The majority of previous longitudinal studies 
have focused on the potential effects of DHA and other long-chain n-3 PUFA during the prenatal 
or infancy periods on early or middle childhood behavior problems. In all (14, 15, 17, 18) but 
one (16) studies DHA biomarkers during pregnancy have not been associated with childhood 
externalizing problems. In addition, maternal or early childhood intake of fatty fish, a major 
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source of DHA, has not been related to behavior problems (39, 40). DHA supplementation 
during the second half of pregnancy resulted in an increase of total problems at ages 4 and 7 
years among Australian children (41, 42). Only a handful of investigations have addressed the 
potential effect of DHA on behavior problems during adolescence. DHA supplementation of 
schoolchildren in Mauritius and the UK was related to decreased aggressive and disruptive 
behavior, respectively (21, 22). The apparent discrepancy between the positive association we 
found and the protective effect of supplementation trials might be related to other PUFA present 
in the supplement. An adverse effect of DHA in middle childhood could be explained through a 
number of mechanisms. Fish oil supplementation has been associated with delayed 
neurodevelopment in rodents, potentially due to reduced myelination in the brainstem (43). High 
DHA concentration has also been associated with behavioral delays in rodents when there is an 
imbalance of n-3 and n-6 PUFA (44). Some methodological limitations of observational studies 
could also explain these findings. For example, the association of DHA and behavior problems in 
our study may be confounded by mercury or lead since these neurotoxic heavy metals are readily 
found in fish consumed in Bogotá (45) and fish intake is an important source of preformed DHA.  
The D5D activity index in middle childhood was related to lower total externalizing 
problems scores in adolescence, possibly through lower aggressive and rule breaking behavior. 
Although no prior study has examined the association between the D5D activity index and 
behavior problems, some investigations have examined whether single nucleotide 
polymorphisms (SNPs) that influence D5D activity are related to child development. SNPs 
which encode for lower D5D activity were positively associated with infant psychomotor 
development (46) or child cognition (47), but it is unknown whether they are related to 
behavioral outcomes.  
115 
 
Serum ALA was positively related to total internalizing problems scores. These results 
are in line with those from a study of 10 year-old German children in whom prenatal ALA 
concentration was positively associated with peer relationship problems, an internalizing 
problem (18). The nature of this association is unclear. Lifelong ALA supplementation has been 
associated with more depressive-like behaviors in rodents, potentially attributable to alterations 
in the endocannabinoid system (48).  
AdA, a product of AA elongation, was inversely related to total internalizing problems 
scores, possibly through decreased anxious/depressed feelings. AA was inversely related to 
problems scores in some subscales. Epidemiologic evidence of the potential effects of n-6 PUFA 
on behavior is limited and conflicting. Studies to date have only examined the association of 
prenatal or infant AA concentration with behavior problems; three studies found no relation (14, 
15, 17), one found an inverse association (18), and another found a positive relation (16). 
Mechanisms underlying these associations are speculative; AA may enhance long-term 
potentiation of synapses in areas of the brain involved in reward (49), learning, and memory, 
(50) while AdA could be important in myelination (51). Of note, the D5D activity index and AA 
concentration were associated with rule breaking behavior in the same direction. It is plausible 
that the associations with AA represent underlying genetic polymorphisms related to D5D 
activity.  
Our study has several strengths. First, the prospective design limits bias due to reverse 
causation. While previous studies primarily focused on DHA and AA, we examined the 
associations of other PUFA biomarkers that may be biologically relevant. Further, serum 
biomarkers of several FA are highly correlated with measures of long-term PUFA intake (52). 
The YSR is a validated measure of externalizing and internalizing problems in adolescence (53). 
116 
 
Finally, we controlled for many potential confounders of the associations between PUFA 
concentration and behavior problems, including FA precursors.  
There are limitations as well. We do not have a baseline measurement of behavior 
problems and thus cannot preclude reverse causation as an explanation for our findings if 
behavior problems developed before middle childhood. Our ability to identify a time at which 
PUFA may exert a potential effect on behavior is limited since PUFA concentrations in middle 
childhood may be correlated with concentrations at other periods in development. We were 
unable to measure heavy metals which may share dietary sources with long-chain n-3 PUFA, 
especially EPA and DHA; thus, residual confounding may have attenuated or changed the 
direction of the associations. Finally, our results may not be generalizable to children from the 
highest socioeconomic status since they do not attend public schools in Bogotá.  
In conclusion, DPA concentration was inversely associated with externalizing problems 
whereas DHA concentration was positively related to this outcome. The D5D activity index was 
related to decreased externalizing problems. ALA concentration was positively associated with 
internalizing problems whereas AdA was inversely related to this outcome. Additional studies in 
other populations with different distributions of PUFA are warranted.  
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Table 4.1. Total behavior problems scores at 11-18 y of age according to sociodemographic 
characteristics in middle childhood among children from Bogota, Colombia 
    Externalizing  Internalizing 
Characteristic  
n1 
 problems 
Mean ± SD 
 problems 
Mean ± SD 
       
Sex       
Boys  189  51.4 ± 9.5  52.4 ± 9.2 
Girls  255  52.4 ± 9.4  53.8 ± 10.1 
P2    0.27  0.13 
       
Child’s age at baseline, y       
5-6  78  48.5 ± 10.5  52.6 ± 11.5 
7-8  171  51.1 ± 9.1  52.5 ± 9.2 
9-10  170  53.7 ± 8.6  53.8 ± 9.2 
11-12  25  56.5 ± 9.8  56.1 ± 11.0 
P-trend3    <0.0001  0.12 
       
Height-for-age Z score3 at 
baseline 
 
 
 
 
 
 
<-2.0   35  51.4 ± 9.8  52.7 ± 9.4 
-2.0 to <-1.0  135  51.0 ± 9.7  52.4 ± 10.1 
-1.0 to <0.0  164  52.1 ± 9.2  53.8 ± 9.7 
≥0.0  97  53.4 ± 9.4  53.8 ± 9.6 
P-trend     0.08  0.24 
       
BMI-for-age Z score3 at baseline       
<-1.0   61  50.4 ± 8.9  51.2 ± 8.5 
-1.0 to <0.0  145  51.0 ± 9.5  52.4 ± 10.3 
0.0 to <1.0  152  53.0 ± 9.7  54.2 ± 9.5 
≥1.0  73  53.2 ± 9.0  54.8 ± 10.0 
P-trend    0.02  0.008 
       
Time spent watching television / 
playing video games, h/wk 
 
 
 
 
 
 
<10  140  51.1 ± 9.3  53.9 ± 8.7 
10 to <20  106  51.7 ± 9.9  52.4 ± 10.7 
20 to <30  115  51.5 ± 8.9  52.8 ± 10.0 
≥30  76  54.7 ± 9.7  54.2 ± 9.8 
P-trend    0.02  0.98 
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    Externalizing  Internalizing 
Characteristic  
n1 
 problems 
Mean ± SD 
 problems 
Mean ± SD 
 
Mother’s education, y 
 
 
 
 
 
 
Incomplete primary, 1-4   29  53.9 ± 8.5  56.4 ± 9.1 
Complete primary, 5   82  53.3 ± 8.8  54.2 ± 10.0 
Incomplete secondary, 6-10   105  51.9 ± 9.4  53.8 ± 9.8 
Complete secondary, 11   189  51.4 ± 10.2  52.3 ± 9.7 
University, >11   29  50.3 ± 8.1  50.8 ± 9.4 
P-trend    0.03  0.005 
       
Mother’s height quartile 
(median), cm 
 
 
 
 
 
 
Q1, (150)  108  52.6 ± 9.8  54.8 ± 10.0 
Q2, (155)  112  51.3 ± 10.0  52.0 ± 10.2 
Q3, (160)  101  51.6 ± 8.9  53.8 ± 9.3 
Q4, (165)  111  52.2 ± 9.3  52.4 ± 9.4 
P-trend    0.79  0.20 
       
Mother’s BMI, kg/m2       
<18.5  11  49.0 ± 8.9  47.2 ± 11.1 
18.5 to <25.0  259  51.5 ± 9.3  52.9 ± 9.7 
25.0 to <30.0  126  52.2 ± 9.8  53.4 ± 9.4 
≥30.0  32  55.9 ± 9.5  57.6 ± 9.2 
P-trend    0.02  0.007 
       
Food insecurity       
Secure  108  51.3 ± 9.0  53.4 ± 9.6 
Insecure – no hunger  222  51.9 ± 9.9  53.1 ± 10.0 
Insecure – moderate hunger  61  53.2 ± 9.1  54.8 ± 9.1 
Insecure – severe hunger  52  52.1 ± 9.3  51.8 ± 9.7 
P-trend    0.35  0.66 
       
Socioeconomic status       
1 (lowest)  33  49.7 ± 10.4  53.9 ± 10.8 
2  101  51.9 ± 8.9  52.2 ± 9.9 
3  250  52.6 ± 9.6  53.5 ± 9.7 
4  60  50.6 ± 9.1  53.4 ± 9.1 
P-trend    0.65  0.67 
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Footnotes to Table 4.1 
 
1 Sums may be less than the total due to missing values in covariates. 
 
2  χ2 score statistic from linear regression with the behavior problems score as the continuous 
outcome and sex as the categorical predictor. Empirical estimates of the variance were used in all 
models.   
 
3  Test for linear trend when a variable representing ordinal categories of the characteristic was 
introduced into a linear regression model as a continuous covariate.   
 
4 According to the World Health Organization growth reference for children and adolescents 
(31).  
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Table 4.2. Total externalizing problems scores at 11-18 y of age according to serum fatty acid (FA) percentage weight concentration in 
middle childhood among children from Bogota, Colombia 
Total externalizing  Q1  Q2  Q3  Q4    Mean difference  
problems scores  n=111  n=111  n=111  n=111  P1  per 1 SD2  
              
n-3 polyunsaturated FA (PUFA)              
18:3n-3 α-linolenic acid              
Mean ± SD   51.4  ±  8.8   51.7  ±  8.8   52.5  ±  10.4   52.3  ±  9.8  0.40   0.4  (-0.4, 1.3)  
Adjusted differences4  Reference  0.4 (-2.0, 2.8)  0.3 (-2.2, 2.8)  0.9 (-1.5, 3.4)  0.48   0.4  (-0.4, 1.3)  
20:5n-3 eicosapentaenoic acid              
Mean ± SD   53.0  ±  9.4   52.6  ±  9.7   51.4  ±  10.2   50.8  ±  8.4  0.05   -0.8  (-1.5, 0.0)  
Adjusted differences  Reference  0.0 (-2.5, 2.4)  -0.1 (-2.6, 2.4)  -1.0 (-3.4, 1.3)  0.42   -0.3 (-1.1, 0.5)  
22:5n-3 docosapentaenoic acid              
Mean ± SD   52.6  ±  10.0   52.3  ±  9.1   53.0  ±  9.3   49.8  ±  9.1  0.02   -1.0  (-1.8, -0.2)  
Adjusted differences  Reference  -1.3 (-3.8, 1.2)  -0.2 (-2.7, 2.4)  -3.0 (-5.7, -0.3)  0.05   -0.9 (-1.7, 0.0)  
22:6n-3 docosahexaenoic acid              
Mean ± SD   51.3  ±  9.7   51.7  ±  9.3   51.5  ±  9.9   53.3  ±  8.9  0.11   1.0  (0.1, 1.9)  
Adjusted differences  Reference  0.9 (-1.5, 3.3)  -0.5 (-3.1, 2.1)  1.7 (-0.7, 4.1)  0.22   1.0  (0.1, 1.9)  
              
n-6 PUFA              
18:2n-6 linoleic acid              
Mean ± SD   51.2  ±  9.7   51.6  ±  9.6   53.5  ±  9.6   51.6  ±  8.8  0.49   0.1  (-0.8, 0.9)  
Adjusted differences  Reference  0.9 (-1.6, 3.4)  2.8 (0.3, 5.3)  0.6 (-1.8, 2.9)  0.41   0.2  (-0.7, 1.0)  
18:3n-6 γ-linolenic acid              
Mean ± SD   51.7  ±  9.3   52.2  ±  9.9   51.8  ±  9.5   52.1  ±  9.3  0.80   -0.1  (-1.0, 0.7)  
Adjusted differences  Reference  -0.1 (-2.7, 2.4)  -0.5 (-3.0, 2.0)  -0.1 (-2.6, 2.5)  0.95   -0.1 (-1.0, 0.8)  
20:2n-6 eicosadienoic acid              
Mean ± SD   52.2  ±  9.1   53.2  ±  10.2   51.4  ±  9.4   51.1  ±  9.0  0.23   -0.2  (-1.0, 0.6)  
Adjusted differences  Reference  1.5 (-1.0, 4.1)  -0.9 (-3.3, 1.6)  -0.5 (-3.2, 2.1)  0.40   -0.1 (-1.0, 0.7)  
20:3n-6 dihomo-γ-linolenic acid              
Mean ± SD   50.5  ±  9.1   52.9  ±  10.0   52.0  ±  9.9   52.4  ±  8.8  0.20   0.3  (-0.6, 1.3)  
Adjusted differences  Reference  2.4 (-0.1, 4.9)  1.1 (-1.4, 3.7)  2.6 (0.0, 5.3)  0.14   0.6  (-0.5, 1.7)  
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Total externalizing  Q1  Q2  Q3  Q4    Mean difference  
problems scores  n=111  n=111  n=111  n=111  P1  per 1 SD2  
 
n-6 PUFA, cont. 
 
         
 
  
20:4n-6 arachidonic acid              
Mean ± SD   52.9  ±  9.7   52.3  ±  9.5   51.8  ±  9.1   50.8  ±  9.5  0.09   -0.9  (-1.8, 0.0)  
Adjusted differences  Reference  0.2 (-2.4, 2.7)  -0.3 (-2.7, 2.1)  -1.8 (-4.3, 0.8)  0.15   -0.8 (-1.7, 0.1)  
22:4n-6 adrenic acid              
Mean ± SD   52.8  ±  9.5   51.8  ±  9.0   51.8  ±  10.3   51.5  ±  9.1  0.28   -0.5  (-1.3, 0.4)  
Adjusted differences  Reference  -1.6 (-3.9, 0.8)  -0.9 (-3.3, 1.6)  -1.6 (-4.0, 0.8)  0.25   -0.5 (-1.4, 0.3)  
              
Enzyme activity indices              
Δ6-desaturase 18:3n-6/18:2n-6              
Mean ± SD   52.3  ±  9.3   51.3  ±  9.2   52.2  ±  10.0   52.1  ±  9.3  0.89   -0.2  (-1.0, 0.7)  
Adjusted differences  Reference  -1.5 (-3.9, 0.9)  -0.4 (-2.9, 2.2)  -0.5 (-3.2, 2.2)  0.97   -0.2 (-1.2, 0.8)  
Δ5-desaturase 20:4n-6/20:3n-6              
Mean ± SD   53.2  ±  9.7   51.1  ±  9.3   53.5  ±  9.4   50.0  ±  9.2  0.05   -0.8  (-1.8, 0.2)  
Adjusted differences  Reference  -1.6 (-4.1, 0.8)  0.7 (-1.8, 3.2)  -3.2 (-5.8, -0.6)  0.05   -0.7 (-1.8, 0.3)  
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Footnotes to Table 4.2. 
 
1 Test for linear trend when a variable representing the median of each quartile was introduced into the linear regression model as a 
continuous predictor. Empirical estimates of the variance were specified in all models. 
 
2 From a linear regression model with total externalizing problems score as the outcome and % of total serum FA per 1 SD 
(continuous) as the predictor.  
 
3 Adjusted for child’s sex (dichotomous), child’s age at baseline (continuous), weekly hours spent watching television / playing video 
games (continuous), years of mother’s education (continuous) and mother’s BMI (continuous). n-3 and n-6 PUFA were adjusted for 
the continuous % of total serum FA per 1 SD of linoleic acid and α-linolenic acid, respectively. Long-chain FA were additionally 
adjusted for their immediate FA precursor(s) (continuous). Δ6-desaturase activity was additionally adjusted for α-linolenic acid and 
linoleic acid (continuous). Δ5-desaturase activity was additionally adjusted for α-linolenic acid, γ-linolenic acid, and eicosadienoic 
acid (continuous). 
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Table 4.3. Total internalizing problems scores at 11-18 y of age according to serum fatty acid (FA) percentage weight concentration in 
middle childhood among children from Bogota, Colombia 
Total internalizing  Q1  Q2  Q3  Q4    Mean difference  
problems scores  n=111  n=111  n=111  n=111  P1  per 1 SD2  
              
n-3 polyunsaturated FA (PUFA)              
18:3n-3 α-linolenic acid              
Mean ± SD   52.3  ±  10.0   52.2  ±  9.4   53.5  ±  9.8   54.9  ±  9.6  0.03   1.0  (0.1, 2.0)  
Adjusted differences3  Reference  0.0 (-2.7, 2.6)  1.1 (-1.6, 3.8)  2.8 (0.1, 5.5)  0.02   1.2  (0.3, 2.2)  
20:5n-3 eicosapentaenoic acid              
Mean ± SD   52.5  ±  10.0   53.4  ±  9.6   53.7  ±  9.8   53.4  ±  9.5  0.47   0.2  (-0.7, 1.0)  
Adjusted differences  Reference  1.1 (-1.4, 3.7)  1.7 (-0.9, 4.3)  1.5 (-1.1, 4.1)  0.22   0.4  (-0.4, 1.3)  
22:5n-3 docosapentaenoic acid              
Mean ± SD   54.7  ±  11.2   53.3  ±  9.5   52.4  ±  9.1   52.5  ±  9.0  0.12   -0.4  (-1.3, 0.4)  
Adjusted differences  Reference  -1.8 (-4.6, 1.0)  -2.6 (-5.3, 0.2)  -2.0 (-4.8, 0.9)  0.21   -0.2 (-1.1, 0.6)  
22:6n-3 docosahexaenoic acid              
Mean ± SD   53.8  ±  10.5   53.2  ±  10.1   52.8  ±  9.1   53.1  ±  9.3  0.60   0.2  (-0.7, 1.2)  
Adjusted differences  Reference  0.0 (-2.7, 2.7)  -0.9 (-3.5, 1.8)  -0.4 (-3.0, 2.2)  0.69   0.4  (-0.6, 1.3)  
              
n-6 PUFA              
18:2n-6 linoleic acid              
Mean ± SD   52.3  ±  8.9   53.3  ±  9.9   54.1  ±  10.0   53.3  ±  10.1  0.37   0.3  (-0.6, 1.2)  
Adjusted differences  Reference  0.7 (-1.8, 3.2)  1.2 (-1.3, 3.8)  0.7 (-1.8, 3.1)  0.54   0.2  (-0.6, 1.1)  
18:3n-6 γ-linolenic acid              
Mean ± SD   53.4  ±  10.0   53.4  ± 9.9   53.2  ±  9.5   52.9  ±  9.7  0.64   -0.3  (-1.2, 0.7)  
Adjusted differences  Reference  -0.3 (-3.0, 2.3)  -0.4 (-3.1, 2.2)  -0.3 (-3.0, 2.4)  0.84   0.0  (-1.0, 1.0)  
20:2n-6 eicosadienoic acid              
Mean ± SD   52.3  ±  9.8   54.5  ±  10.5   54.1  ±  9.7   52.1  ±  8.8  0.71   0.2  (-0.6, 1.1)  
Adjusted differences  Reference  2.0 (-0.8, 4.8)  0.9 (-1.7, 3.5)  -0.5 (-3.2, 2.3)  0.58   0.2  (-0.8, 1.1)  
20:3n-6 dihomo-γ-linolenic acid              
Mean ± SD   52.4  ±  9.7   53.6  ±  10.1   53.9  ±  10.0   53.1  ±  9.2  0.57   0.0  (-0.9, 0.8)  
Adjusted differences  Reference  1.1 (-1.6, 3.9)  1.2 (-1.6, 3.9)  0.9 (-2.0, 3.8)  0.60   -0.1 (-1.1, 0.9)  
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Total internalizing  Q1  Q2  Q3  Q4    Mean difference  
problems scores  n=111  n=111  n=111  n=111  P1  per 1 SD2  
 
n-6 PUFA, cont. 
 
         
 
  
20:4n-6 arachidonic acid              
Mean ± SD   54.2  ±  9.7   53.4  ±  10.3   53.7  ±  9.4   51.8  ±  9.5  0.08   -0.8  (-1.6, 0.1)  
Adjusted differences  Reference  -0.7 (-3.5, 2.0)  -0.3 (-2.8, 2.2)  -2.0 (-4.6, 0.5)  0.16   -0.6 (-1.5, 0.3)  
22:4n-6 adrenic acid              
Mean ± SD   55.2  ±  10.3   52.4  ±  9.3   54.1  ±  9.8   51.3  ±  9.2  0.01   -1.1  (-2.1, -0.2)  
Adjusted differences  Reference  -3.1 (-5.6, -0.6)  -0.3 (-2.9, 2.3)  -3.2 (-5.8, -0.7)  0.06   -0.8 (-1.7, 0.0)   
              
Enzymatic activity indices              
Δ6-desaturase 18:3n-6/18:2n-6              
Mean ± SD  54.1 ± 10.3   52.7  ±  9.6   53.5  ±  9.3   52.6  ±  9.8  0.40   -0.3  (-1.2, 0.5)  
Adjusted differences  Reference  -1.1 (-3.8, 1.5)  -0.6 (-3.2, 2.1)  -0.9 (-3.8, 2.0)  0.67   -0.1 (-1.1, 0.9)  
Δ5-desaturase 20:4n-6/20:3n-6              
Mean ± SD  53.7 ± 9.2   52.8  ± 10.2   55.1  ±  10.8   51.3  ±  8.4  0.14   -0.4  (-1.4, 0.6)  
Adjusted differences  Reference  -0.4 (-3.0, 2.2)  1.8 (-0.8, 4.5)  -1.9 (-4.4, 0.5)  0.22   -0.2 (-1.1, 0.7)  
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Footnotes to Table 4.3. 
 
1 Test for linear trend when a variable representing the median of each quartile was introduced into the linear regression model as a 
continuous predictor. Empirical estimates of the variance were specified in all models. 
 
2 From a linear regression model with total internalizing problems score as the outcome and % of total serum FA per 1 SD 
(continuous) as the predictor.  
 
3 Adjusted for child’s sex (dichotomous), child’s age at baseline (continuous), weekly hours spent watching television / playing video 
games (continuous), years of mother’s education (continuous) and mother’s BMI (continuous). n-3 and n-6 PUFA were adjusted for 
the continuous % of total serum FA per 1 SD of linoleic acid and α-linolenic acid, respectively. Long-chain FA were additionally 
adjusted for their immediate FA precursor(s) (continuous). Δ6-desaturase activity was additionally adjusted for α-linolenic acid and 
linoleic acid (continuous). Δ5-desaturase activity was additionally adjusted for α-linolenic acid, γ-linolenic acid, and eicosadienoic 
acid (continuous).   
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Supplemental Table 4.1 Distribution of serum fatty acid (FA) percentage weight concentrations 
Serum FA percentage weight concentration Mean  ±  SD 
  
n-3 polyunsaturated FA (PUFA) (%)  
   18:3n-3 α-linolenic acid  0.48  ±  0.14 
   20:5n-3 eicosapentaenoic acid  0.23  ±  0.13 
   22:5n-3 docosapentaenoic acid  0.46  ±  0.19 
   22:6n-3 docosahexaenoic acid  2.24  ±  0.92 
   Total long-chain n-3 PUFA1  2.93  ±  0.96 
   Total n-3 PUFA  3.47  ±  0.97 
  
n-6 PUFA (%)  
   18:2n-6 linoleic acid 30.62  ± 3.00 
   18:3n-6 γ-linolenic acid  0.30  ±  0.16 
   20:2n-6 eicosadienoic acid  0.29  ±  0.08 
   20:3n-6 dihomo-γ-linolenic acid  1.59  ±  0.36 
   20:4n-6 arachidonic acid  6.04  ±  1.17 
   22:4n-6 adrenic acid  3.15  ±  1.20 
   Total long-chain n-6 PUFA2 11.07  ±  1.76 
   Total n-6 PUFA 41.99  ±  3.31 
  
Enzymatic activity  
Δ6-desaturase 18:3n-6/18:2n-6  0.01  ±  0.01 
Δ5-desaturase 20:4n-6/20:3n-6  4.01  ±  1.49 
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Footnotes to Supplemental Table 4.1. 
 
 
1 Sum of 20:5n-3 eicosapentaenoic acid, 22:5n-3 docosapentaenoic acid, and 22:6n-3 
docosahexaenoic acid. 
 
2 Sum of 20:2n-6 eicosadienoic acid, 20:3n-6 dihomo-γ-linolenic acid, 20:4n-6 arachidonic 
acid, and 22:4n-6 adrenic acid. 
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Supplemental Table 4.2 Aggressive behavior scores at 11-18 y of age according to serum fatty acid (FA) percentage weight 
concentration in middle childhood among children from Bogota, Colombia 
Aggressive behavior scores 
 Q1  Q2  Q3  Q4    Mean difference  
 n=111  n=111  n=111  n=111  P1  per 1 SD2  
              
n-3 polyunsaturated FA (PUFA)              
18:3n-3 α-linolenic acid              
Mean ± SD  54.8 ± 6.1  55.1 ± 6.4  56.8 ± 8.7  55.8 ± 6.8  0.13  0.5 (-0.1, 1.1)  
Adjusted differences4  Reference  0.3 (-1.4, 2.0)  1.4 (-0.5, 3.3)  1.1 (-0.7, 2.8)  0.15  0.5 (-0.1, 1.1)  
20:5n-3 eicosapentaenoic acid              
Mean ± SD  56.3 ± 7.5  56.3 ± 8  55.6 ± 7.3  54.3 ± 5.1  0.02   -0.6 (-1.2, -0.1)  
Adjusted differences  Reference  0.3 (-1.7, 2.3)  0.5 (-1.5, 2.4)  -1.3 (-3.0, 0.4)  0.19  -0.3 (-0.9, 0.2)  
22:5n-3 docosapentaenoic acid              
Mean ± SD  56.6 ± 8.0  55.4 ± 6.8  56.3 ± 7.2  54.3 ± 6.0  0.02  -0.8 (-1.4, -0.2)  
Adjusted differences  Reference  -1.7 (-3.7, 0.2)  -0.5 (-2.5, 1.6)  -2.1 (-4.1, 0.0)  0.12  -0.6 (-1.2, 0.0)   
22:6n-3 docosahexaenoic acid              
Mean ± SD  55.3 ± 7.3  55.6 ± 7.3  55.4 ± 7.2  56.3 ± 6.7  0.29  0.8 (0.1, 1.6)  
Adjusted differences  Reference  0.7 (-1.2, 2.6)  -0.3 (-2.2, 1.7)  0.9 (-0.9, 2.8)  0.42  0.9 (0.1, 1.6)  
              
n-6 PUFA              
18:2n-6 linoleic acid              
Mean ± SD  55.0 ± 6.7  55.6 ± 7.0  56.5 ± 7.6  55.4 ± 7.0  0.46  0.1 (-0.6, 0.8)  
Adjusted differences  Reference  1.0 (-0.7, 2.8)  1.9 (0.0, 3.8)  0.6 (-1.1, 2.4)  0.38  0.2 (-0.5, 0.9)  
18:3n-6 γ-linolenic acid              
Mean ± SD  55.3 ± 6.8  55.9 ± 7.9  55.7 ± 7.1  55.6 ± 6.5  0.92  -0.1 (-0.7, 0.5)  
Adjusted differences  Reference  0.1 (-1.8, 2.1)  -0.1 (-1.9, 1.8)  0.1 (-1.8, 1.9)  0.99  0.0 (-0.7, 0.6)  
20:2n-6 eicosadienoic acid              
Mean ± SD  55.4 ± 7.3  56.7 ± 8.3  55.6 ± 6.8  54.8 ± 5.7  0.31  -0.1 (-0.7, 0.5)  
Adjusted differences  Reference  1.5 (-0.6, 3.5)  0.3 (-1.5, 2.2)  -0.6 (-2.5, 1.4)  0.39  -0.1 (-0.7, 0.6)  
20:3n-6 dihomo-γ-linolenic acid              
Mean ± SD  54.5 ± 5.9  56.3 ± 8.3  56.2 ± 7.7  55.5 ± 6.2  0.36  0.2 (-0.4, 0.7)  
Adjusted differences  Reference  1.8 (-0.2, 3.8)  1.3 (-0.5, 3.2)  1.4 (-0.6, 3.3)  0.30  0.3 (-0.3, 1.0)  
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Aggressive behavior scores 
 Q1  Q2  Q3  Q4    Mean difference  
 n=111  n=111  n=111  n=111  P1  per 1 SD2  
 
n-6 PUFA, cont. 
 
            
20:4n-6 arachidonic acid              
Mean ± SD  56.1 ± 7.4  55.9 ± 7.3  55.8 ± 7.2  54.6 ± 6.4  0.11   -0.7 (-1.3, -0.1)  
Adjusted differences  Reference  0.4 (-1.5, 2.4)  0.4 (-1.5, 2.3)  -1.3 (-3.1, 0.6)  0.18  -0.6 (-1.3, 0.0)   
22:4n-6 adrenic acid              
Mean ± SD  56.4 ± 7.3  54.9 ± 6.5  56.1 ± 8.2  55.1 ± 6.2  0.31  -0.3 (-0.9, 0.3)  
Adjusted differences  Reference  -1.8 (-3.7, 0.0)  -0.2 (-2.1, 1.8)  -1.4 (-3.2, 0.4)  0.28  -0.3 (-0.9, 0.3)  
              
Enzyme activity indices              
Δ6-desaturase 18:3n-6/18:2n-6              
Mean ± SD  55.7 ± 7.2  55.3 ± 7.0  55.9 ± 7.7  55.6 ± 6.5  0.86  -0.1 (-0.7, 0.5)  
Adjusted differences  Reference  -0.7 (-2.5, 1.2)  0.2 (-1.7, 2.2)  0.0 (-2.0, 2.0)  0.76  0.0 (-0.7, 0.7)  
Δ5-desaturase 20:4n-6/20:3n-6              
Mean ± SD  56.5 ± 6.9  55.2 ± 7.2  56.6 ± 8.1  54.2 ± 5.7  0.04  -0.5 (-1.2, 0.1)  
Adjusted differences  Reference  -0.9 (-2.8, 0.9)  0.5 (-1.5, 2.5)  -2.2 (-3.9, -0.4)  0.05   -0.5 (-1.2, 0.2)  
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Footnotes to Supplemental Table 4.2. 
 
1  Test for linear trend when a variable representing the median of each quartile was introduced into the linear regression model as a 
continuous predictor. Empirical estimates of the variance were specified in all models. 
 
2  From a linear regression model with aggressive behavior score as the outcome and % of total serum FA per 1 SD (continuous) as 
the predictor.  
 
3 Adjusted for child’s sex (dichotomous), child’s age at baseline (continuous), weekly hours spent watching television / playing 
video games (continuous), years of mother’s education (continuous) and mother’s BMI (continuous). n-3 and n-6 PUFA were 
adjusted for the continuous % of total serum FA per 1 SD of linoleic acid and α-linolenic acid, respectively. Long-chain FA were 
additionally adjusted for their immediate FA precursor(s) (continuous). Δ6-desaturase activity was additionally adjusted for α-
linolenic acid and linoleic acid (continuous). Δ5-desaturase activity was additionally adjusted for α-linolenic acid, γ-linolenic acid, 
and eicosadienoic acid (continuous). 
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Supplemental Table 4.3. Rule breaking behavior scores at 11-18 y of age according to serum fatty acid (FA) percentage weight 
concentration in middle childhood among children from Bogota, Colombia 
Rule breaking  Q1  Q2  Q3  Q4    Mean difference  
behavior scores  n=111  n=111  n=111  n=111  P1  per 1 SD2  
              
n-3 polyunsaturated FA (PUFA)              
18:3n-3 α-linolenic acid              
Mean ± SD  53.9 ± 4.3  54.1 ± 4.5  54.3 ± 5.3  54.6 ± 5.4  0.33  0.2 (-0.3, 0.6)  
Adjusted differences4  Reference  0.2 (-1.0, 1.3)  0.0 (-1.2, 1.3)  0.7 (-0.6, 2.0)  0.31  0.2 (-0.2, 0.7)  
20:5n-3 eicosapentaenoic acid              
Mean ± SD  54.6 ± 4.9  54.4 ± 5.4  54.0 ± 4.8  54.0 ± 4.5  0.29  -0.3 (-0.7, 0.1)  
Adjusted differences  Reference  0.1 (-1.2, 1.5)  0.1 (-1.1, 1.3)  -0.1 (-1.3, 1.2)  0.93  -0.1 (-0.5, 0.3)  
22:5n-3 docosapentaenoic acid              
Mean ± SD  54.5 ± 5.3  54.5 ± 5.0  54.7 ± 4.8  53.3 ± 4.4  0.05  -0.4 (-0.8, 0.0)  
Adjusted differences  Reference  -0.5 (-1.8, 0.9)  -0.1 (-1.5, 1.2)  -1.5 (-2.9, -0.1)  0.04  -0.4 (-0.8, 0.1)  
22:6n-3 docosahexaenoic acid              
Mean ± SD  54.1 ± 4.7  53.7 ± 4.7  54.4 ± 5.1  54.8 ± 5.0  0.18  0.4 (-0.1, 0.9)  
Adjusted differences  Reference  -0.1 (-1.3, 1.2)  0.3 (-1.0, 1.6)  0.7 (-0.6, 2.0)  0.22  0.4 (0.0, 0.9)   
              
n-6 PUFA              
18:2n-6 linoleic acid              
Mean ± SD  54.4 ± 5.0  53.9 ± 4.8  55.1 ± 5.4  53.5 ± 4.1  0.31  -0.3 (-0.8, 0.1)  
Adjusted differences  Reference  -0.5 (-1.7, 0.8)  0.8 (-0.6, 2.1)  -1.0 (-2.2, 0.2)  0.27  -0.3 (-0.8, 0.1)  
18:3n-6 γ-linolenic acid              
Mean ± SD  54.1 ± 4.9  54.5 ± 5.0  54.1 ± 4.9  54.2 ± 4.8  0.90  -0.1 (-0.6, 0.4)  
Adjusted differences  Reference  0.0 (-1.3, 1.4)  -0.6 (-1.9, 0.7)  -0.5 (-1.9, 0.9)  0.36  -0.3 (-0.8, 0.3)  
20:2n-6 eicosadienoic acid              
Mean ± SD  54.3 ± 4.6  55.1 ± 5.4  53.5 ± 4.2  53.9 ± 5.1  0.23  -0.2 (-0.7, 0.2)  
Adjusted differences  Reference  0.7 (-0.7, 2.1)  -1.0 (-2.2, 0.2)  -0.4 (-1.8, 1.0)  0.25  -0.3 (-0.7, 0.2)  
20:3n-6 dihomo-γ-linolenic acid              
Mean ± SD  53.6 ± 4.5  54.8 ± 5.4  53.9 ± 4.5  54.5 ± 5.0  0.31  0.2 (-0.3, 0.7)  
Adjusted differences  Reference  1.2 (-0.1, 2.5)  0.1 (-1.1, 1.3)  1.4 (0.1, 2.8)  0.15  0.4 (-0.1, 0.9)  
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Rule breaking  Q1  Q2  Q3  Q4    Mean difference  
behavior scores  n=111  n=111  n=111  n=111  P1  per 1 SD2  
 
n-6 PUFA, cont. 
 
            
20:4n-6 arachidonic acid              
Mean ± SD  55.2 ± 5.6  54.2 ± 4.9  53.6 ± 4.2  53.9 ± 4.7  0.04  -0.6 (-1.1, -0.1)  
Adjusted differences  Reference  -0.6 (-2.0, 0.8)  -1.2 (-2.6, 0.1)  -1.3 (-2.7, 0.1)  0.05   -0.6 (-1.1, -0.1)  
22:4n-6 adrenic acid              
Mean ± SD  54.3 ± 4.9  54.4 ± 5.1  54.2 ± 4.9  54.0 ± 4.7  0.63  -0.1 (-0.5, 0.4)  
Adjusted differences  Reference  0.1 (-1.2, 1.4)  0.1 (-1.2, 1.3)  -0.1 (-1.4, 1.1)  0.86  0.0 (-0.5, 0.4)  
              
Enzyme activity indices              
Δ6-desaturase 18:3n-6/18:2n-6              
Mean ± SD  54.4 ± 5.1  53.8 ± 4.3  54.5 ± 5.3  54.2 ± 4.9  0.99  -0.1 (-0.5, 0.3)  
Adjusted differences  Reference  -0.9 (-2.1, 0.4)  -0.4 (-1.8, 0.9)  -0.9 (-2.4, 0.6)  0.39  -0.3 (-0.9, 0.2)  
Δ5-desaturase 20:4n-6/20:3n-6              
Mean ± SD  55.2 ± 5.4  53.6 ± 4.5  54.6 ± 5.3  53.5 ± 4.1  0.04  -0.5 (-0.9, -0.1)  
Adjusted differences  Reference  -1.4 (-2.8, -0.1)  -0.4 (-1.8, 1.0)  -1.9 (-3.2, -0.6)  0.02  -0.6 (-1.0, -0.1)  
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Footnotes to Supplemental Table 4.3. 
 
1  Test for linear trend when a variable representing the median of each quartile was introduced into the linear regression model as a 
continuous predictor. Empirical estimates of the variance were specified in all models. 
 
2  From a linear regression model with rule breaking behavior score as the outcome and % of total serum FA per 1 SD (continuous) 
as the predictor.  
 
3 Adjusted for child’s sex (dichotomous), child’s age at baseline (continuous), weekly hours spent watching television / playing 
video games (continuous), years of mother’s education (continuous) and mother’s BMI (continuous). n-3 and n-6 PUFA were 
adjusted for the continuous % of total serum FA per 1 SD of linoleic acid and α-linolenic acid, respectively. Long-chain FA were 
additionally adjusted for their immediate FA precursor(s) (continuous). Δ6-desaturase activity was additionally adjusted for α-
linolenic acid and linoleic acid (continuous). Δ5-desaturase activity was additionally adjusted for α-linolenic acid, γ-linolenic acid, 
and eicosadienoic acid (continuous). 
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Supplemental Table 4.4 Anxious/depressed scores at 11-18 y of age according to serum fatty acid (FA) percentage weight 
concentration in middle childhood among children from Bogota, Colombia 
Anxious/depressed scores 
 Q1  Q2  Q3  Q4    Mean difference  
 n=111  n=111  n=111  n=111  P1  per 1 SD2  
              
n-3 polyunsaturated FA (PUFA)              
18:3n-3 α-linolenic acid              
Mean ± SD  54.7 ± 6.1  54.7 ± 5.8  55.8 ± 7.2  56.0 ± 7.0  0.08  0.5 (-0.1, 1.1)  
Adjusted differences4  Reference  -0.1 (-1.7, 1.5)  1.2 (-0.6, 3.0)  1.5 (-0.3, 3.4)  0.05   0.7 (0.0, 1.3)   
20:5n-3 eicosapentaenoic acid              
Mean ± SD  54.7 ± 6.4  55.1 ± 6.8  55.6 ± 6.0  55.7 ± 7.0  0.21  0.2 (-0.4, 0.8)  
Adjusted differences  Reference  0.6 (-1.1, 2.4)  1.3 (-0.4, 3.0)  1.3 (-0.5, 3.1)  0.11  0.3 (-0.3, 0.9)  
22:5n-3 docosapentaenoic acid              
Mean ± SD  56.9 ± 7.4  55.4 ± 6.7  54.5 ± 5.7  54.2 ± 6.0  0.002  -0.8 (-1.3, -0.2)  
Adjusted differences  Reference  -1.6 (-3.5, 0.3)  -2.6 (-4.3, -0.8)  -3.2 (-5.1, -1.3)  0.001  -0.8 (-1.4, -0.2)  
22:6n-3 docosahexaenoic acid              
Mean ± SD  56.2 ± 7.1  55.8 ± 7.2  54.1 ± 6.0  55.0 ± 5.7  0.12  -0.2 (-0.8, 0.5)  
Adjusted differences  Reference  0.1 (-1.8, 2.0)  -1.7 (-3.6, 0.1)  -0.8 (-2.5, 0.9)  0.24  0.0 (-0.6, 0.7)  
              
n-6 PUFA              
18:2n-6 linoleic acid              
Mean ± SD  54.4 ± 5.3  55.5 ± 6.8  55.7 ± 7.3  55.5 ± 6.7  0.18  0.4 (-0.2, 1.0)  
Adjusted differences  Reference  0.7 (-1.0, 2.3)  0.8 (-0.9, 2.5)  0.6 (-1.0, 2.2)  0.49  0.3 (-0.3, 0.9)  
18:3n-6 γ-linolenic acid              
Mean ± SD  55.2 ± 6.7  55.1 ± 6.1  55.6 ± 7.0  55.1 ± 6.4  0.97  0.0 (-0.6, 0.6)  
Adjusted differences  Reference  -0.4 (-2.1, 1.4)  -0.1 (-1.9, 1.7)  0.0 (-1.8, 1.9)  0.87  0.1 (-0.6, 0.8)  
20:2n-6 eicosadienoic acid              
Mean ± SD  54.9 ± 7.1  55.6 ± 6.3  56.2 ± 7.0  54.5 ± 5.7  0.66  0.0 (-0.5, 0.6)  
Adjusted differences  Reference  0.3 (-1.6, 2.2)  0.8 (-1.2, 2.7)  -0.6 (-2.5, 1.3)  0.61  0.0 (-0.6, 0.7)  
20:3n-6 dihomo-γ-linolenic acid              
Mean ± SD  54.5 ± 5.7  55.7 ± 7.4  55.7 ± 7.0  55.2 ± 5.9  0.53  0.0 (-0.6, 0.5)  
Adjusted differences  Reference  1.0 (-0.8, 2.9)  0.9 (-0.9, 2.6)  0.8 (-1.0, 2.7)  0.51  0.0 (-0.6, 0.7)  
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Anxious/depressed scores 
 Q1  Q2  Q3  Q4    Mean difference  
 n=111  n=111  n=111  n=111  P1  per 1 SD2  
 
n-6 PUFA, cont. 
 
            
20:4n-6 arachidonic acid              
Mean ± SD  55.5 ± 6.4  55.8 ± 7.1  55.9 ± 6.9  54.0 ± 5.6  0.08  -0.5 (-1.1, 0.0)  
Adjusted differences  Reference  0.5 (-1.4, 2.4)  0.6 (-1.2, 2.4)  -1.3 (-3.0, 0.3)  0.13  -0.5 (-1.0, 0.1)  
22:4n-6 adrenic acid              
Mean ± SD  56.9 ± 7.8  54.3 ± 5.6  55.5 ± 6.8  54.3 ± 5.5  0.01  -0.9 (-1.5, -0.2)  
Adjusted differences  Reference  -2.8 (-4.6, -1.0)  -1.0 (-2.9, 0.9)  -2.4 (-4.2, -0.7)  0.03  -0.7 (-1.3, -0.1)  
              
Enzyme activity indices              
Δ6-desaturase 18:3n-6/18:2n-6              
Mean ± SD  55.5 ± 6.9  55.1 ± 6.4  55.4 ± 6.4  55.2 ± 6.5  0.82  -0.1 (-0.7, 0.5)  
Adjusted differences  Reference  -0.3 (-2.2, 1.5)  -0.3 (-2.0, 1.5)  0.2 (-1.8, 2.2)  0.77  0.1 (-0.6, 0.8)  
Δ5-desaturase 20:4n-6/20:3n-6              
Mean ± SD  55.4 ± 6.1  55.3 ± 6.8  56.7 ± 7.8  53.8 ± 4.9  0.08  -0.2 (-0.9, 0.5)  
Adjusted differences  Reference  0.3 (-1.5, 2.0)  1.4 (-0.5, 3.3)  -1.6 (-3.1, 0.0)   0.07  -0.2 (-0.9, 0.6)  
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Footnotes to Supplemental Table 4.4. 
 
1  Test for linear trend when a variable representing the median of each quartile was introduced into the linear regression model as a 
continuous predictor. Empirical estimates of the variance were specified in all models. 
 
2  From a linear regression model with anxious/depressed score as the outcome and % of total serum FA per 1 SD (continuous) as the 
predictor.  
 
3 Adjusted for child’s sex (dichotomous), child’s age at baseline (continuous), weekly hours spent watching television / playing 
video games (continuous), years of mother’s education (continuous) and mother’s BMI (continuous). n-3 and n-6 PUFA were 
adjusted for the continuous % of total serum FA per 1 SD of linoleic acid and α-linolenic acid, respectively. Long-chain FA were 
additionally adjusted for their immediate FA precursor(s) (continuous). Δ6-desaturase activity was additionally adjusted for α-
linolenic acid and linoleic acid (continuous). Δ5-desaturase activity was additionally adjusted for α-linolenic acid, γ-linolenic acid, 
and eicosadienoic acid (continuous). 
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Supplemental Table 4.5. Withdrawn/depressed scores at 11-18 y of age according to serum fatty acid (FA) percentage weight 
concentration in middle childhood among children from Bogota, Colombia 
Withdrawn/depressed scores 
 Q1  Q2  Q3  Q4    Mean difference  
 n=111  n=111  n=111  n=111  P1  per 1 SD2  
              
n-3 polyunsaturated FA (PUFA)              
18:3n-3 α-linolenic acid              
Mean ± SD  55.0 ± 5.9  54.3 ± 5.1  54.9 ± 6.1  56.0 ± 6.7  0.14  0.4 (-0.2, 1.0)  
Adjusted differences4  Reference  -0.8 (-2.3, 0.7)  -0.3 (-1.9, 1.3)  1.1 (-0.6, 2.8)  0.15  0.4 (-0.2, 1.0)  
20:5n-3 eicosapentaenoic acid              
Mean ± SD  55.2 ± 6.7  55.6 ± 6.2  54.7 ± 5.8  54.8 ± 5.3  0.44  -0.3 (-0.9, 0.2)  
Adjusted differences  Reference  0.6 (-1.1, 2.3)  -0.2 (-1.8, 1.4)  -0.2 (-1.8, 1.4)  0.66  -0.2 (-0.8, 0.3)  
22:5n-3 docosapentaenoic acid              
Mean ± SD  56.5 ± 6.6  54.5 ± 5.0  54.5 ± 6.0  54.8 ± 6.1  0.14  -0.3 (-0.8, 0.2)  
Adjusted differences  Reference  -2.4 (-3.9, -0.8)  -2.2 (-3.9, -0.5)  -1.5 (-3.4, 0.4)  0.28  -0.2 (-0.8, 0.3)  
22:6n-3 docosahexaenoic acid              
Mean ± SD  55.1 ± 6.0  55.1 ± 5.7  55.1 ± 6.3  55.0 ± 6.0  0.85  0.1 (-0.5, 0.7)  
Adjusted differences  Reference  0.3 (-1.2, 1.9)  0.1 (-1.6, 1.8)  -0.1 (-1.8, 1.5)  0.77  0.2 (-0.4, 0.8)  
              
n-6 PUFA              
18:2n-6 linoleic acid              
Mean ± SD  54.8 ± 5.7  55.7 ± 6.8  55.1 ± 5.6  54.8 ± 5.9  0.81  -0.1 (-0.6, 0.4)  
Adjusted differences  Reference  0.9 (-0.7, 2.6)  0.2 (-1.3, 1.8)  0.0 (-1.5, 1.5)  0.79  -0.1 (-0.6, 0.4)  
18:3n-6 γ-linolenic acid              
Mean ± SD  55.8 ± 6.6  54.9 ± 6.0  54.7 ± 5.7  54.9 ± 5.7  0.33  -0.2 (-0.9, 0.4)  
Adjusted differences  Reference  -1.2 (-2.9, 0.4)  -1.5 (-3.2, 0.1)  -1.3 (-3.0, 0.4)  0.21  -0.3 (-1.0, 0.4)  
20:2n-6 eicosadienoic acid              
Mean ± SD  54.5 ± 5.7  56.0 ± 7.0  55.5 ± 6.1  54.3 ± 4.9  0.56  0.0 (-0.5, 0.5)  
Adjusted differences  Reference  1.2 (-0.6, 3.0)  0.4 (-1.2, 2.0)  -0.6 (-2.3, 1.0)  0.31  -0.1 (-0.7, 0.5)  
20:3n-6 dihomo-γ-linolenic acid              
Mean ± SD  55.2 ± 6.4  55.2 ± 5.9  55.3 ± 6.3  54.6 ± 5.4  0.41  -0.3 (-0.8, 0.2)  
Adjusted differences  Reference  -0.1 (-1.8, 1.7)  -0.1 (-1.9, 1.7)  -0.5 (-2.3, 1.3)  0.60  -0.2 (-0.8, 0.4)  
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Withdrawn/depressed scores 
 Q1  Q2  Q3  Q4    Mean difference  
 n=111  n=111  n=111  n=111  P1  per 1 SD2  
 
n-6 PUFA, cont. 
 
            
20:4n-6 arachidonic acid              
Mean ± SD  55.8 ± 6.0  55.7 ± 6.8  54.6 ± 5.5  54.2 ± 5.5  0.01  -0.7 (-1.2, -0.1)  
Adjusted differences  Reference  -0.1 (-1.8, 1.7)  -1.3 (-2.9, 0.2)  -1.5 (-3.1, 0.1)  0.03  -0.6 (-1.1, 0.0)   
22:4n-6 adrenic acid              
Mean ± SD  55.7 ± 7.0  54.6 ± 5.5  55.8 ± 6.1  54.1 ± 5.2  0.15  -0.5 (-1.0, 0.1)  
Adjusted differences  Reference  -1.4 (-3.1, 0.2)  0.3 (-1.4, 2.0)  -1.5 (-3.0, 0.1)  0.25  -0.4 (-0.9, 0.2)  
              
Enzyme activity indices              
Δ6-desaturase 18:3n-6/18:2n-6              
Mean ± SD  55.9 ± 6.6  54.8 ± 5.7  54.7 ± 5.8  54.8 ± 5.8  0.26  -0.2 (-0.8, 0.4)  
Adjusted differences  Reference  -1.2 (-2.8, 0.5)  -1.6 (-3.2, 0.1)  -1.5 (-3.4, 0.3)  0.14  -0.3 (-1.1, 0.4)  
Δ5-desaturase 20:4n-6/20:3n-6              
Mean ± SD  54.8 ± 5.6  55.2 ± 6.1  56.0 ± 6.7  54.2 ± 5.4  0.48  -0.3 (-0.8, 0.2)  
Adjusted differences  Reference  0.4 (-1.2, 2.1)  1.1 (-0.6, 2.8)  -0.6 (-2.1, 0.9)  0.46  -0.3 (-0.8, 0.2)  
              
 
  
145 
 
Footnotes to Supplemental Table 4.5. 
 
1  Test for linear trend when a variable representing the median of each quartile was introduced into the linear regression model as a 
continuous predictor. Empirical estimates of the variance were specified in all models. 
 
2  From a linear regression model with withdrawn/depressed score as the outcome and % of total serum FA per 1 SD (continuous) as 
the predictor.  
 
3 Adjusted for child’s sex (dichotomous), child’s age at baseline (continuous), weekly hours spent watching television / playing 
video games (continuous), years of mother’s education (continuous) and mother’s BMI (continuous). n-3 and n-6 PUFA were 
adjusted for the continuous % of total serum FA per 1 SD of linoleic acid and α-linolenic acid, respectively. Long-chain FA were 
additionally adjusted for their immediate FA precursor(s) (continuous). Δ6-desaturase activity was additionally adjusted for α-
linolenic acid and linoleic acid (continuous). Δ5-desaturase activity was additionally adjusted for α-linolenic acid, γ-linolenic acid, 
and eicosadienoic acid (continuous). 
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Supplemental Table 4 6. Somatic complaints scores at 11-18 y of age according to serum fatty acid (FA) percentage weight 
concentration in middle childhood among children from Bogota, Colombia 
Somatic complaints scores 
 Q1  Q2  Q3  Q4    Mean difference  
 n=111  n=111  n=111  n=111  P1  per 1 SD2  
              
n-3 polyunsaturated FA (PUFA)              
18:3n-3 α-linolenic acid              
Mean ± SD  56.9 ± 7.2  56.5 ± 7.3  56.8 ± 7.8  57.3 ± 7.5  0.61  0.3 (-0.4, 1.1)  
Adjusted differences4  Reference  -0.2 (-2.1, 1.7)  0.0 (-2.0, 1.9)  0.6 (-1.3, 2.6)  0.49  0.5 (-0.2, 1.3)  
20:5n-3 eicosapentaenoic acid              
Mean ± SD  56.8 ± 7.0  56.7 ± 7.1  57.4 ± 8.4  56.6 ± 7.2  0.95  0.1 (-0.5, 0.8)  
Adjusted differences  Reference  0.1 (-1.8, 2.0)  0.9 (-1.2, 3.0)  0.4 (-1.5, 2.3)  0.51  0.4 (-0.3, 1.1)  
22:5n-3 docosapentaenoic acid              
Mean ± SD  57.4 ± 8.8  57.2 ± 6.7  55.9 ± 6.8  56.9 ± 7.2  0.55  -0.1 (-0.8, 0.6)  
Adjusted differences  Reference  -0.3 (-2.4, 1.7)  -1.3 (-3.4, 0.7)  0.3 (-1.9, 2.5)  0.84  0.2 (-0.5, 0.9)  
22:6n-3 docosahexaenoic acid              
Mean ± SD  57.4 ± 8.4  56.2 ± 7.1  57.2 ± 7.5  56.7 ± 6.7  0.64  0.3 (-0.6, 1.2)  
Adjusted differences  Reference  -0.9 (-2.9, 1.1)  -0.2 (-2.4, 1.9)  -0.5 (-2.5, 1.4)  0.76  0.4 (-0.5, 1.3)  
              
n-6 PUFA              
18:2n-6 linoleic acid              
Mean ± SD  56.2 ± 7.4  56.6 ± 7.4  57.5 ± 7.6  57.2 ± 7.5  0.25  0.3 (-0.4, 1.1)  
Adjusted differences  Reference  -0.1 (-2.0, 1.8)  1.0 (-1.0, 3.1)  0.8 (-1.2, 2.8)  0.32  0.4 (-0.5, 1.2)  
18:3n-6 γ-linolenic acid              
Mean ± SD  56.8 ± 7.6  57.5 ± 8.5  56.6 ± 6.6  56.5 ± 7.1  0.51  -0.3 (-1.0, 0.4)  
Adjusted differences  Reference  0.6 (-1.6, 2.7)  0.0 (-1.9, 1.9)  0.4 (-1.7, 2.5)  0.87  0.1 (-0.7, 0.8)  
20:2n-6 eicosadienoic acid              
Mean ± SD  56.4 ± 6.3  58.5 ± 9.6  56.7 ± 7.1  55.9 ± 6  0.25  -0.1 (-0.7, 0.4)  
Adjusted differences  Reference  2.0 (-0.2, 4.2)  0.1 (-1.8, 1.9)  -0.5 (-2.4, 1.5)  0.33  -0.1 (-0.7, 0.6)  
20:3n-6 dihomo-γ-linolenic acid              
Mean ± SD  56.4 ± 7.5  56.9 ± 7.7  57.3 ± 6.8  56.9 ± 7.8  0.63  0.1 (-0.6, 0.8)  
Adjusted differences  Reference  0.6 (-1.5, 2.7)  0.8 (-1.2, 2.8)  1.0 (-1.3, 3.3)  0.39  0.1 (-0.7, 0.9)  
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Somatic complaints scores 
 Q1  Q2  Q3  Q4    Mean difference  
 n=111  n=111  n=111  n=111  P1  per 1 SD2  
 
n-6 PUFA, cont. 
 
            
20:4n-6 arachidonic acid              
Mean ± SD  57.5 ± 8.4  56.5 ± 7.0  56.6 ± 7.3  56.8 ± 7.0  0.55  -0.4 (-1.2, 0.3)  
Adjusted differences  Reference  -1.3 (-3.3, 0.8)  -0.9 (-3.0, 1.3)  -0.7 (-2.8, 1.4)  0.64  -0.4 (-1.1, 0.4)  
22:4n-6 adrenic acid              
Mean ± SD  57.9 ± 7.7  56.9 ± 7.3  57.3 ± 8.1  55.5 ± 6.4  0.03  -0.7 (-1.3, 0.0)  
Adjusted differences  Reference  -1.0 (-2.9, 0.9)  0.1 (-2.0, 2.2)  -1.8 (-3.6, 0.0)  0.14  -0.4 (-1.1, 0.2)  
              
Enzyme activity indices              
Δ6-desaturase 18:3n-6/18:2n-6              
Mean ± SD  57.6 ± 8.3  56.5 ± 6.8  57.2 ± 7.4  56.3 ± 7.1  0.31  -0.4 (-1.1, 0.3)  
Adjusted differences  Reference  -0.9 (-2.9, 1.2)  -0.2 (-2.3, 1.9)  -0.3 (-2.6, 2.0)  0.97  0.0 (-0.8, 0.8)  
Δ5-desaturase 20:4n-6/20:3n-6              
Mean ± SD  57.5 ± 8.3  56.2 ± 6.8  57.9 ± 8.4  55.9 ± 5.8  0.23  -0.2 (-0.8, 0.3)  
Adjusted differences  Reference  -1.2 (-3.2, 0.8)  0.5 (-1.8, 2.8)  -1.8 (-3.8, 0.3)  0.21  -0.3 (-0.8, 0.3)  
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. 
Footnotes to Supplemental Table 4.6. 
 
1  Test for linear trend when a variable representing the median of each quartile was introduced into the linear regression model as a 
continuous predictor. Empirical estimates of the variance were specified in all models. 
 
2  From a linear regression model with somatic complaints score as the outcome and % of total serum FA per 1 SD (continuous) as 
the predictor.  
 
3 Adjusted for child’s sex (dichotomous), child’s age at baseline (continuous), weekly hours spent watching television / playing 
video games (continuous), years of mother’s education (continuous) and mother’s BMI (continuous). n-3 and n-6 PUFA were 
adjusted for the continuous % of total serum FA per 1 SD of linoleic acid and α-linolenic acid, respectively. Long-chain FA were 
additionally adjusted for their immediate FA precursor(s) (continuous). Δ6-desaturase activity was additionally adjusted for α-
linolenic acid and linoleic acid (continuous). Δ5-desaturase activity was additionally adjusted for α-linolenic acid, γ-linolenic acid, 
and eicosadienoic acid (continuous). 
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Chapter 5 Conclusions 
Summary of Findings 
This work generates new knowledge on the potential effects of nutritional exposures in 
middle childhood on externalizing and internalizing problems in adolescence.  
In Chapter 2, we found that ID, anemia, and low vitamin B-12 in middle childhood were 
positively associated with total externalizing problems among boys in Bogotá, Colombia. The 
association between low vitamin B-12 and total externalizing problems may be explained by 
higher aggressive behavior scores. In addition, ID was positively associated with total 
internalizing problems among boys, perhaps due to higher anxious/depressed and somatic 
complaints scores. These nutritional exposures in middle childhood were not associated with 
total externalizing or internalizing problems in adolescence among girls. Previous studies 
focused on iron status in infancy as an exposure. Chronic iron deficiency in infancy has been 
related to behavior problems in early and middle childhood, adolescence, and young adulthood 
(1-4). Iron is required for the production of the monoamine neurotransmitters (dopamine, 
serotonin, and norepinephrine) as well as gamma-aminobutyric acid and glutamate (5). In our 
population, anemia was not related to biomarkers of nutrients relevant to the hemoglobin 
metabolism, thus the nature of this association is uncertain. Anemia may be indicative of 
micronutrient deficiencies that we did not measure such as vitamin C or riboflavin. Vitamin B-12 
intake in adolescence has not been associated with behavior problems in cross-sectional studies 
(6-8). Vitamin B-12 is involved in the formation of S-adenosylmethionine, a precursor to the 
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monoamine neurotransmitters which govern mood and behavior, which has used to treat clinical 
depression in adults (9).  
In Chapter 3, we focus on vitamin D and its carrier protein, DBP, as exposures. VDD was 
positively associated with total externalizing problems. In addition, low DBP was related to 
higher aggressive behavior and anxious/depressed scores. The associations between DBP and 
behavior problems were not mediated by VDD. Previous findings on the association of vitamin 
D status and behavior problems have been inconsistent (10-14). Vitamin D deficiency alters 
dopamine metabolism and thus the vitamin may be related to the regulation of emotions and 
motivation. In middle childhood, VDD may regulate glial cell line-derived neurotrophic factor 
(15) which influences dopaminergic neuronal pruning (16). Our finding that low DBP 
concentration was associated with behavior problems is novel and hypothesis generating. DBP is 
involved in the innate immune response (17), which could influence behavior problems.  
Chapter 4 examines the associations of PUFA concentrations in middle childhood with 
total externalizing and internalizing problems in adolescence. The n-3 PUFA DPA was inversely 
associated with total externalizing problems, while DHA was positively related to this outcome. 
In addition, the D5D activity index was inversely related to total externalizing problems. ALA 
concentration was positively related to total internalizing problems, whereas AdA was inversely 
related to this outcome. Although not related to total externalizing or internalizing problems, AA 
was inversely associated with the behavior problems subscales rule breaking behavior and 
withdrawn/depressed scores. The positive association of DHA with total externalizing problems 
was unexpected, though consistent with several previous studies (18-20). A few rodent studies 
have found that DHA is related to delayed neurodevelopment (21, 22). Alternatively, limitations 
of observational studies may account for this positive association. For example, the association 
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between DHA and behavior problems may be confounded by environmental toxicants found in 
fatty fish, a dietary source of DHA. Mechanisms explaining the inverse associations of DPA, 
AA, and AdA with behavior problems are speculative. DPA and AA influence long-term 
potentiation of synapses in the striatum or the hippocampus, areas of the brain involved in 
behavior and cognition, whereas AdA may be involved in myelination (23). Since AA and the 
D5D activity index were both inversely related to rule breaking behavior scores, it is plausible 
that the associations with AA represent individual differences related to D5D activity. 
This dissertation has several strengths. The longitudinal study design minimizes the 
possibility of bias due to reverse causation. We used plasma or serum biomarkers to measure 
nutrient intake, which is considered an objective measurement method free of recall bias (24). 
Serum ferritin concentrations are adequately correlated with iron stores in the absence of 
inflammation (25). We excluded those with CRP >10 mg/L, thereby addressing inflammation. 
Total circulating 25(OH)D is considered the most complete way to capture vitamin D status, as it 
integrates dietary and sunlight sources of the vitamin (26). Serum biomarkers of FA adequately 
correlate with long-term intake of PUFA (27). In addition, the YSR is generalizable to many 
populations and widely used in epidemiologic research (28). We adjusted for key potential 
confounding variables collected at baseline including children’s BMI-for-age Z scores, time 
spent watching television or playing video games, maternal BMI, household food insecurity, and 
household socioeconomic status. 
There are some limitations as well. We do not have a baseline measurement of behavior 
problems in children and therefore do not know whether the problems measured in adolescence 
developed after the measurement of exposure or were present before. If behavior problems were 
already present at the time of enrollment and had caused changes in dietary behavior, reverse 
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causation cannot be ruled out as an explanation of the results. With regard to internalizing 
problems, reverse causation is unlikely, as average age of onset is during adolescence (29). 
Laboratory methods to quantify serum and plasma biomarkers may introduce random error. 
However, the majority of our coefficients of variation were low (<10%), which indicates small 
amounts of random error. Further, all exposures were assessed only once. However, for many of 
these biomarkers, a single measurement may adequately represent long-term intake (30, 31), and 
may therefore be representative of middle childhood exposure. If middle childhood nutrition is 
correlated with nutrition in other periods of development, then the results may reflect exposure at 
other ages rather than exposure in middle childhood. Ferritin, vitamin B-12, vitamin D, and 
PUFA concentrations may be correlated. However, we were unable to control for all dietary 
biomarker exposures in each Chapter as the study samples in Chapters 2-4 did not coincide. In 
addition, we were not able to control for several independent predictors of behavior problems, 
including genetics, parenting styles, and environmental toxicants. If these unmeasured 
independent predictors of the behavior problems are associated with the nutritional exposures of 
interest, then our results would be subject to residual confounding. Finally, our results may not 
be generalizable to children from the highest socioeconomic status, because they were not 
represented in this sample of children attending public school in Bogotá, Colombia.  
In conclusion, nutrition in middle childhood was associated with externalizing and 
internalizing problems in adolescence. Among boys, ID, anemia, and low vitamin B-12 were 
positively related to externalizing problems. ID was positively associated with internalizing 
problems among boys. VDD was associated with externalizing problems among boys and girls. 
Low DBP was related to high aggressive behavior and anxious/depressed scores. DPA and the 
D5D activity index were inversely related to externalizing problems whereas DHA was 
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positively associated with this outcome. ALA and AdA were positively and inversely related to 
internalizing problems, respectively. These results contribute knowledge on the relation between 
nutrition in middle childhood and adolescent behavior problems and may eventually form the 
basis for planning effective interventions in school-aged children.  
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Public Health Implications 
This dissertation represents a relatively comprehensive investigation of middle childhood 
diet in relation to adolescent behavior problems in the context of the BoSCCo study. Most 
studies conducted to date have only examined the influence of diet during the prenatal or infancy 
periods on child behavior problems. Middle childhood is a key period in cognitive development, 
as the frontal and temporal lobes undergo further changes (32). Many behavior problems first 
occur in adolescence (29). Thus, it is a critical time period to investigate behavior problem 
outcomes.  
We found that middle childhood ID, anemia, and low vitamin B-12 were associated with 
adolescent behavior problems among boys. As the association with ID is consistent with studies 
that have examined ID in infancy, results from this observational investigation could be the basis 
for the planning of intervention studies aimed at testing the effect of correcting ID or low vitamin 
B-12 in childhood on behavior problems later in life. In this population, administration of a 
school snack designed to provide 30, 50, and 40% of the recommended daily intake of energy, 
iron, and calcium, respectively, increased vitamin B-12 concentrations after approximately 3 
months (33). Public schools in Bogotá continue to administer this daily school snack. In addition, 
a limited number of schools with the necessary infrastructure provide a hot breakfast or lunch for 
their students. In 1996, Colombia mandated wheat flour fortification of iron and folate, however, 
vitamin B-12 fortification is not required by law (34). Daily vitamin supplementation or 
fortification of commonly eaten food sources could be implemented and scaled up at very low 
cost. School-based dietary interventions can be highly cost-effective, since they can be 
implemented as part of ongoing school nutrition programs.     
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The associations observed between middle childhood VDD and DBP concentrations are 
quite novel and need replication in other populations with different distributions of these 
nutrients or biomarkers. For example, the prevalence of VDD in Hispanic children in the United 
States is higher than the prevalence in our study (35, 36). To strengthen causal inference, future 
observational studies should use various informants to measure adolescent behavior problems. In 
addition, future studies should measure DBP with a polyclonal assay to account for potential 
confounding by isoform. If these results are replicated in future observational studies, then the 
planning of intervention studies would be warranted. Milk fortified with vitamin D increases 
25(OH)D concentrations in various populations (37). A school-based intervention in Bogotá 
could offer vitamin D fortified milk as part of the existing school snack program. DBP cannot be 
provided as a supplement, and there are few modifiable predictors of DBP concentration. 
Therefore, it would be difficult to intervene on DBP concentration. Associations between DPB 
and behavior may represent underlying genetic differences in children. If replicated, this finding 
could advance the etiologic understanding of adolescent behavior problems.  
The associations between PUFA concentrations and behavior problems also need 
replication in different populations. Future observational studies should investigate the PUFA 
metabolites DPA and AdA as exposures, since they may be important in the development of 
behavior problems. In addition, it would be valuable to elucidate the role of the D5D enzyme in 
the development of behavior problems. The D5D activity is regulated by genetic and 
environmental factors. Thus, future research could identify modifiable environmental factors that 
enhance the activity of this enzyme. The positive association between DHA concentrations and 
behavior problems should be interpreted with caution, since the observed association could be 
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confounded by intake of heavy metals or environmental pollutants, as these exposures are related 
to fatty fish intake, a source of preformed DHA.  
These studies are especially relevant because they took place among low- and middle- 
income schoolchildren in Bogotá, Colombia. Mental health is understudied in low- to middle-
income countries and often neglected in pediatric populations. Over the next 35 years, the 
number of children with psychiatric and developmental disorders is expected to increase in low- 
to middle-income countries (38), which largely do not have the resources to address psychiatric 
disorders adequately (39)  This is particularly relevant in a country like Colombia, which has 
been subjected to political and social unrest for the past 6 decades in what sociologists and 
historians call a new “culture of violence” (40) and thus may have a high prevalence of 
childhood behavior problems.  
Psychiatric and substance use disorders are the fifth leading cause of disability adjusted 
life years worldwide. They are the leading cause of years lived with disability (41). Externalizing 
problems are related to violent and criminal behavior (42), which may not only affect the 
immediate environment of children (e.g., family and school) but also adversely impact the 
dynamics of a society as a whole. Internalizing problems in adolescence are highly correlated 
with depressive and anxiety disorders in adults (43). Identifying modifiable predictors of 
externalizing and internalizing problems is the first step in lowering the burden of disease 
attributable to psychiatric disorders. 
In summation, this dissertation research shows that nutrition in middle childhood is 
associated with externalizing and internalizing problems in adolescence. As research on 
adolescent behavior problems and psychiatric disorders continues to advance, we anticipate that 
middle childhood and adolescence will be increasingly considered as critical periods in 
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development that are responsive to environmental conditions. With additional research on the 
correlates of nutrition in middle childhood with later behavioral health outcomes, these findings 
may have implications for planning effective intervention studies among school-aged children.  
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Future Directions 
 The work presented in this dissertation may eventually provide scientific rationale for 
planning school-based dietary interventions. However, several steps should be taken to 
strengthen causal inference before planning intervention studies. 
 First, the mechanisms presented throughout this dissertation are speculative. Most animal 
models focus on the effects of nutrition on central nervous system development in the prenatal 
period. Mechanisms in middle childhood are unknown. There are a variety of possible 
mechanisms; nutrition in middle childhood could alter synaptic plasticity, influence neuronal 
pruning, impact neurotransmitter metabolisms, or alter glial cell functioning. Identifying these 
mechanisms would provide biologic rationale for a long-term effect of nutrition in middle 
childhood on behavior. In addition, knowledge of the specific insults of nutritional deficiencies 
on brain development may allow future researchers to develop targeted interventions to restore 
optimal brain functioning. 
In this work, we were not able to account for nutrition in the prenatal or infancy period 
and thus cannot determine if the associations found in these studies represent the potential effect 
of middle childhood nutrition or the cumulative effect of early life and middle childhood 
nutrition. To isolate the critical period relevant to the development of behavior problems, future 
observational studies should control for nutrition in the prenatal or infancy period. If the results 
in this dissertation are replicated in studies which account for earlier nutrition, this would 
indicate that the association between nutrition in middle childhood and adolescent behavior 
problems is independent of nutrition earlier in life and strengthen justification for planning 
intervention studies among school-aged children.  
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 If these results are replicated in future observational studies, then testing the hypotheses 
examined in this work with the use of intervention studies would be warranted for some 
exposures examined. Since ID has known negative health effects (44), a randomized controlled 
trial of iron supplementation among children with ID would not be ethical. Randomized 
controlled trials of vitamin D fortification (45, 46) and fish oil supplementation (47, 48) 
conducted in school-aged children have good adherence and high short-term retention. Although 
resource intensive, an intervention study of vitamin D fortification, or vitamin B-12 or DPA 
supplementation with long-term follow-up would provide the strongest epidemiologic evidence 
for causal inference.   
Public health interventions would be merited if these results are replicated in intervention 
studies. In Colombia, fortification of wheat flour with vitamin B-12 or milk with vitamin D is not 
mandatory. I would recommend the addition of products made with vitamin B-12 fortified wheat 
flour and vitamin D fortified milk to the existing school snack program in Bogotá. Vitamin D 
fortification of milk is not required in many Latin American countries (49). Therefore, this 
recommendation could also apply to other countries in the region. Since the prevalence of ID, 
anemia, and VDD were low in our study, screening all schoolchildren to identify those with 
deficiencies or anemia would not be a cost-effective intervention strategy. However, in regions 
where the prevalence of nutritional deficiencies is higher, schools could partner with local 
pediatric clinics to detect children deficient in key nutrients through minimally invasive methods 
and provide supplementation to correct their deficiency.   
 In summary, investigations of the potential effects of middle childhood nutrition on later 
behavior problems are scant. Future research using animal models could identify mechanisms by 
which middle childhood nutrition affects brain development. In tandem, observational 
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epidemiologic research should work to isolate the effect of middle childhood nutrition on later 
behavior problems. Intervention studies of supplementation or fortification of commonly eaten 
foods would strengthen causal inference and could provide the basis for public health 
interventions at the local or national level.   
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Appendix – Associations between Examined Exposures  
The biomarker dietary exposures used across the three aims of this dissertation may be 
correlated. Although it is challenging to properly examine this overlap given that the study 
samples do not coincide, our objective was to present the associations between exposures where 
data was available. 
 Among children with plasma 25-hydroxy vitamin D and vitamin D binding protein 
measured, 8 and 5 children had ID and anemia, respectively. Among children with ID, 37.5% 
were VDD compared with 10.3% of children without ID. None of the anemic children were 
VDD. Among children with low vitamin B-12, 16.7% were VDD; 9.8% of children without low 
vitamin B-12 were VDD. However, there were no statistically significant associations between 
VDD or low DBP with ID, anemia, and low vitamin B-12 (Table 1).  
Among children with PUFA concentration ascertained, 13, 14, and 25 children had ID, 
anemia, and VDD, respectively. ID and anemia were not associated with n-3 or n-6 PUFA 
concentrations or with the D6D or D5D enzyme activity indices (Table 2). Low vitamin B-12 
was positively associated with GLA and DGLA concentrations as well as the D6D activity index 
and inversely associated with AdA concentrations and the D5D activity index. VDD was 
positively associated with ALA concentrations and inversely associated with AA concentrations 
and the D6D and D5D activity indices. DBP was not associated with PUFA concentrations or 
with the D6D or D5D activity indices (Table 2). 
Given these associations, some of the results observed in aims 2 and 3 of this dissertation 
may be confounded by other nutritional exposures. For instance, the inverse association between 
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D5D and externalizing problems may be confounded by low vitamin B-12 or VDD, which were 
each positively associated with externalizing problems. If we had been able to control for low 
vitamin B-12 or VDD, the inverse association between D5D and externalizing problems would 
likely have been attenuated.  
When nutritional exposures share a common food source or enzyme activity may be 
influenced by nutritional deficiencies, future studies should examine the joint distributions of 
nutritional status biomarkers to determine whether to control for other nutritional exposures. 
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Table 6.1. Associations between vitamin D deficiency and low vitamin D binding protein with 
iron deficiency, anemia, and low vitamin B-12 concentration in middle childhood 
 
 
 
Nutritional characteristic 
 
 
Vitamin D 
deficiency1 
 Low vitamin 
D binding 
protein2  
   n  %  n  % 
          
Iron deficiency3          
Yes   8  37.5  8  62.5 
No   213  10.3  213  48.8 
P4     0.17    0.45 
          
Anemia5          
Yes   5  0.0  5  60.0 
No   217  11.5  217  49.3 
P     0.54    0.64 
          
Low vitamin B-126          
Yes   54  16.7  54  42.6 
No   164  9.8  164  52.4 
P     0.22    0.21 
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Footnotes to Table 6.1 
 
1 Plasma 25(OH)D <50 nmol/L. 
 
2 Plasma vitamin D binding protein <2497 nmol/L. 
 
3 Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis. 
 
4 χ2 score test statistic from Poisson regression with vitamin D deficiency or low vitamin D 
binding protein as the dichotomous outcome. Empirical estimates were used in all models. 
Fisher’s exact test for anemia and vitamin D deficiency.   
 
5 Hemoglobin <12.7 g/dL. 
 
6 Plasma vitamin B-12 in quartile 1 (median boys: 204 pmol/L, girls: 218 pmol/L). 
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Table 6.2. Polyunsaturated fatty acid serum percentage weight concentration and enzyme activity indices according to categories of 
micronutrient status indicators among schoolchildren from Bogotá, Colombia 
 
Nutritional characteristic 
 n-3 polyunsaturated fatty acid (PUFA)1  n-6 PUFA  Enzyme activity indices 
 18:3n-3  20:5n-3  22:5n-3  22:6n-3   18:2n-6  18:3n-6  20:2n-6  20:3n-6  20:4n-6  22:4n-6   GLA/LA AA/DGLA 
n ALA EPA DPA DHA  LA GLA EDA DGLA AA AdA  Δ6-desaturase Δ5-desaturase 
                
Iron deficiency2                
Yes 13 0.5 ± 0.1 0.2 ± 0.1 0.5 ± 0.2 2.4 ± 1.1  31.1 ± 2.9 0.3 ± 0.1 0.3 ± 0.1 1.6 ± 0.2 5.9 ± 1.0 3.3 ± 1.0  0.008 ± 0.003 3.8 ± 0.8 
No 428 0.5 ± 0.1 0.2 ± 0.1 0.5 ± 0.2 2.2 ± 0.9  30.6 ± 3.0 0.3 ± 0.2 0.3 ± 0.1 1.6 ± 0.4 6.0 ± 1.2 3.1 ± 1.2    0.01 ± 0.006 4.0 ± 1.5 
P3  0.59 0.89 0.22 0.54  0.54 0.09 0.71 0.82 0.72 0.63  0.06 0.44 
                
Anemia4                
Yes 14 0.5 ± 0.2 0.2 ± 0.2 0.5 ± 0.2 2.6 ± 1.2  31.2 ± 2.4 0.2 ± 0.1 0.3 ± 0.1 1.4 ± 0.4 6.4 ± 1.0 3.4 ± 1.1  0.008 ± 0.004 4.9 ± 2.1 
No 430 0.5 ± 0.1 0.2 ± 0.1 0.5 ± 0.2 2.2 ± 0.9  30.6 ± 3.0 0.3 ± 0.2 0.3 ± 0.1 1.6 ± 0.4 6.0 ± 1.2 3.1 ± 1.2    0.01 ± 0.006 4.0 ± 1.5 
P  0.88 0.34 0.56 0.24  0.36 0.10 0.70 0.20 0.14 0.45  0.08 0.10 
                
Low vitamin B-125                
Yes 121 0.5 ± 0.1 0.2 ± 0.1 0.5 ± 0.2 2.1 ± 0.9  30.3 ± 3.0 0.3 ± 0.2 0.3 ± 0.1 1.7 ± 0.4 6.0 ± 1.1 3.0 ± 1.1  0.01 ± 0.007 3.8 ± 1.1 
No 310 0.5 ± 0.1 0.2 ± 0.1 0.5 ± 0.2 2.3 ± 0.9  30.8 ± 3.0 0.3 ± 0.1 0.3 ± 0.1 1.6 ± 0.4 6.1 ± 1.2 3.2 ± 1.2  0.01 ± 0.006 4.1 ± 1.6 
P  0.59 0.08 0.68 0.12  0.12 0.01 0.93 0.04  0.33 0.03   0.01 0.02 
                
Vitamin D deficiency6                
Yes 25 0.6 ± 0.1 0.2 ± 0.1 0.4 ± 0.1 2.4 ± 0.8  30.8 ± 3.2 0.3 ± 0.1 0.3 ± 0.1 1.6 ± 0.2 5.3 ± 0.9 3.0 ± 1.2  0.008 ± 0.004 3.5 ± 0.9 
No 197 0.5 ± 0.1 0.2 ± 0.1 0.4 ± 0.2 2.6 ± 1.1  30.2 ± 2.9 0.3 ± 0.2 0.3 ± 0.1 1.6 ± 0.4 5.9 ± 1.1 3.1 ± 1.0    0.01 ± 0.006 4.0 ± 1.8 
P  0.03 0.43 0.58 0.25  0.34 0.09 0.70 0.61 0.01 0.69  0.06 0.03 
                
Low vitamin D binding  
protein7      
 
         
Yes 110 0.5 ± 0.1 0.2 ± 0.1 0.4 ± 0.2 2.7 ± 1.1  30.5 ± 2.9 0.3 ± 0.1 0.3 ± 0.1 1.6 ± 0.3 5.9 ± 1.2 3.1 ± 1.1  0.01 ± 0.005 4.0 ± 2.2 
No 112 0.5 ± 0.1 0.2 ± 0.1 0.4 ± 0.1 2.6 ± 0.9  29.9 ± 3.0 0.3 ± 0.2 0.3 ± 0.1 1.6 ± 0.4 5.9 ± 1.1 3.1 ± 0.9  0.01 ± 0.006 3.8 ± 1.1 
P  0.91 0.22 0.76 0.64  0.12 0.39 0.12 0.56 0.85 0.66  0.24 0.54 
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Footnotes to Table 6.2 
 
1 Mean ± SD of serum fatty acid percentage weight concentration. Abbreviations are as follows: 
alpha-linolenic acid, ALA; eicosapentaenoic acid, EPA; docosapentaenoic acid, DPA; 
docosahexaenoic acid, DHA; linoleic acid, LA; gamma-linolenic acid, GLA; eicosadienoic acid, 
EDA; dihomo-gamma-linolenic acid, DGLA; arachidonic acid, AA; and adrenic acid, AdA. 
 
2 χ2 score test statistic from linear regression with PUFA percentage weight concentration as the 
continuous outcome. Empirical estimates were used in all models.   
 
3 Plasma ferritin concentration <15 µg/L. 13 children with CRP >10 mg/L were excluded from 
the analysis. 
 
4 Hemoglobin <12.7 g/dL. 
 
5 Plasma vitamin B-12 in quartile 1 (median boys: 204 pmol/L, girls: 218 pmol/L). 
 
6 Plasma 25(OH)D <50 nmol/L. 
 
7 Plasma vitamin D binding protein <2497 nmol/L. 
